GLI3 (GLI family zinc finger 3) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: GLI3 (GLI family zinc finger 3) Homo sapiens
Analyze
Symbol: GLI3
Name: GLI family zinc finger 3
RGD ID: 1314553
HGNC Page HGNC:4319
Description: Enables several functions, including beta-catenin binding activity; enzyme binding activity; and mediator complex binding activity. Involved in several processes, including negative regulation of canonical Wnt signaling pathway; regulation of DNA-templated transcription; and smoothened signaling pathway. Acts upstream of or within negative regulation of transcription by RNA polymerase II. Located in GLI-SUFU complex; cilium; and nuclear lumen. Implicated in Greig cephalopolysyndactyly syndrome; Pallister-Hall syndrome; anodontia; polydactyly; and syndactyly. Biomarker of liver cirrhosis.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: ACLS; DNA-binding protein; GCPS; GLI-Kruppel family member GLI3; GLI3 form of 190 kDa; GLI3 full length protein; GLI3-190; GLI3FL; glioma-associated oncogene family zinc finger 3; oncogene GLI3; PAP-A; PAPA; PAPA1; PAPB; PHS; PPDIV; transcriptional activator GLI3; zinc finger protein GLI3
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38741,960,949 - 42,264,268 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl741,960,949 - 42,264,100 (-)EnsemblGRCh38hg38GRCh38
GRCh37742,000,547 - 42,276,808 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36741,967,072 - 42,243,137 (-)NCBINCBI36Build 36hg18NCBI36
Build 34741,776,919 - 42,036,135NCBI
Celera741,991,319 - 42,267,350 (-)NCBICelera
Cytogenetic Map7p14.1NCBI
HuRef741,885,427 - 42,162,362 (-)NCBIHuRef
CHM1_1742,003,855 - 42,280,223 (-)NCBICHM1_1
T2T-CHM13v2.0742,119,298 - 42,422,619 (-)NCBIT2T-CHM13v2.0
CRA_TCAGchr7v2742,040,400 - 42,316,460 (-)NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(-)-epigallocatechin 3-gallate  (EXP)
1,2-dimethylhydrazine  (ISO)
17beta-estradiol  (EXP,ISO)
2,3,7,8-tetrachlorodibenzodioxine  (ISO)
2,3,7,8-Tetrachlorodibenzofuran  (ISO)
2-hydroxypropanoic acid  (EXP)
6-propyl-2-thiouracil  (ISO)
Ac-Ser-Asp-Lys-Pro-OH  (EXP,ISO)
aflatoxin B1  (EXP)
antimycin A  (EXP)
antirheumatic drug  (EXP)
aristolochic acid A  (EXP)
Aroclor 1254  (ISO)
arsane  (EXP)
arsenic atom  (EXP)
arsenous acid  (EXP)
atrazine  (ISO)
azoxystrobin  (EXP)
benzo[a]pyrene  (EXP,ISO)
benzo[a]pyrene diol epoxide I  (EXP)
bisphenol A  (EXP,ISO)
bromobenzene  (ISO)
cadmium atom  (EXP)
cadmium dichloride  (EXP,ISO)
caffeine  (EXP)
captopril  (EXP,ISO)
carbon nanotube  (ISO)
CGP 52608  (EXP)
chlorpyrifos  (ISO)
choline  (ISO)
chromium(6+)  (EXP)
cisplatin  (EXP)
copper atom  (EXP)
copper(0)  (EXP)
cyclosporin A  (EXP)
deguelin  (EXP)
dextran sulfate  (ISO)
diarsenic trioxide  (EXP)
dibutyl phthalate  (ISO)
dorsomorphin  (EXP)
epoxiconazole  (ISO)
ethanol  (ISO)
fenpyroximate  (EXP)
folic acid  (ISO)
gentamycin  (ISO)
goralatide  (EXP,ISO)
iron atom  (EXP)
iron(0)  (EXP)
L-methionine  (ISO)
melphalan  (EXP)
methimazole  (ISO)
methylmercury chloride  (EXP)
miconazole  (ISO)
mono(2-ethylhexyl) phthalate  (EXP)
N-ethyl-N-nitrosourea  (ISO)
N-methyl-4-phenylpyridinium  (ISO)
ochratoxin A  (ISO)
paracetamol  (EXP)
phenylmercury acetate  (EXP)
picoxystrobin  (EXP)
potassium chromate  (EXP)
Ptaquiloside  (ISO)
pyrimidifen  (EXP)
rac-lactic acid  (EXP)
rotenone  (EXP)
SB 431542  (EXP)
silicon dioxide  (ISO)
sodium arsenite  (ISO)
succimer  (EXP,ISO)
sunitinib  (EXP)
titanium dioxide  (ISO)
trichostatin A  (EXP)
valproic acid  (EXP,ISO)
vismodegib  (EXP)
zinc oxide  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
alpha-beta T cell differentiation  (IEA,ISO)
anatomical structure formation involved in morphogenesis  (IEA,ISO)
anterior semicircular canal development  (IEA,ISO)
anterior/posterior pattern specification  (IEA,ISO)
apoptotic process  (IEA,ISO)
artery development  (IEA,ISO)
axon guidance  (IEA,ISO)
brain development  (IEA,ISO)
branching involved in ureteric bud morphogenesis  (IEA,ISO)
branching morphogenesis of an epithelial tube  (IEA,ISO)
camera-type eye development  (IEA,ISO)
camera-type eye morphogenesis  (IEA,ISO)
cell differentiation involved in kidney development  (IEA,ISO)
cell population proliferation  (IEA,ISO)
central nervous system development  (IEA,ISO)
cerebral cortex radial glia-guided migration  (IEA,ISO)
chondrocyte differentiation  (IEA,ISO)
developmental growth  (IEA,ISO)
dorsal/ventral pattern formation  (IEA,ISO)
embryonic digestive tract development  (IEA,ISO,TAS)
embryonic digestive tract morphogenesis  (IEA,ISO)
embryonic digit morphogenesis  (IEA,ISO,TAS)
embryonic limb morphogenesis  (IEA,ISO)
embryonic morphogenesis  (IEA,ISO)
embryonic neurocranium morphogenesis  (IEA,ISO)
embryonic skeletal system morphogenesis  (IEA,ISO)
forebrain development  (IEA,ISO)
forebrain dorsal/ventral pattern formation  (IEA,ISO)
forebrain radial glial cell differentiation  (IEA,ISO)
frontal suture morphogenesis  (IEA,ISO)
gene expression  (IEA,ISO)
heart development  (IEA,ISO)
hindgut morphogenesis  (IEA,ISO)
hippocampus development  (IEA,ISO)
in utero embryonic development  (IEA,ISO)
inner ear development  (IEA,ISO)
kidney development  (IEA,ISO)
lambdoid suture morphogenesis  (IEA,ISO)
larynx morphogenesis  (IEA,ISO)
lateral ganglionic eminence cell proliferation  (IEA,ISO)
lateral semicircular canal development  (IEA,ISO)
layer formation in cerebral cortex  (IEA,ISO)
limb development  (IEA)
limb morphogenesis  (IEA,IMP,ISO)
liver regeneration  (ISO)
lung development  (IEA,ISO)
mammary gland development  (IEA,ISO)
mammary gland specification  (IEA,ISO)
melanocyte differentiation  (IEA,ISO)
metanephros development  (IEA,ISO)
negative regulation of alpha-beta T cell differentiation  (IEA,ISS)
negative regulation of apoptotic process  (IEA,ISO)
negative regulation of canonical Wnt signaling pathway  (IDA)
negative regulation of cell population proliferation  (IEA,ISO)
negative regulation of chondrocyte differentiation  (IEA,ISO)
negative regulation of DNA-templated transcription  (IDA,IEA,ISO)
negative regulation of neuron differentiation  (IEA,ISO)
negative regulation of smoothened signaling pathway  (IEA,ISS)
negative regulation of stem cell proliferation  (IEA,ISO)
negative regulation of transcription by RNA polymerase II  (IDA)
negative thymic T cell selection  (IEA,ISS)
neural tube development  (IEA,ISO)
neuroblast proliferation  (IEA,ISO)
neuron differentiation  (IEA,ISO)
neuron fate commitment  (IEA,ISO)
nose morphogenesis  (TAS)
odontogenesis of dentin-containing tooth  (IEA,ISO)
oligodendrocyte differentiation  (IEA,ISO)
optic nerve morphogenesis  (IEA,ISO)
osteoblast differentiation  (IEA,ISO)
pallium development  (IEA,ISO)
pattern specification process  (IEA,ISO)
positive regulation of alpha-beta T cell differentiation  (IEA,ISS)
positive regulation of chondrocyte differentiation  (IEA,ISO)
positive regulation of DNA-templated transcription  (IEA,ISO,ISS)
positive regulation of neuroblast proliferation  (IEA,ISO)
positive regulation of osteoblast differentiation  (IEA,ISO)
positive regulation of protein import into nucleus  (IEA,ISO)
positive regulation of transcription by RNA polymerase II  (IDA,IEA,IMP)
prostate gland development  (ISO)
protein import into nucleus  (IEA,ISO)
protein processing  (IEA,ISO)
proximal/distal pattern formation  (IEA,ISO)
regulation of apoptotic process  (IEA,ISO)
regulation of bone development  (IEA,ISO)
regulation of cell differentiation  (IEA,ISO)
regulation of cell population proliferation  (IEA,ISO)
regulation of DNA-templated transcription  (IDA,IEA,ISO)
regulation of gene expression  (IEA,ISO)
regulation of smoothened signaling pathway  (IEA,ISO)
regulation of transcription by RNA polymerase II  (IBA,IEA)
response to estrogen  (ISO)
roof of mouth development  (IEA,ISO)
sagittal suture morphogenesis  (IEA,ISO)
smoothened signaling pathway  (IBA,IDA,IEA,ISO,TAS)
smoothened signaling pathway involved in dorsal/ventral neural tube patterning  (IEA,ISO)
smoothened signaling pathway involved in spinal cord motor neuron cell fate specification  (IEA,ISO)
smoothened signaling pathway involved in ventral spinal cord interneuron specification  (IEA,ISO)
spinal cord dorsal/ventral patterning  (IEA,ISO)
spinal cord motor neuron differentiation  (IEA,ISO)
stem cell proliferation  (IEA,ISO)
subpallium development  (IEA,ISO)
T cell differentiation in thymus  (IEA,ISO,ISS)
telencephalon development  (IEA,ISO)
thymocyte apoptotic process  (IEA,ISS)
tongue development  (IEA,ISO)
tube development  (IEA,ISO)
vocalization behavior  (IEA,ISO)

Cellular Component

Molecular Pathway Annotations     Click to see Annotation Detail View
Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
1-3 toe syndactyly  (IAGP)
1-5 toe syndactyly  (IAGP)
3-4 finger cutaneous syndactyly  (IAGP)
3-4 finger syndactyly  (IAGP)
Abnormal basal ganglia MRI signal intensity  (IAGP)
Abnormal calvaria morphology  (IAGP)
Abnormal clavicle morphology  (IAGP)
Abnormal corpus callosum morphology  (IAGP)
Abnormal heart morphology  (IAGP)
Abnormal lung lobation  (IAGP)
Abnormal muscle fiber morphology  (IAGP)
Abnormal prolactin level  (IAGP)
Abnormality of prenatal development or birth  (IAGP)
Absent hallux  (IAGP)
Absent radius  (IAGP)
Absent tibia  (IAGP)
Accelerated skeletal maturation  (IAGP)
Accessory oral frenulum  (IAGP)
Adrenal hypoplasia  (IAGP)
Adrenocorticotropic hormone deficiency  (IAGP)
Agenesis of corpus callosum  (IAGP)
Ambiguous genitalia  (IAGP)
Anal atresia  (IAGP)
Anteriorly placed anus  (IAGP)
Anteverted nares  (IAGP)
Aplasia of the 2nd metacarpal  (IAGP)
Aplasia of the 4th metacarpal  (IAGP)
Aplasia/Hypoplasia of the cerebellum  (IAGP)
Aplasia/Hypoplasia of the corpus callosum  (IAGP)
Aplasia/hypoplasia of the uterus  (IAGP)
Aplasia/Hypoplasia of the vagina  (IAGP)
Arrhinencephaly  (IAGP)
Atresia of the external auditory canal  (IAGP)
Atrial septal defect  (IAGP)
Atrioventricular canal defect  (IAGP)
Auricular tag  (IAGP)
Autosomal dominant inheritance  (IAGP)
Babinski sign  (IAGP)
Basilar invagination  (IAGP)
Bifid epiglottis  (IAGP)
Bifid uvula  (IAGP)
Bilateral postaxial polydactyly  (IAGP)
Bilateral renal agenesis  (IAGP)
Brachydactyly  (IAGP)
Broad hallux  (IAGP)
Broad hallux phalanx  (IAGP)
Broad thumb  (IAGP)
Broad toe  (IAGP)
Camptodactyly of toe  (IAGP)
Central adrenal insufficiency  (IAGP)
Cerebellar hypoplasia  (IAGP)
Choanal atresia  (IAGP)
Cleft lip  (IAGP)
Cleft palate  (IAGP)
Cleft upper lip  (IAGP)
Coarctation of aorta  (IAGP)
Congenital diaphragmatic hernia  (IAGP)
Congenital onset  (IAGP)
Coxa valga  (IAGP)
Craniosynostosis  (IAGP)
Cryptorchidism  (IAGP)
Cutaneous finger syndactyly  (IAGP)
Dandy-Walker malformation  (IAGP)
Decreased circulating cortisol level  (IAGP)
Decreased response to growth hormone stimulation test  (IAGP)
Decreased testicular size  (IAGP)
Delayed cranial suture closure  (IAGP)
Depressed nasal bridge  (IAGP)
Depressed nasal ridge  (IAGP)
Distal arthrogryposis  (IAGP)
Distal shortening of limbs  (IAGP)
Distal urethral duplication  (IAGP)
Dolichocephaly  (IAGP)
Downslanted palpebral fissures  (IAGP)
Duplication of thumb phalanx  (IAGP)
Dysplastic distal thumb phalanges with a central hole  (IAGP)
Ectopic kidney  (IAGP)
Facial grimacing  (IAGP)
Finger syndactyly  (IAGP)
Focal emotional seizure with laughing  (IAGP)
Foot oligodactyly  (IAGP)
Frontal bossing  (IAGP)
Functional motor deficit  (IAGP)
Generalized dystonia  (IAGP)
Global developmental delay  (IAGP)
Gonadotropin deficiency  (IAGP)
Hand polydactyly  (IAGP)
Hearing impairment  (IAGP)
Hemivertebrae  (IAGP)
Hepatoblastoma  (IAGP)
High forehead  (IAGP)
Hip dislocation  (IAGP)
Hip dysplasia  (IAGP)
Hirsutism  (IAGP)
Holoprosencephaly  (IAGP)
Hydrocephalus  (IAGP)
Hydrometrocolpos  (IAGP)
Hydronephrosis  (IAGP)
Hydroureter  (IAGP)
Hyperglycemia  (IAGP)
Hyperreflexia  (IAGP)
Hypertelorism  (IAGP)
Hypopituitarism  (IAGP)
Hypoplasia of the epiglottis  (IAGP)
Hypospadias  (IAGP)
Hypothalamic hamartoma  (IAGP)
Increased laxity of ankles  (IAGP)
Inguinal hernia  (IAGP)
Intellectual disability  (IAGP)
Intellectual disability, mild  (IAGP)
Intellectual disability, severe  (IAGP)
Intrauterine growth retardation  (IAGP)
Joint contracture of the hand  (IAGP)
Knee flexion contracture  (IAGP)
Large for gestational age  (IAGP)
Laryngeal cleft  (IAGP)
Low-set, posteriorly rotated ears  (IAGP)
Macrocephaly  (IAGP)
Mesoaxial foot polydactyly  (IAGP)
Mesoaxial hand polydactyly  (IAGP)
Mesoaxial polydactyly  (IAGP)
Mesomelia  (IAGP)
Mesomelic leg shortening  (IAGP)
Metatarsus adductus  (IAGP)
Metopic synostosis  (IAGP)
Microglossia  (IAGP)
Micropenis  (IAGP)
Microphthalmia  (IAGP)
Microretrognathia  (IAGP)
Microtia  (IAGP)
Midline facial capillary hemangioma  (IAGP)
Myelomeningocele  (IAGP)
Nail dysplasia  (IAGP)
Natal tooth  (IAGP)
Neonatal death  (IAGP)
Oligodactyly  (IAGP)
Oligohydramnios  (IAGP)
Osteochondroma  (IAGP)
Overlapping toe  (IAGP)
Panhypopituitarism  (IAGP)
Paroxysmal bursts of laughter  (IAGP)
Partial absence of foot  (IAGP)
Patent ductus arteriosus  (IAGP)
Pituitary hypothyroidism  (IAGP)
Pleomorphic xanthoastrocytoma  (IAGP)
Polydactyly  (IAGP)
Polydactyly affecting the 3rd finger  (IAGP)
Polydactyly affecting the 4th finger  (IAGP)
Polysyndactyly of hallux  (IAGP)
Postaxial foot polydactyly  (IAGP)
Postaxial hand polydactyly  (IAGP)
Postaxial polydactyly  (IAGP)
Postaxial polydactyly type A  (IAGP)
Posteriorly rotated ears  (IAGP)
Preaxial foot polydactyly  (IAGP)
Preaxial hand polydactyly  (IAGP)
Preaxial polydactyly  (IAGP)
Precocious puberty  (IAGP)
Preductal coarctation of the aorta  (IAGP)
Primary adrenal insufficiency  (IAGP)
Prominent occiput  (IAGP)
Proximal tibial and fibular fusion  (IAGP)
Ptosis  (IAGP)
Radial bowing  (IAGP)
Radial club hand  (IAGP)
Radial head subluxation  (IAGP)
Recurrent upper and lower respiratory tract infections  (IAGP)
Renal cyst  (IAGP)
Renal dysplasia  (IAGP)
Renal hypoplasia  (IAGP)
Respiratory insufficiency  (IAGP)
Rib fusion  (IAGP)
Rudimentary to absent tibiae  (IAGP)
Scaphocephaly  (IAGP)
Secondary growth hormone deficiency  (IAGP)
Seizure  (IAGP)
Sensorineural hearing impairment  (IAGP)
Short 4th metacarpal  (IAGP)
Short nose  (IAGP)
Short palpebral fissure  (IAGP)
Short stature  (IAGP)
Short tibia  (IAGP)
Skeletal dysplasia  (IAGP)
Sloping forehead  (IAGP)
Small scrotum  (IAGP)
Split foot  (IAGP)
Split hand  (IAGP)
Supernumerary metacarpal bones  (IAGP)
Syndactyly  (IAGP)
Talipes  (IAGP)
Talipes equinovarus  (IAGP)
Tall stature  (IAGP)
Tarsal synostosis  (IAGP)
Telecanthus  (IAGP)
Thyroid dysgenesis  (IAGP)
Thyroid hypoplasia  (IAGP)
Toe syndactyly  (IAGP)
Trigonocephaly  (IAGP)
Triphalangeal thumb  (IAGP)
Umbilical hernia  (IAGP)
Unilateral renal agenesis  (IAGP)
Variable expressivity  (IAGP)
Ventricular septal defect  (IAGP)
Ventriculomegaly  (IAGP)
Wide anterior fontanel  (IAGP)
Wide nasal bridge  (IAGP)
Y-shaped metacarpals  (IAGP)
References

References - curated
# Reference Title Reference Citation
1. Pallister-Hall syndrome phenotype in mice mutant for Gli3. Böse J, etal., Hum Mol Genet. 2002 May 1;11(9):1129-35.
2. Dynamic changes of Sonic Hedgehog signaling pathway in gastric mucosa of rats with MNNG-induced gastric precancerous lesions. Cai D, etal., J Cell Physiol. 2019 Jul;234(7):10827-10834. doi: 10.1002/jcp.27908. Epub 2018 Dec 7.
3. The expression of Gli3, regulated by HOXD13, may play a role in idiopathic congenital talipes equinovarus. Cao D, etal., BMC Musculoskelet Disord. 2009 Nov 19;10:142. doi: 10.1186/1471-2474-10-142.
4. Crossed polydactyly type I caused by a point mutation in the GLI3 gene in a large Chinese pedigree. Cheng B, etal., J Clin Lab Anal. 2006;20(4):133-8.
5. Hedgehog signaling update. Cohen MM, Am J Med Genet A. 2010 Aug;152A(8):1875-914. doi: 10.1002/ajmg.a.32909.
6. New insights into genotype-phenotype correlation for GLI3 mutations. Démurger F, etal., Eur J Hum Genet. 2015 Jan;23(1):92-102. doi: 10.1038/ejhg.2014.62. Epub 2014 Apr 16.
7. Molecular analysis of non-syndromic preaxial polydactyly: preaxial polydactyly type-IV and preaxial polydactyly type-I. Fujioka H, etal., Clin Genet. 2005 May;67(5):429-33.
8. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
9. Gli3-deficient mice exhibit cleft palate associated with abnormal tongue development. Huang X, etal., Dev Dyn. 2008 Oct;237(10):3079-87. doi: 10.1002/dvdy.21714.
10. Expanded mutational spectrum of the GLI3 gene substantiates genotype-phenotype correlations. Jamsheer A, etal., J Appl Genet. 2012 Nov;53(4):415-22. doi: 10.1007/s13353-012-0109-x. Epub 2012 Aug 18.
11. Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations. Johnston JJ, etal., Am J Hum Genet. 2005 Apr;76(4):609-22. Epub 2005 Feb 28.
12. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Jones S, etal., Science. 2008 Sep 26;321(5897):1801-6. Epub 2008 Sep 4.
13. Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome. Kalff-Suske M, etal., Hum Mol Genet. 1999 Sep;8(9):1769-77.
14. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Kang S, etal., Nat Genet. 1997 Mar;15(3):266-8.
15. Murine models of VACTERL syndrome: Role of sonic hedgehog signaling pathway. Kim PC, etal., J Pediatr Surg. 2001 Feb;36(2):381-4. doi: 10.1053/jpsu.2001.20722.
16. Replicated anterior zeugopod (raz): a polydactylous mouse mutant with lowered Shh signaling in the limb bud. Krebs O, etal., Development. 2003 Dec;130(24):6037-47.
17. Gli3 is a novel downstream target of miR‑200a with an anti‑fibrotic role for progression of liver fibrosis in vivo and in vitro. Li L, etal., Mol Med Rep. 2020 Apr;21(4):1861-1871. doi: 10.3892/mmr.2020.10997. Epub 2020 Feb 21.
18. A case-control study of the association between tooth-development gene polymorphisms and non-syndromic hypodontia in the Chinese Han population. Liu H, etal., Eur J Oral Sci. 2012 Oct;120(5):378-85. doi: 10.1111/j.1600-0722.2012.00986.x. Epub 2012 Aug 18.
19. Genetic research and structural dysplasia assessment of anorectal malformations in neonatal male rats induced by di(n-butyl) phthalate. Liu ZH, etal., Environ Toxicol. 2016 Mar;31(3):261-8. doi: 10.1002/tox.22040. Epub 2014 Sep 12.
20. A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy. Matera I, etal., Hum Mol Genet. 2008 Jul 15;17(14):2118-31. doi: 10.1093/hmg/ddn110. Epub 2008 Apr 7.
21. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies. Mimeault M and Batra SK, Pharmacol Rev. 2010 Sep;62(3):497-524.
22. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
23. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
24. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
25. Mutation in GLI3 in postaxial polydactyly type A. Radhakrishna U, etal., Nat Genet. 1997 Nov;17(3):269-71.
26. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
27. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
28. RGD HPO Phenotype Annotation Pipeline RGD automated import pipeline for human HPO-to-gene-to-disease annotations
29. The mouse mutation Pdn (Polydactyly Nagoya) is caused by the integration of a retrotransposon into the Gli3 gene. Thien H and Rüther U, Mamm Genome. 1999 Mar;10(3):205-9.
30. A novel GLI3 mutation affecting the zinc finger domain leads to preaxial-postaxial polydactyly-syndactyly complex. Volodarsky M, etal., BMC Med Genet. 2014 Sep 30;15:110. doi: 10.1186/s12881-014-0110-9.
31. A hypermorphic mouse Gli3 allele results in a polydactylous limb phenotype. Wang C, etal., Dev Dyn. 2007 Mar;236(3):769-76.
32. Novel frame-shift mutations of GLI3 gene in non-syndromic postaxial polydactyly patients. Wang Z, etal., Clin Chim Acta. 2014 Jun 10;433:195-9. doi: 10.1016/j.cca.2014.03.012. Epub 2014 Mar 22.
33. Maternal exposure to di-n-butyl phthalate (DBP) induces combined anorectal and urogenital malformations in male rat offspring. Zhu YP, etal., Reprod Toxicol. 2016 Jun;61:169-76. doi: 10.1016/j.reprotox.2016.04.007. Epub 2016 Apr 11.
Additional References at PubMed
PMID:1879832   PMID:2118997   PMID:2850480   PMID:7566098   PMID:7829101   PMID:8378770   PMID:9302279   PMID:9402960   PMID:9843199   PMID:9847074   PMID:10075717   PMID:10077605  
PMID:10441570   PMID:10564661   PMID:10678662   PMID:10693759   PMID:10806483   PMID:11001584   PMID:11238441   PMID:11960000   PMID:12142027   PMID:12414818   PMID:12435627   PMID:12477932  
PMID:12545275   PMID:12575660   PMID:12575661   PMID:12794692   PMID:12853948   PMID:14608643   PMID:14611647   PMID:15390181   PMID:16254602   PMID:16344560   PMID:16371461   PMID:16705181  
PMID:17000779   PMID:17029207   PMID:17081983   PMID:17283082   PMID:17331723   PMID:17400206   PMID:17426814   PMID:17764085   PMID:18000979   PMID:18029348   PMID:18057099   PMID:18057317  
PMID:18252217   PMID:18298960   PMID:18478223   PMID:18559511   PMID:18655123   PMID:19084012   PMID:19095771   PMID:19274049   PMID:19389374   PMID:19432668   PMID:19453261   PMID:19490893  
PMID:19592253   PMID:19593328   PMID:19729595   PMID:19829694   PMID:19955409   PMID:19996099   PMID:20050020   PMID:20201963   PMID:20301619   PMID:20301638   PMID:20301753   PMID:20425471  
PMID:20426846   PMID:20583172   PMID:20610541   PMID:20634891   PMID:20672375   PMID:20711444   PMID:21069353   PMID:21108399   PMID:21209912   PMID:21320477   PMID:21326280   PMID:21531006  
PMID:21873635   PMID:21921029   PMID:22036096   PMID:22227409   PMID:22535956   PMID:22678783   PMID:23091001   PMID:23176625   PMID:23293081   PMID:23326517   PMID:23334564   PMID:23382691  
PMID:23442119   PMID:23454725   PMID:23667531   PMID:23736020   PMID:23889567   PMID:23955340   PMID:24102645   PMID:24146948   PMID:24174682   PMID:24278334   PMID:24311597   PMID:24376456  
PMID:24608427   PMID:24819706   PMID:25103784   PMID:25241761   PMID:25278022   PMID:25515538   PMID:25714367   PMID:26120032   PMID:26261006   PMID:26282181   PMID:26290227   PMID:26475525  
PMID:26508445   PMID:26515020   PMID:26598620   PMID:26755652   PMID:26791356   PMID:26972000   PMID:27146893   PMID:27173435   PMID:27220849   PMID:27279789   PMID:27305983   PMID:27793025  
PMID:28127823   PMID:28389227   PMID:28473536   PMID:28514442   PMID:28777844   PMID:28805822   PMID:28884880   PMID:28947718   PMID:28965847   PMID:29180619   PMID:29236091   PMID:29263200  
PMID:29429990   PMID:29465267   PMID:29507755   PMID:29515120   PMID:29555575   PMID:29568061   PMID:29669786   PMID:29722127   PMID:29967343   PMID:29996942   PMID:30226973   PMID:30235038  
PMID:30272273   PMID:30683671   PMID:30848202   PMID:31053742   PMID:31115189   PMID:31279575   PMID:31306531   PMID:31325247   PMID:31573334   PMID:31753913   PMID:31767679   PMID:31911863  
PMID:32112393   PMID:32238831   PMID:32245491   PMID:32253825   PMID:32460013   PMID:32513696   PMID:32591344   PMID:32694731   PMID:32696176   PMID:33058447   PMID:33347954   PMID:33506047  
PMID:33704596   PMID:33891350   PMID:33895473   PMID:33961781   PMID:33990369   PMID:34021128   PMID:34079125   PMID:34296525   PMID:34482537   PMID:34610962   PMID:34702444   PMID:35134468  
PMID:35140242   PMID:35218158   PMID:35271311   PMID:35546307   PMID:35844135   PMID:35937499   PMID:36411030   PMID:37704626  


Genomics

Comparative Map Data
GLI3
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38741,960,949 - 42,264,268 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl741,960,949 - 42,264,100 (-)EnsemblGRCh38hg38GRCh38
GRCh37742,000,547 - 42,276,808 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36741,967,072 - 42,243,137 (-)NCBINCBI36Build 36hg18NCBI36
Build 34741,776,919 - 42,036,135NCBI
Celera741,991,319 - 42,267,350 (-)NCBICelera
Cytogenetic Map7p14.1NCBI
HuRef741,885,427 - 42,162,362 (-)NCBIHuRef
CHM1_1742,003,855 - 42,280,223 (-)NCBICHM1_1
T2T-CHM13v2.0742,119,298 - 42,422,619 (-)NCBIT2T-CHM13v2.0
CRA_TCAGchr7v2742,040,400 - 42,316,460 (-)NCBI
Gli3
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391315,638,308 - 15,904,611 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1315,637,820 - 15,904,611 (+)EnsemblGRCm39 Ensembl
GRCm381315,463,723 - 15,730,026 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1315,463,235 - 15,730,026 (+)EnsemblGRCm38mm10GRCm38
MGSCv371315,555,556 - 15,821,859 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv361315,254,867 - 15,517,860 (+)NCBIMGSCv36mm8
Celera1315,745,941 - 16,017,370 (+)NCBICelera
Cytogenetic Map13A1NCBI
cM Map135.43NCBI
Gli3
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81754,134,064 - 54,405,198 (-)NCBIGRCr8
mRatBN7.21749,438,567 - 49,709,712 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1749,438,567 - 49,709,712 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1752,630,120 - 52,901,404 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01756,633,008 - 56,904,289 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01750,730,889 - 51,002,171 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01752,294,942 - 52,569,036 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1752,294,942 - 52,569,036 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01750,360,049 - 50,629,477 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41757,594,102 - 57,867,710 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11757,781,069 - 57,856,545 (-)NCBI
Celera1745,497,321 - 45,768,089 (-)NCBICelera
Cytogenetic Map17q12.1NCBI
Gli3
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049554601,528,412 - 1,805,918 (+)EnsemblChiLan1.0
ChiLan1.0NW_0049554601,528,457 - 1,805,584 (+)NCBIChiLan1.0ChiLan1.0
GLI3
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v2646,203,233 - 46,479,589 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan1794,528,190 - 94,804,051 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0742,004,965 - 42,280,772 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1742,056,566 - 42,322,865 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl742,056,565 - 42,322,865 (+)Ensemblpanpan1.1panPan2
GLI3
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1187,800,817 - 8,071,531 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl187,801,394 - 8,068,132 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha187,651,291 - 7,921,706 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0187,847,548 - 8,118,213 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl187,846,935 - 8,116,066 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1187,829,563 - 8,099,968 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0187,798,494 - 8,068,961 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0187,912,805 - 8,183,294 (+)NCBIUU_Cfam_GSD_1.0
Gli3
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440511897,915,181 - 98,191,969 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_00493647817,126,911 - 17,403,011 (-)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_00493647817,129,922 - 17,403,630 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
GLI3
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1852,404,072 - 52,697,900 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11852,403,463 - 52,697,906 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21857,616,734 - 57,801,327 (+)NCBISscrofa10.2Sscrofa10.2susScr3
GLI3
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.12116,386,700 - 16,665,648 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl2116,549,789 - 16,662,238 (+)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_0236660625,800,697 - 6,080,257 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Gli3
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_00462474018,975,596 - 19,235,900 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_00462474018,961,395 - 19,238,760 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in GLI3
940 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
NM_000168.6(GLI3):c.1878del (p.Lys626fs) deletion Greig cephalopolysyndactyly syndrome [RCV000549394] Chr7:41972562 [GRCh38]
Chr7:42012161 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.211G>A (p.Val71Ile) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000555251]|Greig cephalopolysyndactyly syndrome [RCV002490972]|not provided [RCV001704666]|not specified [RCV000610080] Chr7:42148382 [GRCh38]
Chr7:42187981 [GRCh37]
Chr7:7p14.1
benign|likely benign
NC_000007.14:g.(?_41960949)_(42264268_?)del deletion Greig cephalopolysyndactyly syndrome [RCV000014824] Chr7:41960949..42264268 [GRCh38]
Chr7:7p14.1
pathogenic
GLI3, CODON 764, FS variation Polydactyly, postaxial, type A1 [RCV000014827] Chr7:7p13 pathogenic
NM_000168.6(GLI3):c.3707del (p.Gly1236fs) deletion Postaxial polydactyly, type A1/B [RCV000014830] Chr7:41965366 [GRCh38]
Chr7:42004964 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2372del (p.Pro791fs) deletion Postaxial polydactyly type B [RCV000014839] Chr7:41967655 [GRCh38]
Chr7:42007253 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4542_4545del (p.His1515fs) deletion Greig cephalopolysyndactyly syndrome [RCV000014844] Chr7:41964528..41964531 [GRCh38]
Chr7:42004126..42004129 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1018del (p.Ser340fs) deletion Greig cephalopolysyndactyly syndrome [RCV000014845] Chr7:42040048 [GRCh38]
Chr7:42079647 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4172del (p.Gly1391fs) deletion Greig cephalopolysyndactyly syndrome [RCV001450017]|Greig cephalopolysyndactyly syndrome [RCV001865919] Chr7:41964901 [GRCh38]
Chr7:42004499 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.366C>A (p.Tyr122Ter) single nucleotide variant Polydactyly, postaxial, type A1 [RCV001450022] Chr7:42148227 [GRCh38]
Chr7:42187826 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2309C>T (p.Ala770Val) single nucleotide variant not provided [RCV000729769] Chr7:41967718 [GRCh38]
Chr7:42007316 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2306C>T (p.Pro769Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000530281]|not provided [RCV001580509] Chr7:41967721 [GRCh38]
Chr7:42007319 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.4564G>T (p.Ala1522Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000528896] Chr7:41964509 [GRCh38]
Chr7:42004107 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1076T>G (p.Met359Arg) single nucleotide variant not provided [RCV000518859] Chr7:42026365 [GRCh38]
Chr7:42065964 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.633A>G (p.Pro211=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002527694] Chr7:42048537 [GRCh38]
Chr7:42088136 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2023del (p.Glu675fs) deletion Pallister-Hall syndrome [RCV000014825] Chr7:41972417 [GRCh38]
Chr7:42012016 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2012del (p.Gly671fs) deletion Pallister-Hall syndrome [RCV000014826] Chr7:41972428 [GRCh38]
Chr7:42012027 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3646dup (p.Leu1216fs) duplication Polysyndactyly 4 [RCV000014828] Chr7:41965426..41965427 [GRCh38]
Chr7:42005024..42005025 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3439G>T (p.Glu1147Ter) single nucleotide variant Pallister-Hall syndrome [RCV000014829] Chr7:41965634 [GRCh38]
Chr7:42005232 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1927C>T (p.Arg643Ter) single nucleotide variant Abnormality of prenatal development or birth [RCV001836708]|GLI3-related condition [RCV003390683]|Postaxial polydactyly, type A1/B [RCV000014831] Chr7:41972513 [GRCh38]
Chr7:42012112 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2179G>A (p.Gly727Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000320330]|Greig cephalopolysyndactyly syndrome [RCV001084662]|Pallister-Hall syndrome [RCV000267521]|Polydactyly [RCV000358789]|Postaxial polydactyly [RCV003458333]|Postaxial polydactyly, type A1/B [RCV000014832]|not provided [RCV000514884]|not specified [RCV000174664] Chr7:41967848 [GRCh38]
Chr7:42007446 [GRCh37]
Chr7:7p14.1
pathogenic|likely pathogenic|benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|no classifications from unflagged records
NM_000168.6(GLI3):c.1627G>T (p.Glu543Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000014833] Chr7:41978619 [GRCh38]
Chr7:42018218 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.5(GLI3):c.2770_2771insNC_012920.1:g.12243..12314 insertion Pallister-Hall syndrome [RCV000014834] Chr7:41966302..41966303 [GRCh38]
Chr7:42005900..42005901 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1873C>T (p.Arg625Trp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000014835] Chr7:41972567 [GRCh38]
Chr7:42012166 [GRCh37]
Chr7:7p14.1
pathogenic|likely pathogenic
NM_000168.6(GLI3):c.868C>T (p.Arg290Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000014837]|Greig cephalopolysyndactyly syndrome [RCV000554724]|Polysyndactyly 4 [RCV000014838] Chr7:42040198 [GRCh38]
Chr7:42079797 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2374C>T (p.Arg792Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000014840]|Greig cephalopolysyndactyly syndrome [RCV001047666]|Polydactyly, postaxial, type A1 [RCV001450016]|not provided [RCV000489344] Chr7:41967653 [GRCh38]
Chr7:42007251 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2188_2206del (p.Leu730fs) deletion Pallister-Hall syndrome [RCV000014841] Chr7:41967821..41967839 [GRCh38]
Chr7:42007419..42007437 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1486C>T (p.Gln496Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000014842] Chr7:42023479 [GRCh38]
Chr7:42063078 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2119C>T (p.Pro707Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000014843]|Greig cephalopolysyndactyly syndrome [RCV000542657]|Hirschsprung disease, susceptibility to, 1 [RCV000508658]|not provided [RCV000782254]|not specified [RCV000500441] Chr7:41967908 [GRCh38]
Chr7:42007506 [GRCh37]
Chr7:7p14.1
pathogenic|likely pathogenic|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000168.6(GLI3):c.2800G>C (p.Ala934Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome, severe [RCV000030896] Chr7:41966273 [GRCh38]
Chr7:42005871 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.5(GLI3):c.1498-15698C>G single nucleotide variant Lung cancer [RCV000106047] Chr7:41994446 [GRCh38]
Chr7:42034045 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.5(GLI3):c.-43+5823C>G single nucleotide variant Lung cancer [RCV000106048] Chr7:42231148 [GRCh38]
Chr7:42270747 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2003_2006del (p.Pro668fs) microsatellite Pallister-Hall syndrome [RCV000031860] Chr7:41972434..41972437 [GRCh38]
Chr7:42012033..42012036 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2032del (p.Asp678fs) deletion Pallister-Hall syndrome [RCV000031861] Chr7:41972408 [GRCh38]
Chr7:42012007 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2058_2059delinsAT (p.Glu687Ter) indel Pallister-Hall syndrome [RCV000031862] Chr7:41972381..41972382 [GRCh38]
Chr7:42011980..42011981 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2062G>T (p.Glu688Ter) single nucleotide variant Pallister-Hall syndrome [RCV000031863] Chr7:41972378 [GRCh38]
Chr7:42011977 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2110C>T (p.Gln704Ter) single nucleotide variant Pallister-Hall syndrome [RCV000031864] Chr7:41967917 [GRCh38]
Chr7:42007515 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2139del (p.Ser712_Cys713insTer) deletion Pallister-Hall syndrome [RCV000031865] Chr7:41967888 [GRCh38]
Chr7:42007486 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2146C>T (p.Gln716Ter) single nucleotide variant Pallister-Hall syndrome [RCV000031866] Chr7:41967881 [GRCh38]
Chr7:42007479 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2149C>T (p.Gln717Ter) single nucleotide variant not provided [RCV003328942] Chr7:41967878 [GRCh38]
Chr7:42007476 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2157del (p.Ile720fs) deletion Pallister-Hall syndrome [RCV000031868] Chr7:41967870 [GRCh38]
Chr7:42007468 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2197_2198del (p.Thr733fs) deletion Pallister-Hall syndrome [RCV000031870] Chr7:41967829..41967830 [GRCh38]
Chr7:42007427..42007428 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2346_2356del (p.Arg782fs) deletion Pallister-Hall syndrome [RCV000031871] Chr7:41967671..41967681 [GRCh38]
Chr7:42007269..42007279 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2351_2355del (p.Lys784fs) deletion Pallister-Hall syndrome [RCV000031872] Chr7:41967672..41967676 [GRCh38]
Chr7:42007270..42007274 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2431+1G>A single nucleotide variant not provided [RCV003886922] Chr7:41967595 [GRCh38]
Chr7:42007193 [GRCh37]
Chr7:7p14.1
pathogenic|likely pathogenic
NM_000168.6(GLI3):c.2483del (p.Pro828fs) deletion Pallister-Hall syndrome [RCV000031874] Chr7:41966590 [GRCh38]
Chr7:42006188 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2567C>A (p.Ser856Ter) single nucleotide variant Pallister-Hall syndrome [RCV000031875] Chr7:41966506 [GRCh38]
Chr7:42006104 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2620del (p.Arg874fs) deletion Pallister-Hall syndrome [RCV000031876] Chr7:41966453 [GRCh38]
Chr7:42006051 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2628del (p.Ser877fs) deletion Pallister-Hall syndrome [RCV000031877] Chr7:41966445 [GRCh38]
Chr7:42006043 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2799C>G (p.Tyr933Ter) single nucleotide variant Pallister-Hall syndrome [RCV000031878] Chr7:41966274 [GRCh38]
Chr7:42005872 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2935del (p.Cys979fs) deletion Pallister-Hall syndrome [RCV000031879] Chr7:41966138 [GRCh38]
Chr7:42005736 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3004del (p.Gly1001_Val1002insTer) deletion Pallister-Hall syndrome [RCV000031880] Chr7:41966069 [GRCh38]
Chr7:42005667 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3324C>G (p.Tyr1108Ter) single nucleotide variant not provided [RCV001596944] Chr7:41965749 [GRCh38]
Chr7:42005347 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3386_3387del (p.Asp1128_Phe1129insTer) deletion Pallister-Hall syndrome [RCV003123330] Chr7:41965686..41965687 [GRCh38]
Chr7:42005284..42005285 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3456G>T (p.Glu1152Asp) single nucleotide variant Pallister-Hall syndrome [RCV000031883] Chr7:41965617 [GRCh38]
Chr7:42005215 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3481C>T (p.Gln1161Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000814115] Chr7:41965592 [GRCh38]
Chr7:42005190 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1616_1617del (p.Arg539fs) deletion Postaxial polydactyly, type A1/B [RCV000032707] Chr7:41978629..41978630 [GRCh38]
Chr7:42018228..42018229 [GRCh37]
Chr7:7p14.1
pathogenic
GRCh38/hg38 7p22.3-q36.3(chr7:53985-159282531)x1 copy number loss See cases [RCV000052250] Chr7:53985..159282531 [GRCh38]
Chr7:53985..159075220 [GRCh37]
Chr7:149068..158767981 [NCBI36]
Chr7:7p22.3-q36.3
pathogenic
GRCh38/hg38 7p14.1(chr7:42055193-42218144)x1 copy number loss Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052315]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052315]|See cases [RCV000052315] Chr7:42055193..42218144 [GRCh38]
Chr7:42094792..42257743 [GRCh37]
Chr7:42061317..42224268 [NCBI36]
Chr7:7p14.1
pathogenic
GRCh38/hg38 7p14.1-12.3(chr7:39814159-45749735)x1 copy number loss See cases [RCV000053132] Chr7:39814159..45749735 [GRCh38]
Chr7:39853758..45789334 [GRCh37]
Chr7:39820283..45755859 [NCBI36]
Chr7:7p14.1-12.3
pathogenic
GRCh38/hg38 7p14.3-q11.21(chr7:33328312-62377476)x3 copy number gain See cases [RCV000053532] Chr7:33328312..62377476 [GRCh38]
Chr7:33367924..61831899 [GRCh37]
Chr7:33334449..61469334 [NCBI36]
Chr7:7p14.3-q11.21
pathogenic
NM_000168.6(GLI3):c.2172dup (p.Asn725fs) duplication Pallister-Hall syndrome [RCV000031869] Chr7:41967854..41967855 [GRCh38]
Chr7:42007452..42007453 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4606T>A (p.Ser1536Thr) single nucleotide variant not provided [RCV000255680] Chr7:41964467 [GRCh38]
Chr7:42004065 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.241G>A (p.Glu81Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000764716]|Greig cephalopolysyndactyly syndrome [RCV001158784]|Greig cephalopolysyndactyly syndrome [RCV003765568]|Pallister-Hall syndrome [RCV001158785]|Polydactyly [RCV001158783]|not provided [RCV000255549] Chr7:42148352 [GRCh38]
Chr7:42187951 [GRCh37]
Chr7:7p14.1
benign|likely benign|uncertain significance
NM_000168.6(GLI3):c.3118G>A (p.Glu1040Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000273966]|Greig cephalopolysyndactyly syndrome [RCV000764715]|Pallister-Hall syndrome [RCV000387520]|Polydactyly [RCV000329014]|not provided [RCV000255158] Chr7:41965955 [GRCh38]
Chr7:42005553 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.368-19G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002055561]|Greig cephalopolysyndactyly syndrome [RCV002492467]|not specified [RCV000125245] Chr7:42076876 [GRCh38]
Chr7:42116475 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3083G>T (p.Ser1028Ile) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000335583]|Pallister-Hall syndrome [RCV000400765]|Polydactyly [RCV000299444]|not provided [RCV001573605]|not specified [RCV000125246] Chr7:41965990 [GRCh38]
Chr7:42005588 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3084C>T (p.Ser1028=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000340954]|Pallister-Hall syndrome [RCV000380291]|Polydactyly [RCV000286033]|not provided [RCV001812049]|not specified [RCV000125247] Chr7:41965989 [GRCh38]
Chr7:42005587 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2826G>C (p.Pro942=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000374326]|Greig cephalopolysyndactyly syndrome [RCV000544283]|Pallister-Hall syndrome [RCV000319709]|Polydactyly [RCV000283260]|not provided [RCV001707548]|not specified [RCV000174832] Chr7:41966247 [GRCh38]
Chr7:42005845 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3664C>T (p.Pro1222Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000384370]|Greig cephalopolysyndactyly syndrome [RCV000537751]|Inborn genetic diseases [RCV002516647]|Pallister-Hall syndrome [RCV000348496]|Polydactyly [RCV000289928]|not provided [RCV003422066]|not specified [RCV000174833] Chr7:41965409 [GRCh38]
Chr7:42005007 [GRCh37]
Chr7:7p14.1
benign|likely benign|conflicting interpretations of pathogenicity
NM_000168.6(GLI3):c.2835G>C (p.Leu945=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000377660]|Greig cephalopolysyndactyly syndrome [RCV000552308]|Pallister-Hall syndrome [RCV000267991]|Polydactyly [RCV000323129]|not provided [RCV001572936]|not specified [RCV000174834] Chr7:41966238 [GRCh38]
Chr7:42005836 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2419C>T (p.Leu807Phe) single nucleotide variant Inborn genetic diseases [RCV002518751]|not provided [RCV000256074] Chr7:41967608 [GRCh38]
Chr7:42007206 [GRCh37]
Chr7:7p14.1
uncertain significance
GRCh38/hg38 7p22.3-q36.3(chr7:54185-159282390)x1 copy number loss See cases [RCV000135401] Chr7:54185..159282390 [GRCh38]
Chr7:54185..159075079 [GRCh37]
Chr7:149268..158767840 [NCBI36]
Chr7:7p22.3-q36.3
pathogenic
GRCh38/hg38 7p14.1(chr7:41084766-42566517)x1 copy number loss See cases [RCV000135844] Chr7:41084766..42566517 [GRCh38]
Chr7:41124364..42606116 [GRCh37]
Chr7:41090889..42572641 [NCBI36]
Chr7:7p14.1
pathogenic
GRCh38/hg38 7p14.1-11.2(chr7:40534157-56107122)x1 copy number loss See cases [RCV000136092] Chr7:40534157..56107122 [GRCh38]
Chr7:40573756..56174815 [GRCh37]
Chr7:40540281..56142309 [NCBI36]
Chr7:7p14.1-11.2
pathogenic
GRCh38/hg38 7p14.1-12.1(chr7:40020598-50543500)x1 copy number loss See cases [RCV000136904] Chr7:40020598..50543500 [GRCh38]
Chr7:40060197..50611198 [GRCh37]
Chr7:40026722..50578692 [NCBI36]
Chr7:7p14.1-12.1
pathogenic
GRCh38/hg38 7p14.1-12.3(chr7:37303478-48660738)x1 copy number loss See cases [RCV000137139] Chr7:37303478..48660738 [GRCh38]
Chr7:37343082..48700334 [GRCh37]
Chr7:37309607..48670880 [NCBI36]
Chr7:7p14.1-12.3
pathogenic
GRCh38/hg38 7p14.1-13(chr7:39063400-45363096)x1 copy number loss See cases [RCV000137305] Chr7:39063400..45363096 [GRCh38]
Chr7:39103000..45402695 [GRCh37]
Chr7:39069525..45369220 [NCBI36]
Chr7:7p14.1-13
pathogenic
GRCh38/hg38 7p14.2-14.1(chr7:35460776-42013800)x1 copy number loss See cases [RCV000138190] Chr7:35460776..42013800 [GRCh38]
Chr7:35500386..42053399 [GRCh37]
Chr7:35466911..42019924 [NCBI36]
Chr7:7p14.2-14.1
pathogenic
GRCh38/hg38 7p14.1-13(chr7:38177999-45304100)x1 copy number loss See cases [RCV000142297] Chr7:38177999..45304100 [GRCh38]
Chr7:38217601..45343699 [GRCh37]
Chr7:38184126..45310224 [NCBI36]
Chr7:7p14.1-13
pathogenic
NC_000007.14:g.42247568G>A single nucleotide variant Lung cancer [RCV000106049] Chr7:42247568 [GRCh38]
Chr7:42287167 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3695A>C (p.His1232Pro) single nucleotide variant not specified [RCV000192754] Chr7:41965378 [GRCh38]
Chr7:42004976 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1207G>A (p.Val403Ile) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000268836]|Greig cephalopolysyndactyly syndrome [RCV002517076]|Inborn genetic diseases [RCV002517940]|Pallister-Hall syndrome [RCV000326204]|Polydactyly [RCV000365900]|not specified [RCV000193696] Chr7:42026234 [GRCh38]
Chr7:42065833 [GRCh37]
Chr7:7p14.1
benign|likely benign|uncertain significance
NM_000168.6(GLI3):c.1242+8G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000864279]|Greig cephalopolysyndactyly syndrome [RCV002492878]|not specified [RCV000194908] Chr7:42026191 [GRCh38]
Chr7:42065790 [GRCh37]
Chr7:7p14.1
benign|likely benign|uncertain significance
NM_000168.6(GLI3):c.3208A>T (p.Thr1070Ser) single nucleotide variant GLI3-related condition [RCV003922596]|Greig cephalopolysyndactyly syndrome [RCV000357477]|Greig cephalopolysyndactyly syndrome [RCV001085442]|Pallister-Hall syndrome [RCV000262493]|Polydactyly [RCV000298895]|not provided [RCV000756208]|not specified [RCV000424471] Chr7:41965865 [GRCh38]
Chr7:42005463 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*1411G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000324544]|Pallister-Hall syndrome [RCV000264333]|Polydactyly [RCV000379125] Chr7:41962919 [GRCh38]
Chr7:42002517 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.1812+3A>T single nucleotide variant not provided [RCV000190374] Chr7:41977555 [GRCh38]
Chr7:42017154 [GRCh37]
Chr7:7p14.1
not provided
NM_000168.6(GLI3):c.3762T>C (p.Tyr1254=) single nucleotide variant GLI3-related condition [RCV003897610]|Greig cephalopolysyndactyly syndrome [RCV000388438]|Greig cephalopolysyndactyly syndrome [RCV001486626]|Pallister-Hall syndrome [RCV000293622]|Polydactyly [RCV000333919]|not provided [RCV000296340] Chr7:41965311 [GRCh38]
Chr7:42004909 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1959G>A (p.Pro653=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000295417]|Greig cephalopolysyndactyly syndrome [RCV001083051]|Pallister-Hall syndrome [RCV000334254]|Polydactyly [RCV000386435]|not provided [RCV000398266] Chr7:41972481 [GRCh38]
Chr7:42012080 [GRCh37]
Chr7:7p14.1
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000168.6(GLI3):c.1485G>A (p.Glu495=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000283177]|Greig cephalopolysyndactyly syndrome [RCV002521915]|Pallister-Hall syndrome [RCV000341599]|Polydactyly [RCV000380054]|not provided [RCV000290847] Chr7:42023480 [GRCh38]
Chr7:42063079 [GRCh37]
Chr7:7p14.1
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000168.6(GLI3):c.3935T>G (p.Met1312Arg) single nucleotide variant GLI3-related condition [RCV003920057]|Greig cephalopolysyndactyly syndrome [RCV000267903]|Greig cephalopolysyndactyly syndrome [RCV001083375]|Pallister-Hall syndrome [RCV000307954]|Polydactyly [RCV000362619]|not provided [RCV000354909] Chr7:41965138 [GRCh38]
Chr7:42004736 [GRCh37]
Chr7:7p14.1
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000168.6(GLI3):c.1697del (p.His566fs) deletion not provided [RCV000255594] Chr7:41977673 [GRCh38]
Chr7:42017272 [GRCh37]
Chr7:7p14.1
pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:43360-159119707)x1 copy number loss See cases [RCV000446044] Chr7:43360..159119707 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
NM_000168.6(GLI3):c.3667_3670delinsATCAA (p.Tyr1223fs) indel Greig cephalopolysyndactyly syndrome [RCV001450029] Chr7:41965403..41965406 [GRCh38]
Chr7:42005001..42005004 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.650C>G (p.Ser217Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001450023] Chr7:42048520 [GRCh38]
Chr7:42088119 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2424A>G (p.Ile808Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000365837]|Greig cephalopolysyndactyly syndrome [RCV001084195]|Greig cephalopolysyndactyly syndrome [RCV002503879]|Pallister-Hall syndrome [RCV001160021]|Polydactyly [RCV001160020]|not provided [RCV000224342]|not specified [RCV000421865] Chr7:41967603 [GRCh38]
Chr7:42007201 [GRCh37]
Chr7:7p14.1
benign|likely benign|conflicting interpretations of pathogenicity
NM_000168.6(GLI3):c.*1691C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000345149]|Pallister-Hall syndrome [RCV000379886]|Polydactyly [RCV000285401] Chr7:41962639 [GRCh38]
Chr7:42002237 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*1080G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000278709]|Pallister-Hall syndrome [RCV000389541]|Polydactyly [RCV000332895] Chr7:41963250 [GRCh38]
Chr7:42002848 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1028+15G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000351452]|Greig cephalopolysyndactyly syndrome [RCV002058672]|Greig cephalopolysyndactyly syndrome [RCV002502383]|Pallister-Hall syndrome [RCV000280224]|Polydactyly [RCV000372426] Chr7:42040023 [GRCh38]
Chr7:42079622 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.4524C>T (p.Ala1508=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000399412]|Greig cephalopolysyndactyly syndrome [RCV000870850]|Greig cephalopolysyndactyly syndrome [RCV002502381]|Pallister-Hall syndrome [RCV000282685]|Polydactyly [RCV000337741] Chr7:41964549 [GRCh38]
Chr7:42004147 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*249A>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000360641]|Pallister-Hall syndrome [RCV000303448]|Polydactyly [RCV000268293]|not provided [RCV001613200] Chr7:41964081 [GRCh38]
Chr7:42003679 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*2019C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000274066]|Pallister-Hall syndrome [RCV000368874]|Polydactyly [RCV000333911] Chr7:41962311 [GRCh38]
Chr7:42001909 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1911T>C (p.His637=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003765495]|not specified [RCV000243684] Chr7:41972529 [GRCh38]
Chr7:42012128 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2802G>A (p.Ala934=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000875705]|Greig cephalopolysyndactyly syndrome [RCV001162871]|Greig cephalopolysyndactyly syndrome [RCV002479957]|Pallister-Hall syndrome [RCV001162870]|Polydactyly [RCV001164937]|not provided [RCV001682958]|not specified [RCV000246171] Chr7:41966271 [GRCh38]
Chr7:42005869 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1509C>T (p.Asn503=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000329629]|Greig cephalopolysyndactyly syndrome [RCV000528681]|Pallister-Hall syndrome [RCV000271138]|Polydactyly [RCV000386512]|not provided [RCV001610561]|not specified [RCV000248736] Chr7:41978737 [GRCh38]
Chr7:42018336 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1029-7C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000634042]|Greig cephalopolysyndactyly syndrome [RCV002487115]|not specified [RCV000251144] Chr7:42026419 [GRCh38]
Chr7:42066018 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.743G>A (p.Arg248His) single nucleotide variant not specified [RCV000253528] Chr7:42045467 [GRCh38]
Chr7:42085066 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1029-22dup duplication Greig cephalopolysyndactyly syndrome [RCV000280590]|Greig cephalopolysyndactyly syndrome [RCV002057320]|Greig cephalopolysyndactyly syndrome [RCV002487114]|Pallister-Hall syndrome [RCV000377255]|Polydactyly [RCV000337937]|not provided [RCV000839252]|not specified [RCV000246423] Chr7:42026427..42026428 [GRCh38]
Chr7:42066026..42066027 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1498-44G>A single nucleotide variant not specified [RCV000243993] Chr7:41978792 [GRCh38]
Chr7:42018391 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1357-17C>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001522698]|Greig cephalopolysyndactyly syndrome [RCV002503924]|not provided [RCV000513802]|not specified [RCV000246622] Chr7:42023625 [GRCh38]
Chr7:42063224 [GRCh37]
Chr7:7p14.1
benign|likely benign|conflicting interpretations of pathogenicity
NM_000168.6(GLI3):c.1393G>C (p.Gly465Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000391206]|Greig cephalopolysyndactyly syndrome [RCV001083893]|Pallister-Hall syndrome [RCV000336064]|Polydactyly [RCV000314867]|not provided [RCV000433382]|not specified [RCV000251377] Chr7:42023572 [GRCh38]
Chr7:42063171 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2165A>G (p.Asn722Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001085139]|Greig cephalopolysyndactyly syndrome [RCV001161439]|Pallister-Hall syndrome [RCV001161440]|Polydactyly [RCV001162975]|not provided [RCV000514524]|not specified [RCV000253835] Chr7:41967862 [GRCh38]
Chr7:42007460 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1356+11G>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000367167]|Greig cephalopolysyndactyly syndrome [RCV002057321]|Pallister-Hall syndrome [RCV000274891]|Polydactyly [RCV000308865]|Polydactyly, postaxial, type A1 [RCV001701884]|Polysyndactyly 4 [RCV001701804]|not provided [RCV001668414]|not specified [RCV000241837] Chr7:42025253 [GRCh38]
Chr7:42064852 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1243-40A>C single nucleotide variant not specified [RCV000251640] Chr7:42025417 [GRCh38]
Chr7:42065016 [GRCh37]
Chr7:7p14.1
benign|likely benign|conflicting interpretations of pathogenicity
NM_000168.6(GLI3):c.*11A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000277687]|Pallister-Hall syndrome [RCV000369843]|Polydactyly [RCV000316469]|not specified [RCV000254051] Chr7:41964319 [GRCh38]
Chr7:42003917 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3540G>A (p.Gly1180=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001504926]|not specified [RCV000242012] Chr7:41965533 [GRCh38]
Chr7:42005131 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3774C>G (p.Leu1258=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000318649]|Greig cephalopolysyndactyly syndrome [RCV000545847]|Pallister-Hall syndrome [RCV000259940]|Polydactyly [RCV000373252]|not provided [RCV001711649]|not specified [RCV000244347] Chr7:41965299 [GRCh38]
Chr7:42004897 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2104-50C>T single nucleotide variant not provided [RCV001658159]|not specified [RCV000249249] Chr7:41967973 [GRCh38]
Chr7:42007571 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4609C>T (p.Arg1537Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000329797]|Greig cephalopolysyndactyly syndrome [RCV000541353]|Pallister-Hall syndrome [RCV000373473]|Polydactyly [RCV000274709]|not provided [RCV001573073]|not specified [RCV000254161] Chr7:41964464 [GRCh38]
Chr7:42004062 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*2276T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000365178]|Pallister-Hall syndrome [RCV000329234]|Polydactyly [RCV000275269] Chr7:41962054 [GRCh38]
Chr7:42001652 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.528C>G (p.Ile176Met) single nucleotide variant not specified [RCV000244551] Chr7:42048642 [GRCh38]
Chr7:42088241 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1813-47G>A single nucleotide variant not specified [RCV000251880] Chr7:41972674 [GRCh38]
Chr7:42012273 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2432-30C>T single nucleotide variant not specified [RCV000254355] Chr7:41966671 [GRCh38]
Chr7:42006269 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4020C>T (p.Pro1340=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000375053]|Greig cephalopolysyndactyly syndrome [RCV000527883]|Pallister-Hall syndrome [RCV000320488]|Polydactyly [RCV000284158]|not provided [RCV001711525]|not specified [RCV000244659] Chr7:41965053 [GRCh38]
Chr7:42004651 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.679+40C>A single nucleotide variant not specified [RCV000244820] Chr7:42048451 [GRCh38]
Chr7:42088050 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2373G>A (p.Pro791=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000538308]|Greig cephalopolysyndactyly syndrome [RCV002494697]|not provided [RCV001705332]|not specified [RCV000249563] Chr7:41967654 [GRCh38]
Chr7:42007252 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.4071C>T (p.Tyr1357=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000269421]|Greig cephalopolysyndactyly syndrome [RCV001516015]|Pallister-Hall syndrome [RCV000324626]|Polydactyly [RCV000379198]|not provided [RCV001610562]|not specified [RCV000249611] Chr7:41965002 [GRCh38]
Chr7:42004600 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.280C>T (p.Leu94=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000366715]|Greig cephalopolysyndactyly syndrome [RCV000634041]|Greig cephalopolysyndactyly syndrome [RCV002488806]|Pallister-Hall syndrome [RCV000271591]|Polydactyly [RCV000322548]|not specified [RCV000503086] Chr7:42148313 [GRCh38]
Chr7:42187912 [GRCh37]
Chr7:7p14.1
benign|likely benign|conflicting interpretations of pathogenicity
NM_000168.6(GLI3):c.1029-11C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000378598]|Greig cephalopolysyndactyly syndrome [RCV002055028]|Greig cephalopolysyndactyly syndrome [RCV002487113]|Pallister-Hall syndrome [RCV000267718]|Polydactyly [RCV000320269]|not specified [RCV000242428] Chr7:42026423 [GRCh38]
Chr7:42066022 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3894G>A (p.Pro1298=) single nucleotide variant GLI3-related condition [RCV003891836]|Greig cephalopolysyndactyly syndrome [RCV000323042]|Greig cephalopolysyndactyly syndrome [RCV000876007]|Pallister-Hall syndrome [RCV000358165]|Polydactyly [RCV000263335] Chr7:41965179 [GRCh38]
Chr7:42004777 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.680-25C>T single nucleotide variant not specified [RCV000249790] Chr7:42045555 [GRCh38]
Chr7:42085154 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3001G>A (p.Gly1001Ser) single nucleotide variant GLI3-related condition [RCV003891835]|Greig cephalopolysyndactyly syndrome [RCV000871360]|Greig cephalopolysyndactyly syndrome [RCV001161316]|Inborn genetic diseases [RCV002518567]|Pallister-Hall syndrome [RCV001161317]|Polydactyly [RCV001159917]|not provided [RCV001549319]|not specified [RCV000249805] Chr7:41966072 [GRCh38]
Chr7:42005670 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.4007G>A (p.Gly1336Glu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000335523]|Greig cephalopolysyndactyly syndrome [RCV000551735]|Pallister-Hall syndrome [RCV000280581]|Polydactyly [RCV000401764]|not provided [RCV001573938]|not specified [RCV000252238] Chr7:41965066 [GRCh38]
Chr7:42004664 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2993C>T (p.Pro998Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000274578]|Greig cephalopolysyndactyly syndrome [RCV001523404]|Pallister-Hall syndrome [RCV000366034]|Polydactyly [RCV000311017]|Polydactyly, postaxial, type A1 [RCV001701713]|Polysyndactyly 4 [RCV001701714]|not provided [RCV001682959]|not specified [RCV000245039] Chr7:41966080 [GRCh38]
Chr7:42005678 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3772C>G (p.Leu1258Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001854950]|not specified [RCV000252349] Chr7:41965301 [GRCh38]
Chr7:42004899 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1242+42C>G single nucleotide variant not specified [RCV000247703] Chr7:42026157 [GRCh38]
Chr7:42065756 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.900C>T (p.Ser300=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000310872]|Greig cephalopolysyndactyly syndrome [RCV001518790]|Greig cephalopolysyndactyly syndrome [RCV002487116]|Pallister-Hall syndrome [RCV000362699]|Polydactyly [RCV000400548]|not provided [RCV001610564]|not specified [RCV000250104] Chr7:42040166 [GRCh38]
Chr7:42079765 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1242+25C>T single nucleotide variant not specified [RCV000242927] Chr7:42026174 [GRCh38]
Chr7:42065773 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.840C>G (p.Ser280=) single nucleotide variant GLI3-related condition [RCV003891837]|Greig cephalopolysyndactyly syndrome [RCV000304980]|Greig cephalopolysyndactyly syndrome [RCV000542260]|Greig cephalopolysyndactyly syndrome [RCV002494698]|Pallister-Hall syndrome [RCV000361950]|Polydactyly [RCV000392843]|not provided [RCV001682960]|not specified [RCV000245545] Chr7:42040226 [GRCh38]
Chr7:42079825 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2184C>T (p.Leu728=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001439996]|not specified [RCV000245648] Chr7:41967843 [GRCh38]
Chr7:42007441 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3312C>T (p.Asn1104=) single nucleotide variant not specified [RCV000250442] Chr7:41965761 [GRCh38]
Chr7:42005359 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1647+13G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000276850]|Greig cephalopolysyndactyly syndrome [RCV002058671]|Greig cephalopolysyndactyly syndrome [RCV002488805]|Pallister-Hall syndrome [RCV000298262]|Polydactyly [RCV000369323]|not specified [RCV000604884] Chr7:41978586 [GRCh38]
Chr7:42018185 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*30G>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000312851]|Pallister-Hall syndrome [RCV000273998]|Polydactyly [RCV000366153]|not provided [RCV001597002]|not specified [RCV000250678] Chr7:41964300 [GRCh38]
Chr7:42003898 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*15dup duplication not specified [RCV000245928] Chr7:41964314..41964315 [GRCh38]
Chr7:42003912..42003913 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.537C>T (p.His179=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000262115]|Greig cephalopolysyndactyly syndrome [RCV001518791]|Pallister-Hall syndrome [RCV000353450]|Polydactyly [RCV000300907]|not provided [RCV001711526]|not specified [RCV000248282] Chr7:42048633 [GRCh38]
Chr7:42088232 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.547A>G (p.Thr183Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000359147]|Greig cephalopolysyndactyly syndrome [RCV001513945]|Pallister-Hall syndrome [RCV000301892]|Polydactyly [RCV000393085]|not provided [RCV001610563]|not specified [RCV000253268] Chr7:42048623 [GRCh38]
Chr7:42088222 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3149C>T (p.Thr1050Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000332936]|Greig cephalopolysyndactyly syndrome [RCV002524531]|Pallister-Hall syndrome [RCV000278006]|Polydactyly [RCV000354031] Chr7:41965924 [GRCh38]
Chr7:42005522 [GRCh37]
Chr7:7p14.1
benign|likely benign|uncertain significance
NM_000168.6(GLI3):c.*655A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000356133]|Pallister-Hall syndrome [RCV000402993]|Polydactyly [RCV000298940] Chr7:41963675 [GRCh38]
Chr7:42003273 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*2146_*2150del deletion Greig cephalopolysyndactyly syndrome [RCV000283862]|Pallister-Hall syndrome [RCV000337711]|Polydactyly [RCV000407785] Chr7:41962180..41962184 [GRCh38]
Chr7:42001778..42001782 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.444C>T (p.Tyr148=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000383193]|Greig cephalopolysyndactyly syndrome [RCV001085551]|Greig cephalopolysyndactyly syndrome [RCV002502386]|Pallister-Hall syndrome [RCV000284105]|Polydactyly [RCV000328780]|not provided [RCV000429089] Chr7:42076781 [GRCh38]
Chr7:42116380 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*2357T>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000358278]|Pallister-Hall syndrome [RCV000299561]|Polydactyly [RCV000402983]|not provided [RCV003422354] Chr7:41961973 [GRCh38]
Chr7:42001571 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*265A>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000392631]|Pallister-Hall syndrome [RCV000299795]|Polydactyly [RCV000338396]|not provided [RCV001672695] Chr7:41964065 [GRCh38]
Chr7:42003663 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.99C>T (p.Ala33=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000268493]|Greig cephalopolysyndactyly syndrome [RCV000883186]|Pallister-Hall syndrome [RCV000377113]|Polydactyly [RCV000323611] Chr7:42223155 [GRCh38]
Chr7:42262754 [GRCh37]
Chr7:7p14.1
benign|likely benign|uncertain significance
NM_000168.6(GLI3):c.411T>C (p.Ile137=) single nucleotide variant GLI3-related condition [RCV003950278]|Greig cephalopolysyndactyly syndrome [RCV000339184]|Greig cephalopolysyndactyly syndrome [RCV000875083]|Greig cephalopolysyndactyly syndrome [RCV002504180]|Pallister-Hall syndrome [RCV000285362]|Polydactyly [RCV000395319]|not specified [RCV000615516] Chr7:42076814 [GRCh38]
Chr7:42116413 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3598C>G (p.His1200Asp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000302598]|Greig cephalopolysyndactyly syndrome [RCV001087982]|Greig cephalopolysyndactyly syndrome [RCV002480245]|Pallister-Hall syndrome [RCV000406987]|Polydactyly [RCV000341358]|not provided [RCV000514757] Chr7:41965475 [GRCh38]
Chr7:42005073 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*2347C>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000304737]|Pallister-Hall syndrome [RCV000364107]|Polydactyly [RCV000269502] Chr7:41961983 [GRCh38]
Chr7:42001581 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4533C>T (p.Asp1511=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000380693]|Greig cephalopolysyndactyly syndrome [RCV001466208]|Greig cephalopolysyndactyly syndrome [RCV002488804]|Pallister-Hall syndrome [RCV000341146]|Polydactyly [RCV000286335] Chr7:41964540 [GRCh38]
Chr7:42004138 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.341G>A (p.Arg114Lys) single nucleotide variant GLI3-related condition [RCV003922597]|Greig cephalopolysyndactyly syndrome [RCV000370048]|Greig cephalopolysyndactyly syndrome [RCV001085140]|Greig cephalopolysyndactyly syndrome [RCV002502387]|Pallister-Hall syndrome [RCV000307311]|Polydactyly [RCV000270860]|not provided [RCV000513753]|not specified [RCV000501667] Chr7:42148252 [GRCh38]
Chr7:42187851 [GRCh37]
Chr7:7p14.1
benign|likely benign|conflicting interpretations of pathogenicity
NM_000168.6(GLI3):c.*3004G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000287285]|Pallister-Hall syndrome [RCV000342275]|Polydactyly [RCV000379575] Chr7:41961326 [GRCh38]
Chr7:42000924 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.*136T>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000408240]|Pallister-Hall syndrome [RCV000305560]|Polydactyly [RCV000340364] Chr7:41964194 [GRCh38]
Chr7:42003792 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2960A>G (p.Tyr987Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000271369]|Pallister-Hall syndrome [RCV000362411]|Polydactyly [RCV000326387] Chr7:41966113 [GRCh38]
Chr7:42005711 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.*835G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000378757]|Pallister-Hall syndrome [RCV000288137]|Polydactyly [RCV000345417] Chr7:41963495 [GRCh38]
Chr7:42003093 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.474-4C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000287847]|Greig cephalopolysyndactyly syndrome [RCV000634039]|Greig cephalopolysyndactyly syndrome [RCV002502385]|Pallister-Hall syndrome [RCV000382234]|Polydactyly [RCV000332286]|not provided [RCV001705531] Chr7:42048700 [GRCh38]
Chr7:42088299 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1845T>C (p.Thr615=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000288074]|Greig cephalopolysyndactyly syndrome [RCV002523596]|Pallister-Hall syndrome [RCV000390043]|Polydactyly [RCV000345408] Chr7:41972595 [GRCh38]
Chr7:42012194 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1843A>T (p.Thr615Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000358471]|Pallister-Hall syndrome [RCV000406810]|Polydactyly [RCV000306077] Chr7:41972597 [GRCh38]
Chr7:42012196 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3117G>A (p.Ala1039=) single nucleotide variant GLI3-related condition [RCV003970055]|Greig cephalopolysyndactyly syndrome [RCV000344328]|Greig cephalopolysyndactyly syndrome [RCV002058669]|Pallister-Hall syndrome [RCV000383672]|Polydactyly [RCV000289307] Chr7:41965956 [GRCh38]
Chr7:42005554 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.4296G>A (p.Leu1432=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000364028]|Pallister-Hall syndrome [RCV000327920]|Polydactyly [RCV000272872] Chr7:41964777 [GRCh38]
Chr7:42004375 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*428C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000328387]|Pallister-Hall syndrome [RCV000289654]|Polydactyly [RCV000385228] Chr7:41963902 [GRCh38]
Chr7:42003500 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.*3309C>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000365037]|Pallister-Hall syndrome [RCV000306970]|Polydactyly [RCV000404520] Chr7:41961021 [GRCh38]
Chr7:42000619 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3631G>A (p.Gly1211Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000305075]|Greig cephalopolysyndactyly syndrome [RCV001034036]|Pallister-Hall syndrome [RCV000406991]|Polydactyly [RCV000344954] Chr7:41965442 [GRCh38]
Chr7:42005040 [GRCh37]
Chr7:7p14.1
benign|likely benign|uncertain significance
NM_000168.6(GLI3):c.681G>A (p.Ala227=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000347284]|Greig cephalopolysyndactyly syndrome [RCV003766068]|Pallister-Hall syndrome [RCV000398784]|Polydactyly [RCV000290017] Chr7:42045529 [GRCh38]
Chr7:42085128 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.*2117A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000343492]|Pallister-Hall syndrome [RCV000308479]|Polydactyly [RCV000405334] Chr7:41962213 [GRCh38]
Chr7:42001811 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*2757C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000288412]|Pallister-Hall syndrome [RCV000382828]|Polydactyly [RCV000347961]|not provided [RCV001709632] Chr7:41961573 [GRCh38]
Chr7:42001171 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1497C>T (p.His499=) single nucleotide variant GLI3-related condition [RCV003897803]|Greig cephalopolysyndactyly syndrome [RCV000328810]|Greig cephalopolysyndactyly syndrome [RCV001415336]|Pallister-Hall syndrome [RCV000288908]|Polydactyly [RCV000381070] Chr7:42023468 [GRCh38]
Chr7:42063067 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*741A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000291578]|Pallister-Hall syndrome [RCV000392139]|Polydactyly [RCV000349044] Chr7:41963589 [GRCh38]
Chr7:42003187 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2493C>A (p.Ser831Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000348583]|Pallister-Hall syndrome [RCV000393591]|Polydactyly [RCV000308790] Chr7:41966580 [GRCh38]
Chr7:42006178 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.-68G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000309892]|Pallister-Hall syndrome [RCV000401190]|Polydactyly [RCV000364615] Chr7:42236996 [GRCh38]
Chr7:42276595 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1800G>A (p.Thr600=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000356603]|Greig cephalopolysyndactyly syndrome [RCV002502382]|Pallister-Hall syndrome [RCV000259342]|Polydactyly [RCV000300111]|not provided [RCV000975287] Chr7:41977570 [GRCh38]
Chr7:42017169 [GRCh37]
Chr7:7p14.1
benign|likely benign|uncertain significance
NM_000168.6(GLI3):c.*2666G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000301159]|Pallister-Hall syndrome [RCV000260011]|Polydactyly [RCV000355919]|not provided [RCV003430937] Chr7:41961664 [GRCh38]
Chr7:42001262 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.*1087A>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000329369]|Pallister-Hall syndrome [RCV000275453]|Polydactyly [RCV000386175] Chr7:41963243 [GRCh38]
Chr7:42002841 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*3238C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000318952]|Pallister-Hall syndrome [RCV000367689]|Polydactyly [RCV000275569] Chr7:41961092 [GRCh38]
Chr7:42000690 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*943G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000275718]|Pallister-Hall syndrome [RCV000333637]|Polydactyly [RCV000367971] Chr7:41963387 [GRCh38]
Chr7:42002985 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*1623A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000310905]|Pallister-Hall syndrome [RCV000391539]|Polydactyly [RCV000352272] Chr7:41962707 [GRCh38]
Chr7:42002305 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2412C>G (p.Val804=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000393597]|Pallister-Hall syndrome [RCV000359839]|Polydactyly [RCV000307651] Chr7:41967615 [GRCh38]
Chr7:42007213 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*3262A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000333969]|Pallister-Hall syndrome [RCV000364261]|Polydactyly [RCV000276682]|not provided [RCV001778944] Chr7:41961068 [GRCh38]
Chr7:42000666 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.-42-11G>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000348425]|Greig cephalopolysyndactyly syndrome [RCV002502388]|Pallister-Hall syndrome [RCV000293487]|Polydactyly [RCV000374676]|not provided [RCV001712547]|not specified [RCV001702360] Chr7:42223306 [GRCh38]
Chr7:42262905 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3984C>T (p.Leu1328=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000366105]|Greig cephalopolysyndactyly syndrome [RCV000634040]|Pallister-Hall syndrome [RCV000393660]|Polydactyly [RCV000311389]|not provided [RCV001697765] Chr7:41965089 [GRCh38]
Chr7:42004687 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.961C>T (p.Leu321Phe) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000401377]|Pallister-Hall syndrome [RCV000311946]|Polydactyly [RCV000350453] Chr7:42040105 [GRCh38]
Chr7:42079704 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.*911A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000260928]|Pallister-Hall syndrome [RCV000318441]|Polydactyly [RCV000353464] Chr7:41963419 [GRCh38]
Chr7:42003017 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.501G>A (p.Thr167=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000367232]|Greig cephalopolysyndactyly syndrome [RCV001514567]|Greig cephalopolysyndactyly syndrome [RCV002502384]|Pallister-Hall syndrome [RCV000331276]|Polydactyly [RCV000277354]|not provided [RCV000871924] Chr7:42048669 [GRCh38]
Chr7:42088268 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*2715G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000348966]|Pallister-Hall syndrome [RCV000312855]|Polydactyly [RCV000391308]|not provided [RCV001778945] Chr7:41961615 [GRCh38]
Chr7:42001213 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1958C>T (p.Pro653Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000346998]|Pallister-Hall syndrome [RCV000294462]|Polydactyly [RCV000398955] Chr7:41972482 [GRCh38]
Chr7:42012081 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*2071C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000404465]|Pallister-Hall syndrome [RCV000309568]|Polydactyly [RCV000363041] Chr7:41962259 [GRCh38]
Chr7:42001857 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.*726A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000371025]|Pallister-Hall syndrome [RCV000314090]|Polydactyly [RCV000392150] Chr7:41963604 [GRCh38]
Chr7:42003202 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3015C>T (p.Ala1005=) single nucleotide variant GLI3-related condition [RCV003932485]|Greig cephalopolysyndactyly syndrome [RCV000391304]|Greig cephalopolysyndactyly syndrome [RCV001520695]|Pallister-Hall syndrome [RCV000314477]|Polydactyly [RCV000369102]|not specified [RCV000432805] Chr7:41966058 [GRCh38]
Chr7:42005656 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*1464A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000299509]|Pallister-Hall syndrome [RCV000263081]|Polydactyly [RCV000359090] Chr7:41962866 [GRCh38]
Chr7:42002464 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2083G>A (p.Val695Ile) single nucleotide variant GLI3-related condition [RCV003950277]|Greig cephalopolysyndactyly syndrome [RCV000316559]|Greig cephalopolysyndactyly syndrome [RCV002058670]|Pallister-Hall syndrome [RCV000263729]|Polydactyly [RCV000373507] Chr7:41972357 [GRCh38]
Chr7:42011956 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*185G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000371464]|Pallister-Hall syndrome [RCV000279710]|Polydactyly [RCV000333142] Chr7:41964145 [GRCh38]
Chr7:42003743 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.*1297G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000407244]|Pallister-Hall syndrome [RCV000351440]|Polydactyly [RCV000296593] Chr7:41963033 [GRCh38]
Chr7:42002631 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.748C>T (p.Pro250Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000329883]|Greig cephalopolysyndactyly syndrome [RCV003105883]|Pallister-Hall syndrome [RCV000295892]|Polydactyly [RCV000386462]|not provided [RCV001770283] Chr7:42045462 [GRCh38]
Chr7:42085061 [GRCh37]
Chr7:7p14.1
benign|likely benign|uncertain significance
NM_000168.6(GLI3):c.2635G>A (p.Ala879Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000334992]|Greig cephalopolysyndactyly syndrome [RCV001088744]|Pallister-Hall syndrome [RCV000390459]|Polydactyly [RCV000296031]|not provided [RCV000437566] Chr7:41966438 [GRCh38]
Chr7:42006036 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.4005G>A (p.Pro1335=) single nucleotide variant GLI3-related condition [RCV003957846]|Greig cephalopolysyndactyly syndrome [RCV000295772]|Greig cephalopolysyndactyly syndrome [RCV000877587]|Greig cephalopolysyndactyly syndrome [RCV002504179]|Pallister-Hall syndrome [RCV000393604]|Polydactyly [RCV000350655]|not provided [RCV001705530]|not specified [RCV000444747] Chr7:41965068 [GRCh38]
Chr7:42004666 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.4510A>C (p.Ile1504Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000371288]|Greig cephalopolysyndactyly syndrome [RCV000547412]|Pallister-Hall syndrome [RCV000297963]|Polydactyly [RCV000391379]|not provided [RCV001808777] Chr7:41964563 [GRCh38]
Chr7:42004161 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*1296T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000297839]|Pallister-Hall syndrome [RCV000405356]|Polydactyly [RCV000338792] Chr7:41963034 [GRCh38]
Chr7:42002632 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.*2358del deletion Greig cephalopolysyndactyly syndrome [RCV000404956]|Pallister-Hall syndrome [RCV000298377]|Polydactyly [RCV000334670]|not provided [RCV001778946] Chr7:41961972 [GRCh38]
Chr7:42001570 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1462G>A (p.Ala488Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000340635]|Greig cephalopolysyndactyly syndrome [RCV001204137]|Pallister-Hall syndrome [RCV000399556]|Polydactyly [RCV000297459]|not provided [RCV001753837] Chr7:42023503 [GRCh38]
Chr7:42063102 [GRCh37]
Chr7:7p14.1
benign|likely benign|uncertain significance
NM_000168.6(GLI3):c.*2620C>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000379806]|Pallister-Hall syndrome [RCV000320672]|Polydactyly [RCV000265507] Chr7:41961710 [GRCh38]
Chr7:42001308 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.4356G>A (p.Gln1452=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000367442]|Pallister-Hall syndrome [RCV000406439]|Polydactyly [RCV000312739]|not provided [RCV000896963] Chr7:41964717 [GRCh38]
Chr7:42004315 [GRCh37]
Chr7:7p14.1
benign|likely benign|uncertain significance
NM_000168.6(GLI3):c.*847C>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000283068]|Pallister-Hall syndrome [RCV000321764]|Polydactyly [RCV000375227] Chr7:41963483 [GRCh38]
Chr7:42003081 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.367C>T (p.His123Tyr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000390009]|Pallister-Hall syndrome [RCV000335666]|Polydactyly [RCV000300541] Chr7:42148226 [GRCh38]
Chr7:42187825 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.827-19dup duplication Greig cephalopolysyndactyly syndrome [RCV000387783]|Greig cephalopolysyndactyly syndrome [RCV002058673]|Pallister-Hall syndrome [RCV000316962]|Polydactyly [RCV000263684] Chr7:42040252..42040253 [GRCh38]
Chr7:42079851..42079852 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.648C>T (p.Ile216=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001088086]|not provided [RCV000304319] Chr7:42048522 [GRCh38]
Chr7:42088121 [GRCh37]
Chr7:7p14.1
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000168.6(GLI3):c.*1386A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000384978]|Pallister-Hall syndrome [RCV000325484]|Polydactyly [RCV000270457] Chr7:41962944 [GRCh38]
Chr7:42002542 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*1780C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000375671]|Pallister-Hall syndrome [RCV000322199]|Polydactyly [RCV000281116] Chr7:41962550 [GRCh38]
Chr7:42002148 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1346G>C (p.Arg449Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003765599]|not provided [RCV000271583] Chr7:42025274 [GRCh38]
Chr7:42064873 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.1357-3C>T single nucleotide variant not provided [RCV000304334] Chr7:42023611 [GRCh38]
Chr7:42063210 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*1042dup duplication Greig cephalopolysyndactyly syndrome [RCV000374320]|Pallister-Hall syndrome [RCV000336075]|Polydactyly [RCV000282401] Chr7:41963287..41963288 [GRCh38]
Chr7:42002885..42002886 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.363C>T (p.His121=) single nucleotide variant GLI3-related condition [RCV003977806]|Greig cephalopolysyndactyly syndrome [RCV002059258]|not provided [RCV003430824]|not specified [RCV000273338] Chr7:42148230 [GRCh38]
Chr7:42187829 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*3094T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000322575]|Pallister-Hall syndrome [RCV000260345]|Polydactyly [RCV000376012] Chr7:41961236 [GRCh38]
Chr7:42000834 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*1858C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000369928]|Pallister-Hall syndrome [RCV000260965]|Polydactyly [RCV000316467] Chr7:41962472 [GRCh38]
Chr7:42002070 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*1239T>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000272102]|Pallister-Hall syndrome [RCV000307373]|Polydactyly [RCV000364292] Chr7:41963091 [GRCh38]
Chr7:42002689 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*2216T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000282649]|Pallister-Hall syndrome [RCV000317711]|Polydactyly [RCV000372490] Chr7:41962114 [GRCh38]
Chr7:42001712 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*265dup duplication Greig cephalopolysyndactyly syndrome [RCV000296647]|Pallister-Hall syndrome [RCV000334979]|Polydactyly [RCV000392620]|not provided [RCV001707682] Chr7:41964064..41964065 [GRCh38]
Chr7:42003662..42003663 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.*248dup duplication Greig cephalopolysyndactyly syndrome [RCV000272370]|Pallister-Hall syndrome [RCV000364747]|Polydactyly [RCV000307719]|not provided [RCV003430938] Chr7:41964081..41964082 [GRCh38]
Chr7:42003679..42003680 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.*165A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000337053]|Pallister-Hall syndrome [RCV000283290]|Polydactyly [RCV000375440] Chr7:41964165 [GRCh38]
Chr7:42003763 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*266_*267insA insertion Greig cephalopolysyndactyly syndrome [RCV000350345]|Pallister-Hall syndrome [RCV000388585]|Polydactyly [RCV000293031] Chr7:41964063..41964064 [GRCh38]
Chr7:42003661..42003662 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*3341dup duplication Greig cephalopolysyndactyly syndrome [RCV000403680]|Pallister-Hall syndrome [RCV000343252]|Polydactyly [RCV000303316]|not provided [RCV001537136] Chr7:41960988..41960989 [GRCh38]
Chr7:42000586..42000587 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.4349T>G (p.Phe1450Cys) single nucleotide variant not provided [RCV000347627] Chr7:41964724 [GRCh38]
Chr7:42004322 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2245A>G (p.Ile749Val) single nucleotide variant GLI3-related condition [RCV003930106]|Greig cephalopolysyndactyly syndrome [RCV000814882]|Greig cephalopolysyndactyly syndrome [RCV001161436]|Pallister-Hall syndrome [RCV001161438]|Polydactyly [RCV001161437]|not provided [RCV000725555] Chr7:41967782 [GRCh38]
Chr7:42007380 [GRCh37]
Chr7:7p14.1
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000168.6(GLI3):c.*589T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000262886]|Pallister-Hall syndrome [RCV000320362]|Polydactyly [RCV000358752] Chr7:41963741 [GRCh38]
Chr7:42003339 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3903A>G (p.Pro1301=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001089316]|not provided [RCV000350836] Chr7:41965170 [GRCh38]
Chr7:42004768 [GRCh37]
Chr7:7p14.1
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000168.6(GLI3):c.*248del deletion Greig cephalopolysyndactyly syndrome [RCV000275792]|Pallister-Hall syndrome [RCV000386580]|Polydactyly [RCV000329769] Chr7:41964082 [GRCh38]
Chr7:42003680 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.827-6T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000264891]|Pallister-Hall syndrome [RCV000356069]|Polydactyly [RCV000322379] Chr7:42040245 [GRCh38]
Chr7:42079844 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.-78G>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000265471]|Pallister-Hall syndrome [RCV000301835]|Polydactyly [RCV000361352] Chr7:42237006 [GRCh38]
Chr7:42276605 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3119A>T (p.Glu1040Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001162753]|Pallister-Hall syndrome [RCV001162752]|Polydactyly [RCV001162754]|not specified [RCV000359414] Chr7:41965954 [GRCh38]
Chr7:42005552 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.2826G>T (p.Pro942=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001078832]|not provided [RCV000396560] Chr7:41966247 [GRCh38]
Chr7:42005845 [GRCh37]
Chr7:7p14.1
benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000168.6(GLI3):c.*512C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000266303]|Pallister-Hall syndrome [RCV000323805]|Polydactyly [RCV000381784] Chr7:41963818 [GRCh38]
Chr7:42003416 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2200G>A (p.Asp734Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002494821]|Greig cephalopolysyndactyly syndrome [RCV002518846]|Inborn genetic diseases [RCV003258718]|not provided [RCV000361427] Chr7:41967827 [GRCh38]
Chr7:42007425 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1498-6C>A single nucleotide variant not provided [RCV000397394] Chr7:41978754 [GRCh38]
Chr7:42018353 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*2508G>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000266667]|Pallister-Hall syndrome [RCV000326535]|Polydactyly [RCV000381138] Chr7:41961822 [GRCh38]
Chr7:42001420 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.-83C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000266701]|Pallister-Hall syndrome [RCV000317215]|Polydactyly [RCV000371885] Chr7:42237011 [GRCh38]
Chr7:42276610 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.223C>G (p.Pro75Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001366912]|Greig cephalopolysyndactyly syndrome [RCV002504000]|not provided [RCV000294796] Chr7:42148370 [GRCh38]
Chr7:42187969 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1671C>T (p.Tyr557=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000541310]|Greig cephalopolysyndactyly syndrome [RCV002494818]|not provided [RCV001534311]|not specified [RCV000295615] Chr7:41977699 [GRCh38]
Chr7:42017298 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.-3A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000278943]|Pallister-Hall syndrome [RCV000338772]|Polydactyly [RCV000373546] Chr7:42223256 [GRCh38]
Chr7:42262855 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4560G>A (p.Ser1520=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002519273]|not provided [RCV000265139] Chr7:41964513 [GRCh38]
Chr7:42004111 [GRCh37]
Chr7:7p14.1
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000168.6(GLI3):c.3083_3084delinsTT (p.Ser1028Ile) indel Greig cephalopolysyndactyly syndrome [RCV000544497]|Greig cephalopolysyndactyly syndrome [RCV002502142]|not provided [RCV001651320]|not specified [RCV000332595] Chr7:41965989..41965990 [GRCh38]
Chr7:42005587..42005588 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2652C>T (p.Gly884=) single nucleotide variant not provided [RCV000331772] Chr7:41966421 [GRCh38]
Chr7:42006019 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*1263C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000358676]|Pallister-Hall syndrome [RCV000268564]|Polydactyly [RCV000301581] Chr7:41963067 [GRCh38]
Chr7:42002665 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2741del (p.Gly914fs) deletion GLI3-Related Disorders [RCV000279878] Chr7:41966332 [GRCh38]
Chr7:42005930 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3829C>G (p.Gln1277Glu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001085856]|Inborn genetic diseases [RCV002518885]|not provided [RCV000725297]|not specified [RCV000269527] Chr7:41965244 [GRCh38]
Chr7:42004842 [GRCh37]
Chr7:7p14.1
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000168.6(GLI3):c.3243C>G (p.Asp1081Glu) single nucleotide variant not provided [RCV002288054] Chr7:41965830 [GRCh38]
Chr7:42005428 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*1688C>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000391532]|Pallister-Hall syndrome [RCV000291411]|Polydactyly [RCV000346368] Chr7:41962642 [GRCh38]
Chr7:42002240 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*2465G>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000346447]|Pallister-Hall syndrome [RCV000291493]|Polydactyly [RCV000386445] Chr7:41961865 [GRCh38]
Chr7:42001463 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.353T>C (p.Met118Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000315395]|Pallister-Hall syndrome [RCV000408372]|Polydactyly [RCV000350390] Chr7:42148240 [GRCh38]
Chr7:42187839 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*2419T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000292673]|Pallister-Hall syndrome [RCV000407181]|Polydactyly [RCV000352187] Chr7:41961911 [GRCh38]
Chr7:42001509 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1111G>C (p.Gly371Arg) single nucleotide variant not provided [RCV000521362] Chr7:42026330 [GRCh38]
Chr7:42065929 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*2257A>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000330544]|Pallister-Hall syndrome [RCV000389796]|Polydactyly [RCV000295506] Chr7:41962073 [GRCh38]
Chr7:42001671 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*1007G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000342739]|Pallister-Hall syndrome [RCV000408019]|Polydactyly [RCV000307786] Chr7:41963323 [GRCh38]
Chr7:42002921 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.-94C>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000332966]|Pallister-Hall syndrome [RCV000355111]|Polydactyly [RCV000260122] Chr7:42237022 [GRCh38]
Chr7:42276621 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.*3369C>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000407868]|Pallister-Hall syndrome [RCV000285854]|Polydactyly [RCV000334600] Chr7:41960961 [GRCh38]
Chr7:42000559 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*1027C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000285922]|Pallister-Hall syndrome [RCV000339763]|Polydactyly [RCV000408018] Chr7:41963303 [GRCh38]
Chr7:42002901 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*66G>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000309270]|Pallister-Hall syndrome [RCV000344020]|Polydactyly [RCV000408232] Chr7:41964264 [GRCh38]
Chr7:42003862 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*1471C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000298458]|Pallister-Hall syndrome [RCV000353368]|Polydactyly [RCV000403449] Chr7:41962859 [GRCh38]
Chr7:42002457 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*974T>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000364814]|Pallister-Hall syndrome [RCV000310967]|Polydactyly [RCV000404603] Chr7:41963356 [GRCh38]
Chr7:42002954 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.5(GLI3):c.*3392G>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000277996]|Pallister-Hall syndrome [RCV000367881]|Polydactyly [RCV000308574]|not provided [RCV001718800] Chr7:41960938 [GRCh38]
Chr7:42000536 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.641C>T (p.Ser214Phe) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000399679]|Pallister-Hall syndrome [RCV000341674]|Polydactyly [RCV000288976] Chr7:42048529 [GRCh38]
Chr7:42088128 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4590C>T (p.Asn1530=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000384316]|Pallister-Hall syndrome [RCV000326195]|Polydactyly [RCV000289868] Chr7:41964483 [GRCh38]
Chr7:42004081 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.-47C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000400341]|Pallister-Hall syndrome [RCV000313234]|Polydactyly [RCV000345019] Chr7:42236975 [GRCh38]
Chr7:42276574 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2585G>A (p.Arg862His) single nucleotide variant not provided [RCV000519822] Chr7:41966488 [GRCh38]
Chr7:42006086 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*1366C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000290654]|Pallister-Hall syndrome [RCV000386041]|Polydactyly [RCV000350150] Chr7:41962964 [GRCh38]
Chr7:42002562 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*2676C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000314080]|Pallister-Hall syndrome [RCV000354630]|Polydactyly [RCV000404934] Chr7:41961654 [GRCh38]
Chr7:42001252 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3771del (p.Leu1258fs) deletion not provided [RCV000520565] Chr7:41965302 [GRCh38]
Chr7:42004900 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.4619C>A (p.Thr1540Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002491190]|not provided [RCV000592798] Chr7:41964454 [GRCh38]
Chr7:42004052 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1191_1206del (p.Thr398fs) deletion not provided [RCV000598716] Chr7:42026235..42026250 [GRCh38]
Chr7:42065834..42065849 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1452G>A (p.Trp484Ter) single nucleotide variant not provided [RCV000599260] Chr7:42023513 [GRCh38]
Chr7:42063112 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2540G>A (p.Arg847Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002491173]|Greig cephalopolysyndactyly syndrome [RCV002530989]|not provided [RCV000598483] Chr7:41966533 [GRCh38]
Chr7:42006131 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.2856C>T (p.Ser952=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000532995] Chr7:41966217 [GRCh38]
Chr7:42005815 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1008C>A (p.His336Gln) single nucleotide variant not provided [RCV000733769] Chr7:42040058 [GRCh38]
Chr7:42079657 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1002T>A (p.Tyr334Ter) single nucleotide variant not provided [RCV000733770] Chr7:42040064 [GRCh38]
Chr7:42079663 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2252del (p.Asp751fs) deletion Polydactyly, postaxial, type A1 [RCV000415028] Chr7:41967775 [GRCh38]
Chr7:42007373 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2003C>G (p.Pro668Arg) single nucleotide variant not provided [RCV000728876] Chr7:41972437 [GRCh38]
Chr7:42012036 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.29C>A (p.Thr10Asn) single nucleotide variant not provided [RCV000594890] Chr7:42223225 [GRCh38]
Chr7:42262824 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2174A>C (p.Asn725Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001044472]|Greig cephalopolysyndactyly syndrome [RCV002485899]|not provided [RCV000731752] Chr7:41967853 [GRCh38]
Chr7:42007451 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3756G>A (p.Pro1252=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003768216]|not provided [RCV000731850] Chr7:41965317 [GRCh38]
Chr7:42004915 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.313C>T (p.Arg105Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002523932]|not specified [RCV000413583] Chr7:42148280 [GRCh38]
Chr7:42187879 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1919A>G (p.Lys640Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000806041] Chr7:41972521 [GRCh38]
Chr7:42012120 [GRCh37]
Chr7:7p14.1
uncertain significance
TMEM106B-BRAF fusion deletion Pleomorphic xanthoastrocytoma [RCV000454357] Chr7:12258147..140494267 [GRCh37]
Chr7:7p21.3-q34
pathogenic
GRCh37/hg19 7p14.1(chr7:42226378-42244825)x3 copy number gain See cases [RCV000446363] Chr7:42226378..42244825 [GRCh37]
Chr7:7p14.1
benign|likely benign
GRCh37/hg19 7p14.1-12.3(chr7:40350383-47034422)x1 copy number loss See cases [RCV000446941] Chr7:40350383..47034422 [GRCh37]
Chr7:7p14.1-12.3
pathogenic
GRCh37/hg19 7p14.3-13(chr7:32911003-44576005)x1 copy number loss See cases [RCV000446955] Chr7:32911003..44576005 [GRCh37]
Chr7:7p14.3-13
pathogenic
NM_000168.6(GLI3):c.2331C>T (p.His777=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002525527]|not provided [RCV000434244] Chr7:41967696 [GRCh38]
Chr7:42007294 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.680-10C>T single nucleotide variant not specified [RCV000445058] Chr7:42045540 [GRCh38]
Chr7:42085139 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2006C>T (p.Thr669Ile) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000883417]|not provided [RCV001703769]|not specified [RCV000438090] Chr7:41972434 [GRCh38]
Chr7:42012033 [GRCh37]
Chr7:7p14.1
likely benign|conflicting interpretations of pathogenicity
NM_000168.6(GLI3):c.1969G>A (p.Gly657Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002056677]|Inborn genetic diseases [RCV002525514]|not provided [RCV000428276] Chr7:41972471 [GRCh38]
Chr7:42012070 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.1242+16C>T single nucleotide variant not specified [RCV000432072] Chr7:42026183 [GRCh38]
Chr7:42065782 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4431dup (p.Glu1478Ter) duplication Greig cephalopolysyndactyly syndrome [RCV000634034]|Greig cephalopolysyndactyly syndrome [RCV000656366]|not provided [RCV000432432] Chr7:41964641..41964642 [GRCh38]
Chr7:42004239..42004240 [GRCh37]
Chr7:7p14.1
pathogenic|likely pathogenic
NM_000168.6(GLI3):c.1287G>A (p.Pro429=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001402373]|not specified [RCV000426282] Chr7:42025333 [GRCh38]
Chr7:42064932 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4436T>C (p.Leu1479Ser) single nucleotide variant Cronkhite-Canada syndrome [RCV000416500] Chr7:41964637 [GRCh38]
Chr7:42004235 [GRCh37]
Chr7:7p14.1
uncertain significance
GRCh37/hg19 7p14.1(chr7:42226378-42239808)x3 copy number gain See cases [RCV000448333] Chr7:42226378..42239808 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2000G>T (p.Arg667Leu) single nucleotide variant Global developmental delay [RCV000416503]|Greig cephalopolysyndactyly syndrome [RCV001255817]|Greig cephalopolysyndactyly syndrome [RCV002502450]|Inborn genetic diseases [RCV001266646]|not provided [RCV002469146] Chr7:41972440 [GRCh38]
Chr7:42012039 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
GRCh37/hg19 7p21.3-12.1(chr7:11048840-52863626)x3 copy number gain See cases [RCV000512091] Chr7:11048840..52863626 [GRCh37]
Chr7:7p21.3-12.1
pathogenic
NM_000168.6(GLI3):c.3635del (p.Gly1212fs) deletion Polydactyly, postaxial, type A1 [RCV000454366] Chr7:41965438 [GRCh38]
Chr7:42005036 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3140_3141delinsCA (p.Gln1047Pro) indel Greig cephalopolysyndactyly syndrome [RCV002481531]|not specified [RCV000486434] Chr7:41965932..41965933 [GRCh38]
Chr7:42005530..42005531 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4665dup (p.Asn1556fs) duplication not provided [RCV000478594] Chr7:41964407..41964408 [GRCh38]
Chr7:42004005..42004006 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1464_1489dup (p.Leu497fs) duplication not provided [RCV000486221] Chr7:42023475..42023476 [GRCh38]
Chr7:42063074..42063075 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2901del (p.Val968fs) deletion not provided [RCV000486324] Chr7:41966172 [GRCh38]
Chr7:42005770 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.4740A>G (p.Gln1580=) single nucleotide variant GLI3-related condition [RCV003892135]|Greig cephalopolysyndactyly syndrome [RCV000553815] Chr7:41964333 [GRCh38]
Chr7:42003931 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1578del (p.Phe527fs) deletion not provided [RCV000479622] Chr7:41978668 [GRCh38]
Chr7:42018267 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4145G>A (p.Gly1382Asp) single nucleotide variant not provided [RCV000483158] Chr7:41964928 [GRCh38]
Chr7:42004526 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2071C>T (p.Gln691Ter) single nucleotide variant not provided [RCV000498734] Chr7:41972369 [GRCh38]
Chr7:42011968 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3987C>T (p.Gly1329=) single nucleotide variant GLI3-related condition [RCV003925463]|Greig cephalopolysyndactyly syndrome [RCV000558382]|not provided [RCV001567055]|not specified [RCV000501027] Chr7:41965086 [GRCh38]
Chr7:42004684 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2685C>G (p.Tyr895Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000503394] Chr7:41966388 [GRCh38]
Chr7:42005986 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3284A>G (p.Asp1095Gly) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000764714]|not specified [RCV000503551] Chr7:41965789 [GRCh38]
Chr7:42005387 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1182A>G (p.Pro394=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002524190]|not provided [RCV000726840]|not specified [RCV000499402] Chr7:42026259 [GRCh38]
Chr7:42065858 [GRCh37]
Chr7:7p14.1
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000168.6(GLI3):c.3970G>C (p.Ala1324Pro) single nucleotide variant not specified [RCV000500051] Chr7:41965103 [GRCh38]
Chr7:42004701 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3098C>A (p.Pro1033Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002524191]|Inborn genetic diseases [RCV003343870]|not specified [RCV000500463] Chr7:41965975 [GRCh38]
Chr7:42005573 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
GRCh37/hg19 7p22.3-q36.3(chr7:43361-159119707) copy number gain See cases [RCV000510686] Chr7:43361..159119707 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
NM_000168.6(GLI3):c.1593T>C (p.Tyr531=) single nucleotide variant not specified [RCV000503162] Chr7:41978653 [GRCh38]
Chr7:42018252 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2726C>G (p.Ala909Gly) single nucleotide variant Congenital diaphragmatic hernia [RCV000578089] Chr7:41966347 [GRCh38]
Chr7:42005945 [GRCh37]
Chr7:7p14.1
risk factor
GRCh37/hg19 7p22.3-q36.3(chr7:43361-159119707)x3 copy number gain See cases [RCV000511549] Chr7:43361..159119707 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
NM_000168.6(GLI3):c.3147C>G (p.Tyr1049Ter) single nucleotide variant not provided [RCV000578645] Chr7:41965926 [GRCh38]
Chr7:42005524 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3324C>A (p.Tyr1108Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000634030] Chr7:41965749 [GRCh38]
Chr7:42005347 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3079C>T (p.Leu1027Phe) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000634031]|not provided [RCV001584461] Chr7:41965994 [GRCh38]
Chr7:42005592 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1028+1G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000634032]|Polydactyly, postaxial, type A1 [RCV001450021] Chr7:42040037 [GRCh38]
Chr7:42079636 [GRCh37]
Chr7:7p14.1
pathogenic|likely pathogenic
NM_000168.6(GLI3):c.1474G>A (p.Asp492Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000634033]|Inborn genetic diseases [RCV002528864] Chr7:42023491 [GRCh38]
Chr7:42063090 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1874G>A (p.Arg625Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000634035]|not provided [RCV001093382] Chr7:41972566 [GRCh38]
Chr7:42012165 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4638A>G (p.Pro1546=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000634047] Chr7:41964435 [GRCh38]
Chr7:42004033 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3823G>A (p.Gly1275Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000534571]|Greig cephalopolysyndactyly syndrome [RCV002497080] Chr7:41965250 [GRCh38]
Chr7:42004848 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.4395del (p.Ser1466fs) deletion Greig cephalopolysyndactyly syndrome [RCV000534797] Chr7:41964678 [GRCh38]
Chr7:42004276 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2104-8C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003767668]|not specified [RCV000605821] Chr7:41967931 [GRCh38]
Chr7:42007529 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1142T>C (p.Ile381Thr) single nucleotide variant Inborn genetic diseases [RCV003290644] Chr7:42026299 [GRCh38]
Chr7:42065898 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3740A>G (p.Gln1247Arg) single nucleotide variant Inborn genetic diseases [RCV003287864] Chr7:41965333 [GRCh38]
Chr7:42004931 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.772G>T (p.Ala258Ser) single nucleotide variant Inborn genetic diseases [RCV003275674] Chr7:42045438 [GRCh38]
Chr7:42085037 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1343C>T (p.Ala448Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000608659]|Greig cephalopolysyndactyly syndrome [RCV002506487] Chr7:42025277 [GRCh38]
Chr7:42064876 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3453C>T (p.Pro1151=) single nucleotide variant not specified [RCV000602123] Chr7:41965620 [GRCh38]
Chr7:42005218 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2032G>T (p.Asp678Tyr) single nucleotide variant not provided [RCV000594418] Chr7:41972408 [GRCh38]
Chr7:42012007 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3115G>A (p.Ala1039Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000557052] Chr7:41965958 [GRCh38]
Chr7:42005556 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.2615C>G (p.Ser872Cys) single nucleotide variant not provided [RCV003314784] Chr7:41966458 [GRCh38]
Chr7:42006056 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1177A>G (p.Ile393Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000535403] Chr7:42026264 [GRCh38]
Chr7:42065863 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.124+10A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001405010]|not specified [RCV000614643] Chr7:42223120 [GRCh38]
Chr7:42262719 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.563C>A (p.Ser188Tyr) single nucleotide variant GLI3-related condition [RCV003917912]|Greig cephalopolysyndactyly syndrome [RCV001165403]|Greig cephalopolysyndactyly syndrome [RCV002531513]|Pallister-Hall syndrome [RCV001163299]|Polydactyly [RCV001165404]|not specified [RCV000614792] Chr7:42048607 [GRCh38]
Chr7:42088206 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3620G>A (p.Ser1207Asn) single nucleotide variant Inborn genetic diseases [RCV003310742] Chr7:41965453 [GRCh38]
Chr7:42005051 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.750del (p.Tyr251fs) deletion Greig cephalopolysyndactyly syndrome [RCV000627064] Chr7:42045460 [GRCh38]
Chr7:42085059 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.847A>T (p.Arg283Trp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000634036] Chr7:42040219 [GRCh38]
Chr7:42079818 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3669C>T (p.Tyr1223=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000634043] Chr7:41965404 [GRCh38]
Chr7:42005002 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3804C>T (p.Leu1268=) single nucleotide variant GLI3-related condition [RCV003892434]|Greig cephalopolysyndactyly syndrome [RCV000634046] Chr7:41965269 [GRCh38]
Chr7:42004867 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1242+6del deletion Greig cephalopolysyndactyly syndrome [RCV000634048] Chr7:42026193 [GRCh38]
Chr7:42065792 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3351G>A (p.Pro1117=) single nucleotide variant GLI3-related condition [RCV003942669]|Greig cephalopolysyndactyly syndrome [RCV001413484]|not provided [RCV000513484] Chr7:41965722 [GRCh38]
Chr7:42005320 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3549C>T (p.Pro1183=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003790875] Chr7:41965524 [GRCh38]
Chr7:42005122 [GRCh37]
Chr7:7p14.1
likely benign
GRCh37/hg19 7p14.1(chr7:42156923-42225427)x1 copy number loss not provided [RCV000682771] Chr7:42156923..42225427 [GRCh37]
Chr7:7p14.1
likely pathogenic
GRCh37/hg19 7p14.1(chr7:42255311-42634746)x3 copy number gain not provided [RCV000682837] Chr7:42255311..42634746 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3904_3912delinsT (p.Asn1302fs) indel Greig cephalopolysyndactyly syndrome [RCV000700476] Chr7:41965161..41965169 [GRCh38]
Chr7:42004759..42004767 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1451G>A (p.Trp484Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000701080] Chr7:42023514 [GRCh38]
Chr7:42063113 [GRCh37]
Chr7:7p14.1
pathogenic
GRCh37/hg19 7p14.3-13(chr7:30463886-43470805)x3 copy number gain not provided [RCV000682909] Chr7:30463886..43470805 [GRCh37]
Chr7:7p14.3-13
pathogenic
NM_000168.6(GLI3):c.272A>G (p.His91Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000702629] Chr7:42148321 [GRCh38]
Chr7:42187920 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4498G>T (p.Glu1500Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000686853] Chr7:41964575 [GRCh38]
Chr7:42004173 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3790G>A (p.Ala1264Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000702272] Chr7:41965283 [GRCh38]
Chr7:42004881 [GRCh37]
Chr7:7p14.1
uncertain significance
NC_000007.14:g.(?_42048471)_(42148488_?)del deletion Greig cephalopolysyndactyly syndrome [RCV000708127] Chr7:42048471..42148488 [GRCh38]
Chr7:42088070..42188087 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1184G>A (p.Gly395Glu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000706595] Chr7:42026257 [GRCh38]
Chr7:42065856 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.659G>A (p.Arg220His) single nucleotide variant GLI3-related condition [RCV003403606]|Greig cephalopolysyndactyly syndrome [RCV000692750] Chr7:42048511 [GRCh38]
Chr7:42088110 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3122A>G (p.Lys1041Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000693216] Chr7:41965951 [GRCh38]
Chr7:42005549 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3509C>G (p.Ala1170Gly) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000703711]|Inborn genetic diseases [RCV002536373] Chr7:41965564 [GRCh38]
Chr7:42005162 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.4007_4009delinsAGT (p.Gly1336_Ala1337delinsGluSer) indel not provided [RCV000723114] Chr7:41965064..41965066 [GRCh38]
Chr7:42004662..42004664 [GRCh37]
Chr7:7p14.1
uncertain significance
NC_000007.13:g.(20954043_21001537)_(114528369_114556605)inv inversion Childhood apraxia of speech [RCV000234948] Chr7:21001537..114528369 [GRCh37]
Chr7:7p15.3-q31.1
pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:10704-159122532)x3 copy number gain not provided [RCV000746278] Chr7:10704..159122532 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:44935-159126310)x3 copy number gain not provided [RCV000746280] Chr7:44935..159126310 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
NM_000168.6(GLI3):c.45A>T (p.Lys15Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001543685] Chr7:42223209 [GRCh38]
Chr7:42262808 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2233G>A (p.Asp745Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002568166]|not provided [RCV001529531] Chr7:41967794 [GRCh38]
Chr7:42007392 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3579C>T (p.Phe1193=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001480071] Chr7:41965494 [GRCh38]
Chr7:42005092 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.565C>T (p.Pro189Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002064776]|not provided [RCV000874730] Chr7:42048605 [GRCh38]
Chr7:42088204 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4037_4046dup (p.Ser1349delinsArgAlaAspTer) duplication not provided [RCV000762450] Chr7:41965026..41965027 [GRCh38]
Chr7:42004624..42004625 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2881G>A (p.Gly961Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002493394]|not provided [RCV000762451] Chr7:41966192 [GRCh38]
Chr7:42005790 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4317C>A (p.Tyr1439Ter) single nucleotide variant not provided [RCV000760565] Chr7:41964756 [GRCh38]
Chr7:42004354 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.1812+314C>T single nucleotide variant not provided [RCV001576965] Chr7:41977244 [GRCh38]
Chr7:42016843 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3877C>G (p.Leu1293Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001044473]|Greig cephalopolysyndactyly syndrome [RCV002481913] Chr7:41965196 [GRCh38]
Chr7:42004794 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.2735G>A (p.Ser912Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002569037]|not provided [RCV001567363] Chr7:41966338 [GRCh38]
Chr7:42005936 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1527G>C (p.Glu509Asp) single nucleotide variant Disorder of sexual differentiation [RCV001568324]|GLI3-related postaxial polydactyly [RCV000984967] Chr7:41978719 [GRCh38]
Chr7:42018318 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.100G>A (p.Val34Ile) single nucleotide variant not provided [RCV001597512] Chr7:42223154 [GRCh38]
Chr7:42262753 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3183C>G (p.His1061Gln) single nucleotide variant not provided [RCV000903374] Chr7:41965890 [GRCh38]
Chr7:42005488 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.480C>T (p.Ser160=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001158675]|Greig cephalopolysyndactyly syndrome [RCV001469247]|Pallister-Hall syndrome [RCV001161888]|Polydactyly [RCV001158676] Chr7:42048690 [GRCh38]
Chr7:42088289 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3054G>A (p.Leu1018=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002502895]|Greig cephalopolysyndactyly syndrome [RCV003768908] Chr7:41966019 [GRCh38]
Chr7:42005617 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3986G>T (p.Gly1329Val) single nucleotide variant not provided [RCV000880276] Chr7:41965087 [GRCh38]
Chr7:42004685 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.168C>T (p.Asn56=) single nucleotide variant GLI3-related condition [RCV003935922]|Greig cephalopolysyndactyly syndrome [RCV002066360]|Greig cephalopolysyndactyly syndrome [RCV002489345]|not provided [RCV000959748] Chr7:42148425 [GRCh38]
Chr7:42188024 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.445G>A (p.Asp149Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000983372] Chr7:42076780 [GRCh38]
Chr7:42116379 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3852C>T (p.Thr1284=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000945497] Chr7:41965221 [GRCh38]
Chr7:42004819 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.825T>C (p.Asp275=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001161771]|Pallister-Hall syndrome [RCV001161769]|Polydactyly [RCV001161770]|not provided [RCV000945525] Chr7:42045385 [GRCh38]
Chr7:42084984 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1357-9T>A single nucleotide variant GLI3-related condition [RCV003910764]|Greig cephalopolysyndactyly syndrome [RCV002502667]|Greig cephalopolysyndactyly syndrome [RCV002542062] Chr7:42023617 [GRCh38]
Chr7:42063216 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.558C>T (p.Ser186=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002548272] Chr7:42048612 [GRCh38]
Chr7:42088211 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1779C>T (p.Arg593=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000920988] Chr7:41977591 [GRCh38]
Chr7:42017190 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3889C>T (p.Leu1297=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000882168] Chr7:41965184 [GRCh38]
Chr7:42004782 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.30C>T (p.Thr10=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001502275]|Greig cephalopolysyndactyly syndrome [RCV002489283] Chr7:42223224 [GRCh38]
Chr7:42262823 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4654A>C (p.Met1552Leu) single nucleotide variant GLI3-related condition [RCV003962959]|Greig cephalopolysyndactyly syndrome [RCV000983815]|Inborn genetic diseases [RCV003353105] Chr7:41964419 [GRCh38]
Chr7:42004017 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.885del (p.Ile296fs) deletion Greig cephalopolysyndactyly syndrome [RCV001036674] Chr7:42040181 [GRCh38]
Chr7:42079780 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2098C>T (p.Pro700Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001038712] Chr7:41972342 [GRCh38]
Chr7:42011941 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3621C>A (p.Ser1207Arg) single nucleotide variant Inborn genetic diseases [RCV003310751] Chr7:41965452 [GRCh38]
Chr7:42005050 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4709C>T (p.Ala1570Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001055857]|Greig cephalopolysyndactyly syndrome [RCV002482006] Chr7:41964364 [GRCh38]
Chr7:42003962 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3874del (p.Gln1292fs) deletion Greig cephalopolysyndactyly syndrome [RCV001056604]|Greig cephalopolysyndactyly syndrome [RCV003313984] Chr7:41965199 [GRCh38]
Chr7:42004797 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4019C>A (p.Pro1340His) single nucleotide variant Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome [RCV001007868] Chr7:41965054 [GRCh38]
Chr7:42004652 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2740_2748dup (p.Gly914_Pro916dup) duplication Greig cephalopolysyndactyly syndrome [RCV001034025] Chr7:41966324..41966325 [GRCh38]
Chr7:42005922..42005923 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4636C>T (p.Pro1546Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001034194] Chr7:41964437 [GRCh38]
Chr7:42004035 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1473C>G (p.Phe491Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001034315] Chr7:42023492 [GRCh38]
Chr7:42063091 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1930G>A (p.Gly644Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000809141] Chr7:41972510 [GRCh38]
Chr7:42012109 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1433_1434del (p.Ile477_Tyr478insTer) deletion Greig cephalopolysyndactyly syndrome [RCV000806324] Chr7:42023531..42023532 [GRCh38]
Chr7:42063130..42063131 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3490del (p.Glu1164fs) deletion GLI3-Related Disorders [RCV000778830] Chr7:41965583 [GRCh38]
Chr7:42005181 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1222G>A (p.Gly408Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001500958] Chr7:42026219 [GRCh38]
Chr7:42065818 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3756G>C (p.Pro1252=) single nucleotide variant not provided [RCV000926353] Chr7:41965317 [GRCh38]
Chr7:42004915 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.636G>A (p.Ser212=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001412138] Chr7:42048534 [GRCh38]
Chr7:42088133 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.315C>T (p.Arg105=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000952633] Chr7:42148278 [GRCh38]
Chr7:42187877 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3624G>A (p.Gly1208=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000933067] Chr7:41965449 [GRCh38]
Chr7:42005047 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1206C>T (p.Pro402=) single nucleotide variant not provided [RCV000960773] Chr7:42026235 [GRCh38]
Chr7:42065834 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2625C>G (p.Arg875=) single nucleotide variant not provided [RCV000923850] Chr7:41966448 [GRCh38]
Chr7:42006046 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1062C>T (p.Pro354=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001858580] Chr7:42026379 [GRCh38]
Chr7:42065978 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2432-5T>C single nucleotide variant not provided [RCV000900415] Chr7:41966646 [GRCh38]
Chr7:42006244 [GRCh37]
Chr7:7p14.1
likely benign|conflicting interpretations of pathogenicity
NM_000168.6(GLI3):c.2706C>T (p.Ala902=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002489286]|Greig cephalopolysyndactyly syndrome [RCV002547182] Chr7:41966367 [GRCh38]
Chr7:42005965 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4629G>A (p.Ala1543=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003768896] Chr7:41964444 [GRCh38]
Chr7:42004042 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.546C>A (p.Pro182=) single nucleotide variant not provided [RCV000979201] Chr7:42048624 [GRCh38]
Chr7:42088223 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4698G>A (p.Leu1566=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003768771] Chr7:41964375 [GRCh38]
Chr7:42003973 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.567C>T (p.Pro189=) single nucleotide variant GLI3-related condition [RCV003948219]|Greig cephalopolysyndactyly syndrome [RCV002064775]|not provided [RCV000874729] Chr7:42048603 [GRCh38]
Chr7:42088202 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3141G>A (p.Gln1047=) single nucleotide variant not provided [RCV000921809] Chr7:41965932 [GRCh38]
Chr7:42005530 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1386G>A (p.Lys462=) single nucleotide variant GLI3-related condition [RCV003938320]|Greig cephalopolysyndactyly syndrome [RCV000872829] Chr7:42023579 [GRCh38]
Chr7:42063178 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1728C>T (p.Tyr576=) single nucleotide variant not provided [RCV000872907] Chr7:41977642 [GRCh38]
Chr7:42017241 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.963C>T (p.Leu321=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001163189]|Pallister-Hall syndrome [RCV001163188]|Polydactyly [RCV001163187]|not provided [RCV000872940] Chr7:42040103 [GRCh38]
Chr7:42079702 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1346G>A (p.Arg449Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000804320] Chr7:42025274 [GRCh38]
Chr7:42064873 [GRCh37]
Chr7:7p14.1
conflicting interpretations of pathogenicity|uncertain significance
NC_000007.13:g.42007664del deletion not provided [RCV000841216]   benign
NM_000168.6(GLI3):c.2431+123G>A single nucleotide variant not provided [RCV000841217] Chr7:41967473 [GRCh38]
Chr7:42007071 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.4202del (p.Ser1401fs) deletion Greig cephalopolysyndactyly syndrome [RCV000856781] Chr7:41964871 [GRCh38]
Chr7:42004469 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.-42-149del deletion not provided [RCV000841193] Chr7:42223444 [GRCh38]
Chr7:42263043 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1622C>T (p.Thr541Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001204667]|Hyperreflexia [RCV000855672]|Inborn genetic diseases [RCV001266774]|not provided [RCV002067220] Chr7:41978624 [GRCh38]
Chr7:42018223 [GRCh37]
Chr7:7p14.1
pathogenic|likely pathogenic|uncertain significance
NM_000168.6(GLI3):c.600C>T (p.Tyr200=) single nucleotide variant not provided [RCV000893287] Chr7:42048570 [GRCh38]
Chr7:42088169 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.539G>A (p.Arg180Gln) single nucleotide variant GLI3-related condition [RCV003918272]|Greig cephalopolysyndactyly syndrome [RCV000797078]|Greig cephalopolysyndactyly syndrome [RCV001849447]|Greig cephalopolysyndactyly syndrome [RCV002495052] Chr7:42048631 [GRCh38]
Chr7:42088230 [GRCh37]
Chr7:7p14.1
likely pathogenic|benign|uncertain significance
NM_000168.6(GLI3):c.1357-4T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001503238] Chr7:42023612 [GRCh38]
Chr7:42063211 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.125-263A>G single nucleotide variant not provided [RCV000843323] Chr7:42148731 [GRCh38]
Chr7:42188330 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.974G>A (p.Arg325His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002481793]|not provided [RCV000998791] Chr7:42040092 [GRCh38]
Chr7:42079691 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4245C>T (p.Thr1415=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002544512] Chr7:41964828 [GRCh38]
Chr7:42004426 [GRCh37]
Chr7:7p14.1
likely benign
NC_000007.14:g.42026428dup duplication not provided [RCV000839252] Chr7:7p14.1 benign
NM_000168.6(GLI3):c.753T>G (p.Tyr251Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000799089] Chr7:42045457 [GRCh38]
Chr7:42085056 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4649T>C (p.Leu1550Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000815947]|Inborn genetic diseases [RCV002534880] Chr7:41964424 [GRCh38]
Chr7:42004022 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
GRCh37/hg19 7p14.1(chr7:40198215-43252984)x3 copy number gain not provided [RCV000849081] Chr7:40198215..43252984 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1992G>A (p.Ser664=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000816681] Chr7:41972448 [GRCh38]
Chr7:42012047 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.368-248C>T single nucleotide variant not provided [RCV000841196] Chr7:42077105 [GRCh38]
Chr7:42116704 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1096C>T (p.Arg366Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000822914]|not provided [RCV001579780] Chr7:42026345 [GRCh38]
Chr7:42065944 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.827-181C>T single nucleotide variant not provided [RCV000841736] Chr7:42040420 [GRCh38]
Chr7:42080019 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1356+64C>A single nucleotide variant not provided [RCV000841737] Chr7:42025200 [GRCh38]
Chr7:42064799 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1778del (p.Arg593fs) deletion Greig cephalopolysyndactyly syndrome [RCV000796308] Chr7:41977592 [GRCh38]
Chr7:42017191 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.680-14_680-13del deletion not provided [RCV000840254] Chr7:42045543..42045544 [GRCh38]
Chr7:42085142..42085143 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.935C>T (p.Thr312Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001165281]|Greig cephalopolysyndactyly syndrome [RCV003769799]|Pallister-Hall syndrome [RCV001165282]|Polydactyly [RCV001165280] Chr7:42040131 [GRCh38]
Chr7:42079730 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*28C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159577]|Pallister-Hall syndrome [RCV001164510]|Polydactyly [RCV001164509] Chr7:41964302 [GRCh38]
Chr7:42003900 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1957C>T (p.Pro653Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001165055]|Polydactyly [RCV001165054] Chr7:41972483 [GRCh38]
Chr7:42012082 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1497+256C>T single nucleotide variant not provided [RCV000828698] Chr7:42023212 [GRCh38]
Chr7:42062811 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.367+49TG[20] microsatellite Greig cephalopolysyndactyly syndrome [RCV000987865]|not provided [RCV001712839] Chr7:42148136..42148137 [GRCh38]
Chr7:42187735..42187736 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.*2744T>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001163997]|Polydactyly [RCV001163998] Chr7:41961586 [GRCh38]
Chr7:42001184 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.826+255T>C single nucleotide variant not provided [RCV000843326] Chr7:42045129 [GRCh38]
Chr7:42084728 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1028+281G>T single nucleotide variant not provided [RCV000843327] Chr7:42039757 [GRCh38]
Chr7:42079356 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.781G>A (p.Ala261Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000812607]|Greig cephalopolysyndactyly syndrome [RCV002501108]|not provided [RCV001759572] Chr7:42045429 [GRCh38]
Chr7:42085028 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1647+226C>A single nucleotide variant not provided [RCV000841199] Chr7:41978373 [GRCh38]
Chr7:42017972 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1024A>G (p.Ile342Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000803045]|Greig cephalopolysyndactyly syndrome [RCV002487707] Chr7:42040042 [GRCh38]
Chr7:42079641 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2697C>T (p.Ser899=) single nucleotide variant not provided [RCV000919239] Chr7:41966376 [GRCh38]
Chr7:42005974 [GRCh37]
Chr7:7p14.1
likely benign
GRCh37/hg19 7p22.3-q36.3(chr7:10365-159119707)x3 copy number gain not provided [RCV000848126] Chr7:10365..159119707 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
GRCh37/hg19 7p14.1(chr7:42174178-42319482)x3 copy number gain not provided [RCV000846052] Chr7:42174178..42319482 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2623C>T (p.Arg875Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001044661]|Greig cephalopolysyndactyly syndrome [RCV002481915] Chr7:41966450 [GRCh38]
Chr7:42006048 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.4010del (p.Ala1337fs) deletion not provided [RCV001009115] Chr7:41965063 [GRCh38]
Chr7:42004661 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.-105A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001163511]|Polydactyly [RCV001163512] Chr7:42237033 [GRCh38]
Chr7:42276632 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4316_4724del (p.Tyr1439fs) deletion Greig cephalopolysyndactyly syndrome [RCV001221370] Chr7:41964349..41964757 [GRCh38]
Chr7:42003947..42004355 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4430_4439del (p.Ser1477fs) deletion Greig cephalopolysyndactyly syndrome [RCV001248778] Chr7:41964634..41964643 [GRCh38]
Chr7:42004232..42004241 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4385T>C (p.Ile1462Thr) single nucleotide variant Inborn genetic diseases [RCV003290824] Chr7:41964688 [GRCh38]
Chr7:42004286 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2005A>C (p.Thr669Pro) single nucleotide variant Inborn genetic diseases [RCV003291704] Chr7:41972435 [GRCh38]
Chr7:42012034 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2057G>A (p.Arg686Gln) single nucleotide variant Inborn genetic diseases [RCV003272234] Chr7:41972383 [GRCh38]
Chr7:42011982 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4076G>A (p.Gly1359Glu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000987864] Chr7:41964997 [GRCh38]
Chr7:42004595 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2729G>A (p.Ser910Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001164940]|Greig cephalopolysyndactyly syndrome [RCV001245848]|Polydactyly [RCV001164941] Chr7:41966344 [GRCh38]
Chr7:42005942 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*386A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159468]|Polydactyly [RCV001159469] Chr7:41963944 [GRCh38]
Chr7:42003542 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4016G>T (p.Arg1339Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159692]|Polydactyly [RCV001159691] Chr7:41965057 [GRCh38]
Chr7:42004655 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3622G>T (p.Gly1208Trp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159799]|Inborn genetic diseases [RCV002557365]|Pallister-Hall syndrome [RCV001159798]|Polydactyly [RCV001159797] Chr7:41965451 [GRCh38]
Chr7:42005049 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.2375G>A (p.Arg792Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001160022]|Polydactyly [RCV001161435] Chr7:41967652 [GRCh38]
Chr7:42007250 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.21C>T (p.Ser7=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001160137]|Polydactyly [RCV001160136] Chr7:42223233 [GRCh38]
Chr7:42262832 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1057G>A (p.Ala353Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001161662]|Greig cephalopolysyndactyly syndrome [RCV002505740]|Polydactyly [RCV001161661] Chr7:42026384 [GRCh38]
Chr7:42065983 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*2176G>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001164090]|Polydactyly [RCV001164089] Chr7:41962154 [GRCh38]
Chr7:42001752 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1356+10C>A single nucleotide variant GLI3-related condition [RCV003953542]|Greig cephalopolysyndactyly syndrome [RCV001158453]|Pallister-Hall syndrome [RCV001158455]|Polydactyly [RCV001158454] Chr7:42025254 [GRCh38]
Chr7:42064853 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3490G>T (p.Glu1164Ter) single nucleotide variant not provided [RCV003237157] Chr7:41965583 [GRCh38]
Chr7:42005181 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2798_2803dup (p.Ala934_Ala935insAspAla) duplication not provided [RCV003127111] Chr7:41966269..41966270 [GRCh38]
Chr7:42005867..42005868 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.473+210G>A single nucleotide variant not provided [RCV001576432] Chr7:42076542 [GRCh38]
Chr7:42116141 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.124+181G>T single nucleotide variant not provided [RCV001577501] Chr7:42222949 [GRCh38]
Chr7:42262548 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1463C>T (p.Ala488Val) single nucleotide variant GLI3-related condition [RCV003420543]|Greig cephalopolysyndactyly syndrome [RCV003106724] Chr7:42023502 [GRCh38]
Chr7:42063101 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.-42-257G>A single nucleotide variant not provided [RCV001574840] Chr7:42223552 [GRCh38]
Chr7:42263151 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1357-304_1357-303dup duplication not provided [RCV001575966] Chr7:42023903..42023904 [GRCh38]
Chr7:42063502..42063503 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.-42-55dup duplication not provided [RCV001638713] Chr7:42223336..42223337 [GRCh38]
Chr7:42262935..42262936 [GRCh37]
Chr7:7p14.1
benign
NC_000007.14:g.41960903C>T single nucleotide variant not provided [RCV001680935] Chr7:41960903 [GRCh38]
Chr7:42000501 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.679+156del deletion not provided [RCV001645256] Chr7:42048335 [GRCh38]
Chr7:42087934 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2103+177G>A single nucleotide variant not provided [RCV001560865] Chr7:41972160 [GRCh38]
Chr7:42011759 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1648-220del deletion not provided [RCV001597830] Chr7:41977942 [GRCh38]
Chr7:42017541 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.-42-42del deletion not provided [RCV001645631] Chr7:42223337 [GRCh38]
Chr7:42262936 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2104-209T>G single nucleotide variant not provided [RCV001638365] Chr7:41968132 [GRCh38]
Chr7:42007731 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.679+124T>C single nucleotide variant not provided [RCV001717533] Chr7:42048367 [GRCh38]
Chr7:42087966 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2431+258T>G single nucleotide variant not provided [RCV001550984] Chr7:41967338 [GRCh38]
Chr7:42006936 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3029G>A (p.Arg1010Gln) single nucleotide variant not provided [RCV001551115] Chr7:41966044 [GRCh38]
Chr7:42005642 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.367+49TG[19] microsatellite not provided [RCV001639996] Chr7:42148136..42148139 [GRCh38]
Chr7:42187735..42187738 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1356+228G>A single nucleotide variant not provided [RCV001614061] Chr7:42025036 [GRCh38]
Chr7:42064635 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3780G>A (p.Arg1260=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001494859] Chr7:41965293 [GRCh38]
Chr7:42004891 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2604G>C (p.Ser868=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001443587] Chr7:41966469 [GRCh38]
Chr7:42006067 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1028+3A>T single nucleotide variant GLI3-related condition [RCV003898002]|Greig cephalopolysyndactyly syndrome [RCV001506252]|not specified [RCV001819688] Chr7:42040035 [GRCh38]
Chr7:42079634 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3498C>T (p.Ser1166=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000922701] Chr7:41965575 [GRCh38]
Chr7:42005173 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4089C>T (p.Cys1363=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001461681]|Greig cephalopolysyndactyly syndrome [RCV002495366] Chr7:41964984 [GRCh38]
Chr7:42004582 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.936G>T (p.Thr312=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001416261] Chr7:42040130 [GRCh38]
Chr7:42079729 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3405A>T (p.Pro1135=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001480126] Chr7:41965668 [GRCh38]
Chr7:42005266 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2232C>A (p.Ile744=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002068702] Chr7:41967795 [GRCh38]
Chr7:42007393 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3261C>T (p.Asn1087=) single nucleotide variant GLI3-related condition [RCV003970813]|Greig cephalopolysyndactyly syndrome [RCV002489344]|Greig cephalopolysyndactyly syndrome [RCV002548270]|not provided [RCV003432964] Chr7:41965812 [GRCh38]
Chr7:42005410 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2307G>A (p.Pro769=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002502662]|not provided [RCV000901736] Chr7:41967720 [GRCh38]
Chr7:42007318 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1356+10C>T single nucleotide variant GLI3-related condition [RCV003978087]|not provided [RCV000930719] Chr7:42025254 [GRCh38]
Chr7:42064853 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2966G>T (p.Arg989Leu) single nucleotide variant GLI3-related condition [RCV003978116]|Greig cephalopolysyndactyly syndrome [RCV000940359] Chr7:41966107 [GRCh38]
Chr7:42005705 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4638A>T (p.Pro1546=) single nucleotide variant not provided [RCV000951176] Chr7:41964435 [GRCh38]
Chr7:42004033 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1365C>T (p.Pro455=) single nucleotide variant GLI3-related condition [RCV003948212]|Greig cephalopolysyndactyly syndrome [RCV000874417]|Greig cephalopolysyndactyly syndrome [RCV002487921] Chr7:42023600 [GRCh38]
Chr7:42063199 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2605C>T (p.Pro869Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001046491] Chr7:41966468 [GRCh38]
Chr7:42006066 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3372C>T (p.His1124=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003769843]|not provided [RCV001171986] Chr7:41965701 [GRCh38]
Chr7:42005299 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1648-7T>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001158345]|Polydactyly [RCV001158346] Chr7:41977729 [GRCh38]
Chr7:42017328 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1221C>T (p.Ser407=) single nucleotide variant GLI3-related condition [RCV003938525]|Greig cephalopolysyndactyly syndrome [RCV001158457]|Pallister-Hall syndrome [RCV001158458]|Polydactyly [RCV001158456]|not provided [RCV001310962] Chr7:42026220 [GRCh38]
Chr7:42065819 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1315C>T (p.Pro439Ser) single nucleotide variant Pallister-Hall syndrome [RCV001199081] Chr7:42025305 [GRCh38]
Chr7:42064904 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.658C>T (p.Arg220Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001242651]|Greig cephalopolysyndactyly syndrome [RCV002484334] Chr7:42048512 [GRCh38]
Chr7:42088111 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.*2612A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159081]|Polydactyly [RCV001159080] Chr7:41961718 [GRCh38]
Chr7:42001316 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3670G>A (p.Gly1224Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001207865] Chr7:41965403 [GRCh38]
Chr7:42005001 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.776C>G (p.Ala259Gly) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001161775]|Greig cephalopolysyndactyly syndrome [RCV003769777]|Polydactyly [RCV001161776] Chr7:42045434 [GRCh38]
Chr7:42085033 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.*1399T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159287]|Polydactyly [RCV001159288] Chr7:41962931 [GRCh38]
Chr7:42002529 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*1332C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159289]|Polydactyly [RCV001160647] Chr7:41962998 [GRCh38]
Chr7:42002596 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*603A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001164410]|Pallister-Hall syndrome [RCV001162364]|Polydactyly [RCV001162363] Chr7:41963727 [GRCh38]
Chr7:42003325 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.*333A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159471]|Polydactyly [RCV001159470] Chr7:41963997 [GRCh38]
Chr7:42003595 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2004G>A (p.Pro668=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001162976]|Greig cephalopolysyndactyly syndrome [RCV002067981]|Polydactyly [RCV001162977] Chr7:41972436 [GRCh38]
Chr7:42012035 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.2740G>A (p.Gly914Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001164939]|Polydactyly [RCV001164938] Chr7:41966333 [GRCh38]
Chr7:42005931 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3040G>C (p.Glu1014Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159916]|Greig cephalopolysyndactyly syndrome [RCV002032473]|Polydactyly [RCV001159915] Chr7:41966033 [GRCh38]
Chr7:42005631 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.368-7T>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001163414]|Greig cephalopolysyndactyly syndrome [RCV002558569]|Pallister-Hall syndrome [RCV001163413]|Polydactyly [RCV001163415] Chr7:42076864 [GRCh38]
Chr7:42116463 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.2720del (p.Ser907fs) deletion Greig cephalopolysyndactyly syndrome [RCV001223594] Chr7:41966353 [GRCh38]
Chr7:42005951 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3591G>A (p.Met1197Ile) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001216988]|Greig cephalopolysyndactyly syndrome [RCV002497740] Chr7:41965482 [GRCh38]
Chr7:42005080 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.4382C>T (p.Ser1461Phe) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001047574] Chr7:41964691 [GRCh38]
Chr7:42004289 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.698G>A (p.Ser233Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001034242] Chr7:42045512 [GRCh38]
Chr7:42085111 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4610G>A (p.Arg1537His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001218037] Chr7:41964463 [GRCh38]
Chr7:42004061 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.474-6A>G single nucleotide variant not provided [RCV000933582] Chr7:42048702 [GRCh38]
Chr7:42088301 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3768C>T (p.Asn1256=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV000911258] Chr7:41965305 [GRCh38]
Chr7:42004903 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.252A>G (p.Ser84=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002489247]|Greig cephalopolysyndactyly syndrome [RCV002544476] Chr7:42148341 [GRCh38]
Chr7:42187940 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3024G>A (p.Pro1008=) single nucleotide variant not provided [RCV000912352] Chr7:41966049 [GRCh38]
Chr7:42005647 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.679+281A>C single nucleotide variant not provided [RCV001556516] Chr7:42048210 [GRCh38]
Chr7:42087809 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2686G>C (p.Asp896His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002470432] Chr7:41966387 [GRCh38]
Chr7:42005985 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4217C>G (p.Ser1406Ter) single nucleotide variant not provided [RCV001665013] Chr7:41964856 [GRCh38]
Chr7:42004454 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.474-271T>C single nucleotide variant not provided [RCV001552795] Chr7:42048967 [GRCh38]
Chr7:42088566 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.124+61C>A single nucleotide variant not provided [RCV001635775] Chr7:42223069 [GRCh38]
Chr7:42262668 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3478A>G (p.Ile1160Val) single nucleotide variant not provided [RCV003231820] Chr7:41965595 [GRCh38]
Chr7:42005193 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1459T>A (p.Cys487Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002471384]|Greig cephalopolysyndactyly syndrome [RCV003775510] Chr7:42023506 [GRCh38]
Chr7:42063105 [GRCh37]
Chr7:7p14.1
likely pathogenic|uncertain significance
NM_000168.6(GLI3):c.2257A>G (p.Thr753Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002571433]|not provided [RCV002469707] Chr7:41967770 [GRCh38]
Chr7:42007368 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3734A>G (p.His1245Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002480878]|not provided [RCV001263258] Chr7:41965339 [GRCh38]
Chr7:42004937 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1243-261T>G single nucleotide variant not provided [RCV001659031] Chr7:42025638 [GRCh38]
Chr7:42065237 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.367+49TG[17] microsatellite not provided [RCV001608281] Chr7:42148136..42148143 [GRCh38]
Chr7:42187735..42187742 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.827-204C>T single nucleotide variant not provided [RCV001636568] Chr7:42040443 [GRCh38]
Chr7:42080042 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.679+212C>T single nucleotide variant not provided [RCV001593625] Chr7:42048279 [GRCh38]
Chr7:42087878 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.367+49TG[23] microsatellite not provided [RCV001596126] Chr7:42148135..42148136 [GRCh38]
Chr7:42187734..42187735 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.826+154T>C single nucleotide variant not provided [RCV001677562] Chr7:42045230 [GRCh38]
Chr7:42084829 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.474-175T>G single nucleotide variant not provided [RCV001658685] Chr7:42048871 [GRCh38]
Chr7:42088470 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.*9A>G single nucleotide variant GLI3-related condition [RCV003956321]|not provided [RCV001677085] Chr7:41964321 [GRCh38]
Chr7:42003919 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3155C>G (p.Pro1052Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002488446]|Greig cephalopolysyndactyly syndrome [RCV003771819]|not provided [RCV001658809] Chr7:41965918 [GRCh38]
Chr7:42005516 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2103+245A>G single nucleotide variant not provided [RCV001658977] Chr7:41972092 [GRCh38]
Chr7:42011691 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.*1553T>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001162159]|Polydactyly [RCV001162158] Chr7:41962777 [GRCh38]
Chr7:42002375 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*73C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001164508]|Polydactyly [RCV001162462] Chr7:41964257 [GRCh38]
Chr7:42003855 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3786A>G (p.Pro1262=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001162654]|Polydactyly [RCV001162655] Chr7:41965287 [GRCh38]
Chr7:42004885 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.864G>A (p.Pro288=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001158562]|Pallister-Hall syndrome [RCV001158561]|Polydactyly [RCV001158563] Chr7:42040202 [GRCh38]
Chr7:42079801 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3278C>T (p.Pro1093Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001161200]|Greig cephalopolysyndactyly syndrome [RCV002497591]|Polydactyly [RCV001161201] Chr7:41965795 [GRCh38]
Chr7:42005393 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*2050T>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159187]|Pallister-Hall syndrome [RCV001159185]|Polydactyly [RCV001159186] Chr7:41962280 [GRCh38]
Chr7:42001878 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.*889T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159380]|Polydactyly [RCV001159379] Chr7:41963441 [GRCh38]
Chr7:42003039 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4627G>T (p.Ala1543Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159578]|Polydactyly [RCV001159579] Chr7:41964446 [GRCh38]
Chr7:42004044 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3784_3787dup (p.Val1263fs) duplication Greig cephalopolysyndactyly syndrome [RCV001047710] Chr7:41965285..41965286 [GRCh38]
Chr7:42004883..42004884 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1462_1497+2dup duplication not provided [RCV001093383] Chr7:42023465..42023466 [GRCh38]
Chr7:42063064..42063065 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.*311T>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001160838]|Polydactyly [RCV001159475] Chr7:41964019 [GRCh38]
Chr7:42003617 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4008G>A (p.Gly1336=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159695]|Greig cephalopolysyndactyly syndrome [RCV002497590]|Pallister-Hall syndrome [RCV001159694]|Polydactyly [RCV001159693] Chr7:41965065 [GRCh38]
Chr7:42004663 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.*248T>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001160840]|Polydactyly [RCV001160839]|not provided [RCV001673021] Chr7:41964082 [GRCh38]
Chr7:42003680 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.125-333G>T single nucleotide variant not provided [RCV001671810] Chr7:42148801 [GRCh38]
Chr7:42188400 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2431+201dup duplication not provided [RCV001684120] Chr7:41967388..41967389 [GRCh38]
Chr7:42006986..42006987 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.91G>T (p.Glu31Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001071422] Chr7:42223163 [GRCh38]
Chr7:42262762 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.-43+224G>C single nucleotide variant not provided [RCV001648239] Chr7:42236747 [GRCh38]
Chr7:42276346 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.367+49TG[18] microsatellite not provided [RCV001648382] Chr7:42148136..42148141 [GRCh38]
Chr7:42187735..42187740 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.367+90GC[4] microsatellite not provided [RCV001645234] Chr7:42148130..42148131 [GRCh38]
Chr7:42187729..42187730 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.783C>T (p.Ala261=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001161772]|Greig cephalopolysyndactyly syndrome [RCV003769776]|Pallister-Hall syndrome [RCV001161774]|Polydactyly [RCV001161773] Chr7:42045427 [GRCh38]
Chr7:42085026 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.*2861T>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001161984]|Polydactyly [RCV001161983] Chr7:41961469 [GRCh38]
Chr7:42001067 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3083_3084del (p.Ser1028fs) deletion not provided [RCV001666496] Chr7:41965989..41965990 [GRCh38]
Chr7:42005587..42005588 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2981C>G (p.Pro994Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001034167] Chr7:41966092 [GRCh38]
Chr7:42005690 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2189T>G (p.Leu730Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001034366] Chr7:41967838 [GRCh38]
Chr7:42007436 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.506C>T (p.Pro169Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001034454]|Greig cephalopolysyndactyly syndrome [RCV002489534] Chr7:42048664 [GRCh38]
Chr7:42088263 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4342G>A (p.Val1448Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001162556]|Inborn genetic diseases [RCV003163353]|Pallister-Hall syndrome [RCV001164609]|Polydactyly [RCV001164608] Chr7:41964731 [GRCh38]
Chr7:42004329 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.288C>T (p.His96=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001163701]|Greig cephalopolysyndactyly syndrome [RCV002480572]|Greig cephalopolysyndactyly syndrome [RCV002557400]|Pallister-Hall syndrome [RCV001163700]|Polydactyly [RCV001163699]|not provided [RCV003311952] Chr7:42148305 [GRCh38]
Chr7:42187904 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.1777C>G (p.Arg593Gly) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001231721] Chr7:41977593 [GRCh38]
Chr7:42017192 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.320C>T (p.Thr107Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001217362] Chr7:42148273 [GRCh38]
Chr7:42187872 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3454del (p.Glu1152fs) deletion Greig cephalopolysyndactyly syndrome [RCV001054833] Chr7:41965619 [GRCh38]
Chr7:42005217 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2048C>T (p.Thr683Ile) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003770220]|Pallister-Hall syndrome [RCV001198781] Chr7:41972392 [GRCh38]
Chr7:42011991 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*2089G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159183]|Polydactyly [RCV001159184] Chr7:41962241 [GRCh38]
Chr7:42001839 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3857T>G (p.Met1286Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001036375] Chr7:41965216 [GRCh38]
Chr7:42004814 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*332T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159473]|Pallister-Hall syndrome [RCV001159474]|Polydactyly [RCV001159472]|not provided [RCV003425964] Chr7:41963998 [GRCh38]
Chr7:42003596 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.*1470A>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001164184]|Polydactyly [RCV001164185] Chr7:41962860 [GRCh38]
Chr7:42002458 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3065C>T (p.Pro1022Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001159913]|Polydactyly [RCV001159914] Chr7:41966008 [GRCh38]
Chr7:42005606 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4508A>T (p.Gln1503Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001051098]|Greig cephalopolysyndactyly syndrome [RCV002497400] Chr7:41964565 [GRCh38]
Chr7:42004163 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.*2517G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001160438]|Polydactyly [RCV001160437]|not provided [RCV003433060] Chr7:41961813 [GRCh38]
Chr7:42001411 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1497+1G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001041488]|not provided [RCV001093384] Chr7:42023467 [GRCh38]
Chr7:42063066 [GRCh37]
Chr7:7p14.1
pathogenic
GRCh37/hg19 7p14.1(chr7:41430185-42807426)x1 copy number loss Greig cephalopolysyndactyly syndrome [RCV001004813] Chr7:41430185..42807426 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1540G>A (p.Val514Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001161554]|Greig cephalopolysyndactyly syndrome [RCV002505739]|Polydactyly [RCV001161553] Chr7:41978706 [GRCh38]
Chr7:42018305 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1066T>C (p.Ser356Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001161660]|Polydactyly [RCV001161659] Chr7:42026375 [GRCh38]
Chr7:42065974 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.877_881del (p.Thr293fs) deletion Greig cephalopolysyndactyly syndrome [RCV001063154] Chr7:42040185..42040189 [GRCh38]
Chr7:42079784..42079788 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.473+5G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001052560]|Polysyndactyly 4 [RCV001726427] Chr7:42076747 [GRCh38]
Chr7:42116346 [GRCh37]
Chr7:7p14.1
pathogenic|uncertain significance
NM_000168.6(GLI3):c.*3002A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001161981]|Polydactyly [RCV001161982] Chr7:41961328 [GRCh38]
Chr7:42000926 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4597C>A (p.His1533Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001211050]|Greig cephalopolysyndactyly syndrome [RCV002491647] Chr7:41964476 [GRCh38]
Chr7:42004074 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1862C>T (p.Pro621Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001255861] Chr7:41972578 [GRCh38]
Chr7:42012177 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.240C>T (p.Asp80=) single nucleotide variant GLI3-related condition [RCV003953610]|Greig cephalopolysyndactyly syndrome [RCV001501336]|Greig cephalopolysyndactyly syndrome [RCV002491860] Chr7:42148353 [GRCh38]
Chr7:42187952 [GRCh37]
Chr7:7p14.1
likely benign
GRCh37/hg19 7p14.1(chr7:42115857-42116915) copy number loss Greig cephalopolysyndactyly syndrome [RCV002280609] Chr7:42115857..42116915 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.455C>T (p.Pro152Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001255815]|Greig cephalopolysyndactyly syndrome [RCV002570601] Chr7:42076770 [GRCh38]
Chr7:42116369 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2962G>C (p.Gly988Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001255795] Chr7:41966111 [GRCh38]
Chr7:42005709 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1786C>T (p.His596Tyr) single nucleotide variant not provided [RCV001756640] Chr7:41977584 [GRCh38]
Chr7:42017183 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2709_2763del (p.Arg905fs) deletion Inborn genetic diseases [RCV001266063] Chr7:41966310..41966364 [GRCh38]
Chr7:42005908..42005962 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2690C>G (p.Pro897Arg) single nucleotide variant not provided [RCV001529818] Chr7:41966383 [GRCh38]
Chr7:42005981 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3624dup (p.Pro1209fs) duplication not provided [RCV001268589] Chr7:41965448..41965449 [GRCh38]
Chr7:42005046..42005047 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2647G>T (p.Glu883Ter) single nucleotide variant not provided [RCV001268507] Chr7:41966426 [GRCh38]
Chr7:42006024 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3414del (p.His1138fs) deletion polysyndactyly [RCV001255957] Chr7:41965659 [GRCh38]
Chr7:42005257 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.826+194C>T single nucleotide variant not provided [RCV001546055] Chr7:42045190 [GRCh38]
Chr7:42084789 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2431+270A>G single nucleotide variant not provided [RCV001565511] Chr7:41967326 [GRCh38]
Chr7:42006924 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2773C>T (p.Gln925Ter) single nucleotide variant Inborn genetic diseases [RCV001265902] Chr7:41966300 [GRCh38]
Chr7:42005898 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4148A>G (p.Tyr1383Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002002056] Chr7:41964925 [GRCh38]
Chr7:42004523 [GRCh37]
Chr7:7p14.1
uncertain significance
Single allele complex Ring chromosome 7 [RCV002280646] Chr7:43360..159119707 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
NM_000168.6(GLI3):c.3392_3397del (p.Ala1131_Pro1132del) deletion Greig cephalopolysyndactyly syndrome [RCV001315093] Chr7:41965676..41965681 [GRCh38]
Chr7:42005274..42005279 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4675A>G (p.Ile1559Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001321739] Chr7:41964398 [GRCh38]
Chr7:42003996 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2431+8C>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001392359] Chr7:41967588 [GRCh38]
Chr7:42007186 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1627G>A (p.Glu543Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001363427]|Greig cephalopolysyndactyly syndrome [RCV002471096] Chr7:41978619 [GRCh38]
Chr7:42018218 [GRCh37]
Chr7:7p14.1
uncertain significance
NC_000007.13:g.(?_42187805)_(42262872_?)del deletion Greig cephalopolysyndactyly syndrome [RCV001382338] Chr7:42187805..42262872 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.826+9C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001433222] Chr7:42045375 [GRCh38]
Chr7:42084974 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.789G>A (p.Thr263=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001364183] Chr7:42045421 [GRCh38]
Chr7:42085020 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3362_3363delinsCG (p.Lys1121Thr) indel Greig cephalopolysyndactyly syndrome [RCV001346772] Chr7:41965710..41965711 [GRCh38]
Chr7:42005308..42005309 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3078C>G (p.Ser1026Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001320418] Chr7:41965995 [GRCh38]
Chr7:42005593 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3358A>G (p.Ser1120Gly) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001324336] Chr7:41965715 [GRCh38]
Chr7:42005313 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3611C>G (p.Pro1204Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001344236]|Greig cephalopolysyndactyly syndrome [RCV002493764]|Inborn genetic diseases [RCV003263980] Chr7:41965462 [GRCh38]
Chr7:42005060 [GRCh37]
Chr7:7p14.1
benign|likely benign|uncertain significance
NM_000168.6(GLI3):c.3133G>A (p.Val1045Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001315228] Chr7:41965940 [GRCh38]
Chr7:42005538 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.612C>G (p.Ile204Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001349664] Chr7:42048558 [GRCh38]
Chr7:42088157 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
GRCh37/hg19 7p14.1-12.3(chr7:41124364-47945566) copy number loss Syndactyly [RCV001352654] Chr7:41124364..47945566 [GRCh37]
Chr7:7p14.1-12.3
pathogenic
NM_000168.6(GLI3):c.678T>C (p.Asp226=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001413137] Chr7:42048492 [GRCh38]
Chr7:42088091 [GRCh37]
Chr7:7p14.1
likely benign
NC_000007.13:g.(?_42088070)_(42188087_?)del deletion Greig cephalopolysyndactyly syndrome [RCV001307814] Chr7:42088070..42188087 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2594C>G (p.Ser865Ter) single nucleotide variant Polydactyly, postaxial, type A1 [RCV001450026] Chr7:41966479 [GRCh38]
Chr7:42006077 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1133dup (p.Pro379fs) duplication Greig cephalopolysyndactyly syndrome [RCV001450027] Chr7:42026307..42026308 [GRCh38]
Chr7:42065906..42065907 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2928G>T (p.Pro976=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001413828] Chr7:41966145 [GRCh38]
Chr7:42005743 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.199G>A (p.Gly67Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001365816]|Greig cephalopolysyndactyly syndrome [RCV002488130] Chr7:42148394 [GRCh38]
Chr7:42187993 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1620C>T (p.His540=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001494001] Chr7:41978626 [GRCh38]
Chr7:42018225 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.528C>T (p.Ile176=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001475569]|Greig cephalopolysyndactyly syndrome [RCV002501641] Chr7:42048642 [GRCh38]
Chr7:42088241 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3365_3366del (p.Val1122fs) deletion Greig cephalopolysyndactyly syndrome [RCV001388671] Chr7:41965707..41965708 [GRCh38]
Chr7:42005305..42005306 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.699C>T (p.Ser233=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001409244] Chr7:42045511 [GRCh38]
Chr7:42085110 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1536G>A (p.Glu512=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001404502] Chr7:41978710 [GRCh38]
Chr7:42018309 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.827-2A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001379344] Chr7:42040241 [GRCh38]
Chr7:42079840 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.368-459_473+494del deletion Craniosynostosis syndrome [RCV001532999] Chr7:42076258..42077316 [GRCh38]
Chr7:42115857..42116915 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3162C>T (p.Gly1054=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001430972]|not provided [RCV001552787] Chr7:41965911 [GRCh38]
Chr7:42005509 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1647+56G>A single nucleotide variant not provided [RCV001534179] Chr7:41978543 [GRCh38]
Chr7:42018142 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1610T>G (p.Met537Arg) single nucleotide variant Hand polydactyly [RCV001526399] Chr7:41978636 [GRCh38]
Chr7:42018235 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.4194_4204del (p.Arg1399fs) deletion not provided [RCV001596877] Chr7:41964869..41964879 [GRCh38]
Chr7:42004467..42004477 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.1999C>T (p.Arg667Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001450018]|Inborn genetic diseases [RCV003264039]|Pallister-Hall syndrome [RCV002246386]|not provided [RCV002265029] Chr7:41972441 [GRCh38]
Chr7:42012040 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.758A>G (p.Asp253Gly) single nucleotide variant Polydactyly, postaxial, type A1 [RCV001526463] Chr7:42045452 [GRCh38]
Chr7:42085051 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1880_1881del (p.His627fs) deletion Greig cephalopolysyndactyly syndrome [RCV002501578]|Polydactyly, postaxial, type A1 [RCV001450019] Chr7:41972559..41972560 [GRCh38]
Chr7:42012158..42012159 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1033_1048del (p.Ala345fs) deletion Polydactyly, postaxial, type A1 [RCV001450024] Chr7:42026393..42026408 [GRCh38]
Chr7:42065992..42066007 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2103+2T>A single nucleotide variant Polydactyly, postaxial, type A1 [RCV001450025] Chr7:41972335 [GRCh38]
Chr7:42011934 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1880A>C (p.His627Pro) single nucleotide variant Polydactyly, postaxial, type A1 [RCV001450028] Chr7:41972560 [GRCh38]
Chr7:42012159 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2059del (p.Glu687fs) deletion Polydactyly, postaxial, type A1 [RCV001450030] Chr7:41972381 [GRCh38]
Chr7:42011980 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.780C>T (p.Thr260=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001465349] Chr7:42045430 [GRCh38]
Chr7:42085029 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.827-10T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001503338] Chr7:42040249 [GRCh38]
Chr7:42079848 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.367+49TG[22] microsatellite not provided [RCV001675178] Chr7:42148135..42148136 [GRCh38]
Chr7:42187734..42187735 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.*265del deletion not provided [RCV001589450] Chr7:41964065 [GRCh38]
Chr7:42003663 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4104C>T (p.His1368=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001487141] Chr7:41964969 [GRCh38]
Chr7:42004567 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1464G>A (p.Ala488=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001521956] Chr7:42023501 [GRCh38]
Chr7:42063100 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1029-6G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001452556] Chr7:42026418 [GRCh38]
Chr7:42066017 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1648-230dup duplication not provided [RCV001674212] Chr7:41977941..41977942 [GRCh38]
Chr7:42017540..42017541 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3893C>T (p.Pro1298Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001513199] Chr7:41965180 [GRCh38]
Chr7:42004778 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1793dup (p.Asn598fs) duplication Greig cephalopolysyndactyly syndrome [RCV001450020] Chr7:41977576..41977577 [GRCh38]
Chr7:42017175..42017176 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.901G>A (p.Asp301Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001452932] Chr7:42040165 [GRCh38]
Chr7:42079764 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2703C>T (p.Asp901=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001506330] Chr7:41966370 [GRCh38]
Chr7:42005968 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2604G>A (p.Ser868=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001417958] Chr7:41966469 [GRCh38]
Chr7:42006067 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2090del (p.Ala697fs) deletion Greig cephalopolysyndactyly syndrome [RCV001385743] Chr7:41972350 [GRCh38]
Chr7:42011949 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.972C>T (p.Ser324=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001457968] Chr7:42040094 [GRCh38]
Chr7:42079693 [GRCh37]
Chr7:7p14.1
likely benign
NC_000007.13:g.(?_42116331)_(42188087_?)del deletion Greig cephalopolysyndactyly syndrome [RCV001385078] Chr7:42116331..42188087 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.742C>T (p.Arg248Cys) single nucleotide variant not provided [RCV003127143] Chr7:42045468 [GRCh38]
Chr7:42085067 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4267A>T (p.Met1423Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003108435] Chr7:41964806 [GRCh38]
Chr7:42004404 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4383_4387del (p.Ile1462fs) deletion not provided [RCV001727396] Chr7:41964686..41964690 [GRCh38]
Chr7:42004284..42004288 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.3741G>T (p.Gln1247His) single nucleotide variant not provided [RCV001756249] Chr7:41965332 [GRCh38]
Chr7:42004930 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.186A>G (p.Pro62=) single nucleotide variant not provided [RCV001732440] Chr7:42148407 [GRCh38]
Chr7:42188006 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1550G>T (p.Trp517Leu) single nucleotide variant not provided [RCV001755086] Chr7:41978696 [GRCh38]
Chr7:42018295 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2314A>T (p.Thr772Ser) single nucleotide variant not provided [RCV001754814] Chr7:41967713 [GRCh38]
Chr7:42007311 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.793del (p.Ala265fs) deletion Greig cephalopolysyndactyly syndrome [RCV001730107] Chr7:42045417 [GRCh38]
Chr7:42085016 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.7G>T (p.Ala3Ser) single nucleotide variant not provided [RCV001754928] Chr7:42223247 [GRCh38]
Chr7:42262846 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1613G>A (p.Arg538Lys) single nucleotide variant not provided [RCV001761025] Chr7:41978633 [GRCh38]
Chr7:42018232 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3437_3453del (p.Leu1146fs) deletion not provided [RCV001783382] Chr7:41965620..41965636 [GRCh38]
Chr7:42005218..42005234 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1945C>T (p.Arg649Trp) single nucleotide variant not provided [RCV001764842] Chr7:41972495 [GRCh38]
Chr7:42012094 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2598del (p.Ile867fs) deletion Pallister-Hall syndrome [RCV001775307] Chr7:41966475 [GRCh38]
Chr7:42006073 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2740G>C (p.Gly914Arg) single nucleotide variant not provided [RCV001773135] Chr7:41966333 [GRCh38]
Chr7:42005931 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1525G>A (p.Glu509Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002488594]|Inborn genetic diseases [RCV002540525]|not provided [RCV001771209] Chr7:41978721 [GRCh38]
Chr7:42018320 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4450G>A (p.Ala1484Thr) single nucleotide variant not provided [RCV001764085] Chr7:41964623 [GRCh38]
Chr7:42004221 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2372C>T (p.Pro791Leu) single nucleotide variant not provided [RCV001773004] Chr7:41967655 [GRCh38]
Chr7:42007253 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3325G>T (p.Glu1109Ter) single nucleotide variant Pallister-Hall syndrome [RCV001775287] Chr7:41965748 [GRCh38]
Chr7:42005346 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4453A>T (p.Asn1485Tyr) single nucleotide variant not provided [RCV001800069] Chr7:41964620 [GRCh38]
Chr7:42004218 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1180C>T (p.Pro394Ser) single nucleotide variant not provided [RCV001765642] Chr7:42026261 [GRCh38]
Chr7:42065860 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1084C>G (p.Gln362Glu) single nucleotide variant not provided [RCV001768939] Chr7:42026357 [GRCh38]
Chr7:42065956 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1135C>T (p.Pro379Ser) single nucleotide variant not provided [RCV001774502] Chr7:42026306 [GRCh38]
Chr7:42065905 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1706C>T (p.Ser569Phe) single nucleotide variant not provided [RCV001758220] Chr7:41977664 [GRCh38]
Chr7:42017263 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1813-3C>G single nucleotide variant not provided [RCV001752841] Chr7:41972630 [GRCh38]
Chr7:42012229 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1063G>A (p.Val355Ile) single nucleotide variant not provided [RCV001800003] Chr7:42026378 [GRCh38]
Chr7:42065977 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.507G>A (p.Pro169=) single nucleotide variant not specified [RCV001817102] Chr7:42048663 [GRCh38]
Chr7:42088262 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.*2358dup duplication not provided [RCV001779637] Chr7:41961971..41961972 [GRCh38]
Chr7:42001569..42001570 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3373G>C (p.Gly1125Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001864410] Chr7:41965700 [GRCh38]
Chr7:42005298 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1433A>G (p.Tyr478Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001970736] Chr7:42023532 [GRCh38]
Chr7:42063131 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.4413del (p.Thr1472fs) deletion Greig cephalopolysyndactyly syndrome [RCV002042151] Chr7:41964660 [GRCh38]
Chr7:42004258 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.602_675del (p.Met201fs) deletion Greig cephalopolysyndactyly syndrome [RCV001894291] Chr7:42048495..42048568 [GRCh38]
Chr7:42088094..42088167 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.294G>A (p.Ala98=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002043636] Chr7:42148299 [GRCh38]
Chr7:42187898 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.4543C>A (p.His1515Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001863355] Chr7:41964530 [GRCh38]
Chr7:42004128 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3557C>T (p.Pro1186Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002002336]|Greig cephalopolysyndactyly syndrome [RCV002484774]|not provided [RCV003426264] Chr7:41965516 [GRCh38]
Chr7:42005114 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1459T>G (p.Cys487Gly) single nucleotide variant Polydactyly, postaxial, type A1 [RCV002052146] Chr7:42023506 [GRCh38]
Chr7:42063105 [GRCh37]
Chr7:7p14.1
uncertain significance
GRCh37/hg19 7p14.1-12.2(chr7:40778439-50228656) copy number loss not specified [RCV002053688] Chr7:40778439..50228656 [GRCh37]
Chr7:7p14.1-12.2
pathogenic
GRCh37/hg19 7p14.1(chr7:41986326-42216822) copy number loss not specified [RCV002053689] Chr7:41986326..42216822 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4507C>T (p.Gln1503Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001895418] Chr7:41964566 [GRCh38]
Chr7:42004164 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4187C>A (p.Ala1396Asp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001871239]|Greig cephalopolysyndactyly syndrome [RCV002478207] Chr7:41964886 [GRCh38]
Chr7:42004484 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.245G>A (p.Arg82Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002077329]|Hepatoblastoma [RCV001843897]|not provided [RCV002291774] Chr7:42148348 [GRCh38]
Chr7:42187947 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.4640T>A (p.Phe1547Tyr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001948241] Chr7:41964433 [GRCh38]
Chr7:42004031 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.233C>T (p.Ser78Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002482387]|Greig cephalopolysyndactyly syndrome [RCV003120719]|Hepatoblastoma [RCV001843896] Chr7:42148360 [GRCh38]
Chr7:42187959 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1253C>T (p.Thr418Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001984879]|Inborn genetic diseases [RCV002562076] Chr7:42025367 [GRCh38]
Chr7:42064966 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.4556T>C (p.Met1519Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001892270] Chr7:41964517 [GRCh38]
Chr7:42004115 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1865G>A (p.Ser622Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001888445] Chr7:41972575 [GRCh38]
Chr7:42012174 [GRCh37]
Chr7:7p14.1
likely pathogenic|uncertain significance
NM_000168.6(GLI3):c.1356+10_1356+11delinsAC indel Greig cephalopolysyndactyly syndrome [RCV001956058] Chr7:42025253..42025254 [GRCh38]
Chr7:42064852..42064853 [GRCh37]
Chr7:7p14.1
likely benign
NC_000007.13:g.(?_39726267)_(42262852_?)del deletion Greig cephalopolysyndactyly syndrome [RCV003120786] Chr7:39726267..42262852 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3899C>T (p.Ala1300Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001935901]|Inborn genetic diseases [RCV003264261] Chr7:41965174 [GRCh38]
Chr7:42004772 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.2432-1G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001935371] Chr7:41966642 [GRCh38]
Chr7:42006240 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4369G>A (p.Ala1457Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002015906] Chr7:41964704 [GRCh38]
Chr7:42004302 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NC_000007.13:g.(?_42063047)_(42066031_?)dup duplication Greig cephalopolysyndactyly syndrome [RCV002033319] Chr7:42063047..42066031 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2936_2953dup (p.Ala984_His985insArgSerAspGlyGlyAla) duplication not provided [RCV002034835] Chr7:41966119..41966120 [GRCh38]
Chr7:42005717..42005718 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1380T>C (p.Leu460=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002010584] Chr7:42023585 [GRCh38]
Chr7:42063184 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4292C>T (p.Pro1431Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001906603]|Greig cephalopolysyndactyly syndrome [RCV002478339]|not provided [RCV002253991] Chr7:41964781 [GRCh38]
Chr7:42004379 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3864G>A (p.Gly1288=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001997867]|Greig cephalopolysyndactyly syndrome [RCV002497899] Chr7:41965209 [GRCh38]
Chr7:42004807 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3956dup (p.Gln1320fs) duplication Greig cephalopolysyndactyly syndrome [RCV001918776] Chr7:41965116..41965117 [GRCh38]
Chr7:42004714..42004715 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2975T>C (p.Leu992Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002014013] Chr7:41966098 [GRCh38]
Chr7:42005696 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.4427A>T (p.Asn1476Ile) single nucleotide variant GLI3-related condition [RCV003923387]|Greig cephalopolysyndactyly syndrome [RCV001979971]|Greig cephalopolysyndactyly syndrome [RCV002479559] Chr7:41964646 [GRCh38]
Chr7:42004244 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.2520G>A (p.Met840Ile) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001878035]|Greig cephalopolysyndactyly syndrome [RCV002490131] Chr7:41966553 [GRCh38]
Chr7:42006151 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2944G>A (p.Gly982Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001886129] Chr7:41966129 [GRCh38]
Chr7:42005727 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3762T>G (p.Tyr1254Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001924251] Chr7:41965311 [GRCh38]
Chr7:42004909 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1497+5G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001977713]|not provided [RCV003313255] Chr7:42023463 [GRCh38]
Chr7:42063062 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.973C>T (p.Arg325Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002009917] Chr7:42040093 [GRCh38]
Chr7:42079692 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1159T>C (p.Phe387Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV001919722]|Inborn genetic diseases [RCV003247115] Chr7:42026282 [GRCh38]
Chr7:42065881 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.2308G>T (p.Ala770Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002166102] Chr7:41967719 [GRCh38]
Chr7:42007317 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3486G>A (p.Trp1162Ter) single nucleotide variant not provided [RCV002224483] Chr7:41965587 [GRCh38]
Chr7:42005185 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.4682A>G (p.Asp1561Gly) single nucleotide variant not provided [RCV002226007] Chr7:41964391 [GRCh38]
Chr7:42003989 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1242+16C>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002145886] Chr7:42026183 [GRCh38]
Chr7:42065782 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.474-8G>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002130022] Chr7:42048704 [GRCh38]
Chr7:42088303 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4676T>C (p.Ile1559Thr) single nucleotide variant not provided [RCV002226006] Chr7:41964397 [GRCh38]
Chr7:42003995 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1320T>C (p.Asp440=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002104792] Chr7:42025300 [GRCh38]
Chr7:42064899 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1909C>T (p.His637Tyr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002090949] Chr7:41972531 [GRCh38]
Chr7:42012130 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2361T>C (p.Asn787=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002106696] Chr7:41967666 [GRCh38]
Chr7:42007264 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3549C>G (p.Pro1183=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002196353] Chr7:41965524 [GRCh38]
Chr7:42005122 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1813-15T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002094790] Chr7:41972642 [GRCh38]
Chr7:42012241 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.954C>T (p.Val318=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002105729] Chr7:42040112 [GRCh38]
Chr7:42079711 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.246G>A (p.Arg82=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002108082]|Greig cephalopolysyndactyly syndrome [RCV002494242] Chr7:42148347 [GRCh38]
Chr7:42187946 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4180C>T (p.Arg1394Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002115913]|not provided [RCV003134387] Chr7:41964893 [GRCh38]
Chr7:42004491 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.434G>A (p.Arg145His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002106153]|Inborn genetic diseases [RCV003053421] Chr7:42076791 [GRCh38]
Chr7:42116390 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.367+20G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002115582]|Greig cephalopolysyndactyly syndrome [RCV002486888] Chr7:42148206 [GRCh38]
Chr7:42187805 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2409G>A (p.Ala803=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003774637]|not provided [RCV002214429] Chr7:41967618 [GRCh38]
Chr7:42007216 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1497C>G (p.His499Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002116108] Chr7:42023468 [GRCh38]
Chr7:42063067 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1325A>G (p.Asp442Gly) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002216579] Chr7:42025295 [GRCh38]
Chr7:42064894 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4346del (p.Gly1449fs) deletion Polydactyly, postaxial, type A1 [RCV002226960] Chr7:41964727 [GRCh38]
Chr7:42004325 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.1357-12C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002216701] Chr7:42023620 [GRCh38]
Chr7:42063219 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3900G>A (p.Ala1300=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002179545] Chr7:41965173 [GRCh38]
Chr7:42004771 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1357-10C>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002082038] Chr7:42023618 [GRCh38]
Chr7:42063217 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.636G>T (p.Ser212=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002183977] Chr7:42048534 [GRCh38]
Chr7:42088133 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1366G>T (p.Glu456Ter) single nucleotide variant Pallister-Hall syndrome [RCV002251098] Chr7:42023599 [GRCh38]
Chr7:42063198 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2685C>T (p.Tyr895=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002154849] Chr7:41966388 [GRCh38]
Chr7:42005986 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1740C>T (p.His580=) single nucleotide variant GLI3-related condition [RCV003896003]|Greig cephalopolysyndactyly syndrome [RCV002158631]|Greig cephalopolysyndactyly syndrome [RCV002500341] Chr7:41977630 [GRCh38]
Chr7:42017229 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1506T>C (p.Asn502=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002122478] Chr7:41978740 [GRCh38]
Chr7:42018339 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4625G>A (p.Arg1542Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002216984] Chr7:41964448 [GRCh38]
Chr7:42004046 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2432-16C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002118022] Chr7:41966657 [GRCh38]
Chr7:42006255 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.250T>C (p.Ser84Pro) single nucleotide variant Polydactyly, postaxial, type A1 [RCV002226886] Chr7:42148343 [GRCh38]
Chr7:42187942 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.613C>T (p.Arg205Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002199035]|Inborn genetic diseases [RCV003161677] Chr7:42048557 [GRCh38]
Chr7:42088156 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.2772C>G (p.Ala924=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003116962] Chr7:41966301 [GRCh38]
Chr7:42005899 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1317C>T (p.Pro439=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003117308] Chr7:42025303 [GRCh38]
Chr7:42064902 [GRCh37]
Chr7:7p14.1
benign
NC_000007.13:g.(?_42088070)_(42088315_?)del deletion Greig cephalopolysyndactyly syndrome [RCV003122099] Chr7:42088070..42088315 [GRCh37]
Chr7:7p14.1
pathogenic
NC_000007.13:g.(?_42262709)_(42262852_?)dup duplication Greig cephalopolysyndactyly syndrome [RCV003122100] Chr7:42262709..42262852 [GRCh37]
Chr7:7p14.1
uncertain significance
NC_000007.13:g.(?_42116331)_(42116476_?)dup duplication Greig cephalopolysyndactyly syndrome [RCV003122101] Chr7:42116331..42116476 [GRCh37]
Chr7:7p14.1
likely pathogenic
NC_000007.13:g.(?_42017137)_(42079858_?)dup duplication Greig cephalopolysyndactyly syndrome [RCV003122102] Chr7:42017137..42079858 [GRCh37]
Chr7:7p14.1
likely pathogenic
NC_000007.13:g.(?_42000470)_(42005117_?)del deletion Greig cephalopolysyndactyly syndrome [RCV003122103] Chr7:42000470..42005117 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.438C>G (p.Tyr146Ter) single nucleotide variant Polysyndactyly 4 [RCV002272931] Chr7:42076787 [GRCh38]
Chr7:42116386 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.687T>A (p.His229Gln) single nucleotide variant not provided [RCV003131029] Chr7:42045523 [GRCh38]
Chr7:42085122 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2381A>G (p.Asn794Ser) single nucleotide variant not provided [RCV003131030] Chr7:41967646 [GRCh38]
Chr7:42007244 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1097_1099del (p.Arg366del) deletion not provided [RCV003131031] Chr7:42026342..42026344 [GRCh38]
Chr7:42065941..42065943 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4411G>A (p.Gly1471Arg) single nucleotide variant not provided [RCV003131032] Chr7:41964662 [GRCh38]
Chr7:42004260 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.473+1G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002227906] Chr7:42076751 [GRCh38]
Chr7:42116350 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1693del (p.Thr565fs) deletion Polydactyly, postaxial, type A1 [RCV002251138] Chr7:41977677 [GRCh38]
Chr7:42017276 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.4283dup (p.Pro1429fs) duplication Greig cephalopolysyndactyly syndrome [RCV002255230] Chr7:41964789..41964790 [GRCh38]
Chr7:42004387..42004388 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4019C>G (p.Pro1340Arg) single nucleotide variant not provided [RCV003129213] Chr7:41965054 [GRCh38]
Chr7:42004652 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2624G>T (p.Arg875Leu) single nucleotide variant Inborn genetic diseases [RCV003255608] Chr7:41966449 [GRCh38]
Chr7:42006047 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1983G>C (p.Gln661His) single nucleotide variant not provided [RCV002260858] Chr7:41972457 [GRCh38]
Chr7:42012056 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.800A>C (p.His267Pro) single nucleotide variant not provided [RCV002265277] Chr7:42045410 [GRCh38]
Chr7:42085009 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.421C>T (p.His141Tyr) single nucleotide variant not provided [RCV002276166] Chr7:42076804 [GRCh38]
Chr7:42116403 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.634T>A (p.Ser212Thr) single nucleotide variant not provided [RCV002293902] Chr7:42048536 [GRCh38]
Chr7:42088135 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2447A>C (p.Asn816Thr) single nucleotide variant not provided [RCV002273650] Chr7:41966626 [GRCh38]
Chr7:42006224 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3540_3550del (p.Pro1181fs) deletion not provided [RCV002276165] Chr7:41965523..41965533 [GRCh38]
Chr7:42005121..42005131 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2632del (p.Glu878fs) deletion Pallister-Hall syndrome [RCV002286458] Chr7:41966441 [GRCh38]
Chr7:42006039 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2134T>C (p.Ser712Pro) single nucleotide variant not provided [RCV002267233] Chr7:41967893 [GRCh38]
Chr7:42007491 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1673C>A (p.Ser558Ter) single nucleotide variant Polysyndactyly 4 [RCV002264892] Chr7:41977697 [GRCh38]
Chr7:42017296 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3727G>C (p.Ala1243Pro) single nucleotide variant not provided [RCV002265087] Chr7:41965346 [GRCh38]
Chr7:42004944 [GRCh37]
Chr7:7p14.1
uncertain significance
GRCh37/hg19 7p22.3-q36.3(chr7:56604613-96692931)x1 copy number loss See cases [RCV002287832] Chr7:56604613..96692931 [GRCh37]
Chr7:7p22.3-q36.3
uncertain significance
NM_000168.6(GLI3):c.1030C>G (p.Pro344Ala) single nucleotide variant not provided [RCV002274748] Chr7:42026411 [GRCh38]
Chr7:42066010 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4642C>T (p.Pro1548Ser) single nucleotide variant Pallister-Hall syndrome [RCV002289330] Chr7:41964431 [GRCh38]
Chr7:42004029 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3586G>C (p.Gly1196Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002266796] Chr7:41965487 [GRCh38]
Chr7:42005085 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2137T>C (p.Cys713Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002291083] Chr7:41967890 [GRCh38]
Chr7:42007488 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2867G>A (p.Arg956His) single nucleotide variant not provided [RCV003131028] Chr7:41966206 [GRCh38]
Chr7:42005804 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4236_4237del (p.Gln1414fs) deletion Greig cephalopolysyndactyly syndrome [RCV003226001]|not provided [RCV003129407] Chr7:41964836..41964837 [GRCh38]
Chr7:42004434..42004435 [GRCh37]
Chr7:7p14.1
pathogenic|uncertain significance
NM_000168.6(GLI3):c.286C>A (p.His96Asn) single nucleotide variant Inborn genetic diseases [RCV003286531] Chr7:42148307 [GRCh38]
Chr7:42187906 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2163C>T (p.Ser721=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003778684]|not provided [RCV003129017] Chr7:41967864 [GRCh38]
Chr7:42007462 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.4108A>G (p.Met1370Val) single nucleotide variant not provided [RCV002473961] Chr7:41964965 [GRCh38]
Chr7:42004563 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3601C>T (p.Pro1201Ser) single nucleotide variant not provided [RCV002306229] Chr7:41965472 [GRCh38]
Chr7:42005070 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2985C>A (p.His995Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002305412] Chr7:41966088 [GRCh38]
Chr7:42005686 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1596G>A (p.Met532Ile) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002300196] Chr7:41978650 [GRCh38]
Chr7:42018249 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.158A>G (p.Glu53Gly) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002297948] Chr7:42148435 [GRCh38]
Chr7:42188034 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.2390T>C (p.Leu797Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002299562] Chr7:41967637 [GRCh38]
Chr7:42007235 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1470G>C (p.Glu490Asp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002298152] Chr7:42023495 [GRCh38]
Chr7:42063094 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2659C>A (p.Gln887Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003775010]|not provided [RCV002306142] Chr7:41966414 [GRCh38]
Chr7:42006012 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3946G>C (p.Asp1316His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002299302] Chr7:41965127 [GRCh38]
Chr7:42004725 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3917G>A (p.Gly1306Asp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002298175] Chr7:41965156 [GRCh38]
Chr7:42004754 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2784C>T (p.Arg928=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002904610] Chr7:41966289 [GRCh38]
Chr7:42005887 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.522T>C (p.Ile174=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002839087] Chr7:42048648 [GRCh38]
Chr7:42088247 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1332C>T (p.Pro444=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002972420] Chr7:42025288 [GRCh38]
Chr7:42064887 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4016G>A (p.Arg1339His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002971122] Chr7:41965057 [GRCh38]
Chr7:42004655 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1421C>T (p.Pro474Leu) single nucleotide variant not provided [RCV002512333] Chr7:42023544 [GRCh38]
Chr7:42063143 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3286G>A (p.Val1096Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002967680] Chr7:41965787 [GRCh38]
Chr7:42005385 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1880A>G (p.His627Arg) single nucleotide variant not provided [RCV002512332] Chr7:41972560 [GRCh38]
Chr7:42012159 [GRCh37]
Chr7:7p14.1
likely pathogenic|conflicting interpretations of pathogenicity
NM_000168.6(GLI3):c.1973G>T (p.Ser658Ile) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002615816] Chr7:41972467 [GRCh38]
Chr7:42012066 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3965A>C (p.Tyr1322Ser) single nucleotide variant not provided [RCV002461739] Chr7:41965108 [GRCh38]
Chr7:42004706 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2395C>A (p.Pro799Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003076953] Chr7:41967632 [GRCh38]
Chr7:42007230 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2328G>A (p.Glu776=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002908979] Chr7:41967699 [GRCh38]
Chr7:42007297 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1204C>G (p.Pro402Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003076768] Chr7:42026237 [GRCh38]
Chr7:42065836 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3526A>G (p.Lys1176Glu) single nucleotide variant Inborn genetic diseases [RCV002728945] Chr7:41965547 [GRCh38]
Chr7:42005145 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2329C>T (p.His777Tyr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002922114]|Inborn genetic diseases [RCV002904655] Chr7:41967698 [GRCh38]
Chr7:42007296 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1029-6G>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003074950] Chr7:42026418 [GRCh38]
Chr7:42066017 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1058C>T (p.Ala353Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002876424]|Inborn genetic diseases [RCV002863666] Chr7:42026383 [GRCh38]
Chr7:42065982 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.836dup (p.Ser280fs) duplication Greig cephalopolysyndactyly syndrome [RCV002907614] Chr7:42040229..42040230 [GRCh38]
Chr7:42079828..42079829 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.368-3C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003075349] Chr7:42076860 [GRCh38]
Chr7:42116459 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4144G>C (p.Gly1382Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002904932] Chr7:41964929 [GRCh38]
Chr7:42004527 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1778G>A (p.Arg593His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003103131]|not provided [RCV002462505] Chr7:41977592 [GRCh38]
Chr7:42017191 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4253T>C (p.Val1418Ala) single nucleotide variant Inborn genetic diseases [RCV002748718] Chr7:41964820 [GRCh38]
Chr7:42004418 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1844C>T (p.Thr615Ile) single nucleotide variant Inborn genetic diseases [RCV002902011] Chr7:41972596 [GRCh38]
Chr7:42012195 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.293C>T (p.Ala98Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002574728]|not provided [RCV002510144] Chr7:42148300 [GRCh38]
Chr7:42187899 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.3210C>A (p.Thr1070=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002907913] Chr7:41965863 [GRCh38]
Chr7:42005461 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4064A>G (p.Asn1355Ser) single nucleotide variant Inborn genetic diseases [RCV002692687] Chr7:41965009 [GRCh38]
Chr7:42004607 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3349C>T (p.Pro1117Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002663150] Chr7:41965724 [GRCh38]
Chr7:42005322 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1553T>A (p.Leu518Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003081670] Chr7:41978693 [GRCh38]
Chr7:42018292 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1040G>A (p.Ser347Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002870715] Chr7:42026401 [GRCh38]
Chr7:42066000 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1234T>C (p.Ser412Pro) single nucleotide variant Inborn genetic diseases [RCV002783329] Chr7:42026207 [GRCh38]
Chr7:42065806 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1835C>T (p.Pro612Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003036862] Chr7:41972605 [GRCh38]
Chr7:42012204 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.898_900dup (p.Ser300_Asp301insSer) duplication not provided [RCV002509915] Chr7:42040165..42040166 [GRCh38]
Chr7:42079764..42079765 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1194G>A (p.Thr398=) single nucleotide variant GLI3-related condition [RCV003963546]|Greig cephalopolysyndactyly syndrome [RCV002979505] Chr7:42026247 [GRCh38]
Chr7:42065846 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.90C>T (p.Ser30=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002885519] Chr7:42223164 [GRCh38]
Chr7:42262763 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2382C>A (p.Asn794Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002885546] Chr7:41967645 [GRCh38]
Chr7:42007243 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1289T>C (p.Met430Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002886643] Chr7:42025331 [GRCh38]
Chr7:42064930 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2803G>A (p.Ala935Thr) single nucleotide variant GLI3-related condition [RCV003946285]|Greig cephalopolysyndactyly syndrome [RCV002591562] Chr7:41966270 [GRCh38]
Chr7:42005868 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3514C>T (p.Leu1172=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002796629] Chr7:41965559 [GRCh38]
Chr7:42005157 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3569C>T (p.Ala1190Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002909207] Chr7:41965504 [GRCh38]
Chr7:42005102 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2248A>G (p.Met750Val) single nucleotide variant Inborn genetic diseases [RCV002950098] Chr7:41967779 [GRCh38]
Chr7:42007377 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2438A>C (p.Gln813Pro) single nucleotide variant Inborn genetic diseases [RCV002761861] Chr7:41966635 [GRCh38]
Chr7:42006233 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1356+17G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002622688] Chr7:42025247 [GRCh38]
Chr7:42064846 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.679+9A>G single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003018283] Chr7:42048482 [GRCh38]
Chr7:42088081 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.235A>T (p.Ser79Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002885708] Chr7:42148358 [GRCh38]
Chr7:42187957 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3147C>A (p.Tyr1049Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002889144] Chr7:41965926 [GRCh38]
Chr7:42005524 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2146del (p.Gln716fs) deletion Greig cephalopolysyndactyly syndrome [RCV002871086] Chr7:41967881 [GRCh38]
Chr7:42007479 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4037G>A (p.Gly1346Glu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003066724]|Inborn genetic diseases [RCV003052867] Chr7:41965036 [GRCh38]
Chr7:42004634 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.13T>C (p.Ser5Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002781171] Chr7:42223241 [GRCh38]
Chr7:42262840 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.956C>T (p.Thr319Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002976113] Chr7:42040110 [GRCh38]
Chr7:42079709 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.368-1G>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002820371] Chr7:42076858 [GRCh38]
Chr7:42116457 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2991G>T (p.Ala997=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003019364] Chr7:41966082 [GRCh38]
Chr7:42005680 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.245_299del (p.Arg82fs) deletion Greig cephalopolysyndactyly syndrome [RCV002847628] Chr7:42148294..42148348 [GRCh38]
Chr7:42187893..42187947 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2501C>G (p.Ser834Cys) single nucleotide variant GLI3-related condition [RCV003418688]|Greig cephalopolysyndactyly syndrome [RCV002976094] Chr7:41966572 [GRCh38]
Chr7:42006170 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.4559C>T (p.Ser1520Leu) single nucleotide variant GLI3-related condition [RCV003404156]|Inborn genetic diseases [RCV002758418] Chr7:41964514 [GRCh38]
Chr7:42004112 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1471T>C (p.Phe491Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002999362] Chr7:42023494 [GRCh38]
Chr7:42063093 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3324C>T (p.Tyr1108=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002638804] Chr7:41965749 [GRCh38]
Chr7:42005347 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4105G>A (p.Gly1369Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003077183] Chr7:41964968 [GRCh38]
Chr7:42004566 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2003C>T (p.Pro668Leu) single nucleotide variant GLI3-related condition [RCV003963624]|Greig cephalopolysyndactyly syndrome [RCV003078809] Chr7:41972437 [GRCh38]
Chr7:42012036 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3000C>T (p.His1000=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002705939] Chr7:41966073 [GRCh38]
Chr7:42005671 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2962G>A (p.Gly988Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003001909] Chr7:41966111 [GRCh38]
Chr7:42005709 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.367+19C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002985653] Chr7:42148207 [GRCh38]
Chr7:42187806 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3946G>A (p.Asp1316Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002932784] Chr7:41965127 [GRCh38]
Chr7:42004725 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4052C>A (p.Thr1351Asn) single nucleotide variant Inborn genetic diseases [RCV002712849] Chr7:41965021 [GRCh38]
Chr7:42004619 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2881G>C (p.Gly961Arg) single nucleotide variant Inborn genetic diseases [RCV002826241] Chr7:41966192 [GRCh38]
Chr7:42005790 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4525A>G (p.Ile1509Val) single nucleotide variant Inborn genetic diseases [RCV002854229] Chr7:41964548 [GRCh38]
Chr7:42004146 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.712T>C (p.Tyr238His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003042184] Chr7:42045498 [GRCh38]
Chr7:42085097 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1128C>G (p.His376Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002624429] Chr7:42026313 [GRCh38]
Chr7:42065912 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1254G>A (p.Thr418=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003059064] Chr7:42025366 [GRCh38]
Chr7:42064965 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.4710G>A (p.Ala1570=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003059072] Chr7:41964363 [GRCh38]
Chr7:42003961 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2486G>T (p.Gly829Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003059074] Chr7:41966587 [GRCh38]
Chr7:42006185 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4565C>A (p.Ala1522Asp) single nucleotide variant Inborn genetic diseases [RCV002787744] Chr7:41964508 [GRCh38]
Chr7:42004106 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3102G>T (p.Ala1034=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002801418] Chr7:41965971 [GRCh38]
Chr7:42005569 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.991A>G (p.Ser331Gly) single nucleotide variant Inborn genetic diseases [RCV002983481] Chr7:42040075 [GRCh38]
Chr7:42079674 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3379G>C (p.Gly1127Arg) single nucleotide variant Inborn genetic diseases [RCV002875363] Chr7:41965694 [GRCh38]
Chr7:42005292 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.925A>G (p.Met309Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002642792] Chr7:42040141 [GRCh38]
Chr7:42079740 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3035G>T (p.Gly1012Val) single nucleotide variant Inborn genetic diseases [RCV002743652] Chr7:41966038 [GRCh38]
Chr7:42005636 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1530G>A (p.Lys510=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002711279] Chr7:41978716 [GRCh38]
Chr7:42018315 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2853G>C (p.Met951Ile) single nucleotide variant GLI3-related condition [RCV003973738]|Inborn genetic diseases [RCV002892912] Chr7:41966220 [GRCh38]
Chr7:42005818 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3647_3665del (p.Leu1216fs) deletion Greig cephalopolysyndactyly syndrome [RCV002871660] Chr7:41965408..41965426 [GRCh38]
Chr7:42005006..42005024 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4495C>G (p.Leu1499Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003022339] Chr7:41964578 [GRCh38]
Chr7:42004176 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4392C>T (p.Asp1464=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003083581] Chr7:41964681 [GRCh38]
Chr7:42004279 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.533dup (p.His179fs) duplication Greig cephalopolysyndactyly syndrome [RCV002872385] Chr7:42048636..42048637 [GRCh38]
Chr7:42088235..42088236 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2678A>G (p.Asp893Gly) single nucleotide variant Inborn genetic diseases [RCV002802477] Chr7:41966395 [GRCh38]
Chr7:42005993 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1968C>T (p.Ser656=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003085280] Chr7:41972472 [GRCh38]
Chr7:42012071 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4610G>C (p.Arg1537Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002625215] Chr7:41964463 [GRCh38]
Chr7:42004061 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1958C>G (p.Pro653Arg) single nucleotide variant Inborn genetic diseases [RCV002699602] Chr7:41972482 [GRCh38]
Chr7:42012081 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2445C>A (p.Asn815Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002805459] Chr7:41966628 [GRCh38]
Chr7:42006226 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2434A>T (p.Thr812Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003082478] Chr7:41966639 [GRCh38]
Chr7:42006237 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4164C>T (p.Ser1388=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002720865] Chr7:41964909 [GRCh38]
Chr7:42004507 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1357-7_1357-5del microsatellite Greig cephalopolysyndactyly syndrome [RCV003049258] Chr7:42023613..42023615 [GRCh38]
Chr7:42063212..42063214 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2550C>T (p.Ser850=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003060870] Chr7:41966523 [GRCh38]
Chr7:42006121 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1648delT (p.Phe550fs) deletion Greig cephalopolysyndactyly syndrome [RCV002877275] Chr7:41977720 [GRCh38]
Chr7:42017319 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4020C>G (p.Pro1340=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003065421] Chr7:41965053 [GRCh38]
Chr7:42004651 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4525A>C (p.Ile1509Leu) single nucleotide variant Inborn genetic diseases [RCV002878944] Chr7:41964548 [GRCh38]
Chr7:42004146 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4234A>T (p.Thr1412Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003090387] Chr7:41964839 [GRCh38]
Chr7:42004437 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4477A>G (p.Ser1493Gly) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003031298] Chr7:41964596 [GRCh38]
Chr7:42004194 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4354C>T (p.Gln1452Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002938784] Chr7:41964719 [GRCh38]
Chr7:42004317 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2000G>A (p.Arg667Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003065649] Chr7:41972440 [GRCh38]
Chr7:42012039 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3765G>A (p.Gly1255=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002895322] Chr7:41965308 [GRCh38]
Chr7:42004906 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.548del (p.Thr183fs) deletion Greig cephalopolysyndactyly syndrome [RCV002898865] Chr7:42048622 [GRCh38]
Chr7:42088221 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.135T>A (p.Ser45Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002628947] Chr7:42148458 [GRCh38]
Chr7:42188057 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.368-2A>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003008916] Chr7:42076859 [GRCh38]
Chr7:42116458 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.3109A>G (p.Thr1037Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002898667] Chr7:41965964 [GRCh38]
Chr7:42005562 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.4392C>A (p.Asp1464Glu) single nucleotide variant GLI3-related condition [RCV003418601]|Greig cephalopolysyndactyly syndrome [RCV002746393] Chr7:41964681 [GRCh38]
Chr7:42004279 [GRCh37]
Chr7:7p14.1
benign|uncertain significance
NM_000168.6(GLI3):c.1356+16C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003086814] Chr7:42025248 [GRCh38]
Chr7:42064847 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2408C>T (p.Ala803Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003011193] Chr7:41967619 [GRCh38]
Chr7:42007217 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1091T>G (p.Leu364Arg) single nucleotide variant Inborn genetic diseases [RCV002747537] Chr7:42026350 [GRCh38]
Chr7:42065949 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4186G>C (p.Ala1396Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002833102] Chr7:41964887 [GRCh38]
Chr7:42004485 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2416C>T (p.Pro806Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002578671] Chr7:41967611 [GRCh38]
Chr7:42007209 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3611C>T (p.Pro1204Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002629429] Chr7:41965462 [GRCh38]
Chr7:42005060 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3859C>G (p.Gln1287Glu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002895371] Chr7:41965214 [GRCh38]
Chr7:42004812 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.39_41del (p.Lys15del) deletion Greig cephalopolysyndactyly syndrome [RCV002938785] Chr7:42223213..42223215 [GRCh38]
Chr7:42262812..42262814 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3254A>G (p.Asn1085Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003778594]|Inborn genetic diseases [RCV002719697] Chr7:41965819 [GRCh38]
Chr7:42005417 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4712A>G (p.Glu1571Gly) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002714904] Chr7:41964361 [GRCh38]
Chr7:42003959 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3517TCC[2] (p.Ser1175del) microsatellite Greig cephalopolysyndactyly syndrome [RCV003091325] Chr7:41965548..41965550 [GRCh38]
Chr7:42005146..42005148 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3097C>A (p.Pro1033Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002720998] Chr7:41965976 [GRCh38]
Chr7:42005574 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.474-3C>T single nucleotide variant GLI3-related condition [RCV003898566]|Greig cephalopolysyndactyly syndrome [RCV002899680] Chr7:42048699 [GRCh38]
Chr7:42088298 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.802A>G (p.Met268Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002812152] Chr7:42045408 [GRCh38]
Chr7:42085007 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4362C>T (p.Asp1454=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002721076] Chr7:41964711 [GRCh38]
Chr7:42004309 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4567C>G (p.Leu1523Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002628119] Chr7:41964506 [GRCh38]
Chr7:42004104 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3893C>A (p.Pro1298Gln) single nucleotide variant Inborn genetic diseases [RCV002702978] Chr7:41965180 [GRCh38]
Chr7:42004778 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.827-15T>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002647633] Chr7:42040254 [GRCh38]
Chr7:42079853 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4043_4045del (p.Ile1348del) deletion Greig cephalopolysyndactyly syndrome [RCV003064129] Chr7:41965028..41965030 [GRCh38]
Chr7:42004626..42004628 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1539C>T (p.Phe513=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002576499] Chr7:41978707 [GRCh38]
Chr7:42018306 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3132C>G (p.Leu1044=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003050154] Chr7:41965941 [GRCh38]
Chr7:42005539 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1954C>A (p.Pro652Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002603941] Chr7:41972486 [GRCh38]
Chr7:42012085 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2083G>T (p.Val695Phe) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002633469] Chr7:41972357 [GRCh38]
Chr7:42011956 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4487G>A (p.Ser1496Asn) single nucleotide variant Inborn genetic diseases [RCV002677195] Chr7:41964586 [GRCh38]
Chr7:42004184 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.367+1G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002942550] Chr7:42148225 [GRCh38]
Chr7:42187824 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2961C>T (p.Tyr987=) single nucleotide variant GLI3-related condition [RCV003918900]|Greig cephalopolysyndactyly syndrome [RCV003093172] Chr7:41966112 [GRCh38]
Chr7:42005710 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3539G>C (p.Gly1180Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003069246] Chr7:41965534 [GRCh38]
Chr7:42005132 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.4247G>T (p.Cys1416Phe) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003068354] Chr7:41964826 [GRCh38]
Chr7:42004424 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2862G>T (p.Lys954Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003071350]|Inborn genetic diseases [RCV003171048] Chr7:41966211 [GRCh38]
Chr7:42005809 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.1647+16G>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002604304] Chr7:41978583 [GRCh38]
Chr7:42018182 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.4220G>A (p.Gly1407Glu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002584391] Chr7:41964853 [GRCh38]
Chr7:42004451 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.4234A>G (p.Thr1412Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002610941] Chr7:41964839 [GRCh38]
Chr7:42004437 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3712G>A (p.Gly1238Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002613149] Chr7:41965361 [GRCh38]
Chr7:42004959 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3003C>T (p.Gly1001=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002585389] Chr7:41966070 [GRCh38]
Chr7:42005668 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3092A>G (p.Asn1031Ser) single nucleotide variant GLI3-related condition [RCV003410132]|Greig cephalopolysyndactyly syndrome [RCV002634027] Chr7:41965981 [GRCh38]
Chr7:42005579 [GRCh37]
Chr7:7p14.1
likely benign|uncertain significance
NM_000168.6(GLI3):c.614G>A (p.Arg205His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002611742] Chr7:42048556 [GRCh38]
Chr7:42088155 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1618C>G (p.His540Asp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV002815116] Chr7:41978628 [GRCh38]
Chr7:42018227 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3110C>G (p.Thr1037Arg) single nucleotide variant Inborn genetic diseases [RCV002722809] Chr7:41965963 [GRCh38]
Chr7:42005561 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1493T>C (p.Val498Ala) single nucleotide variant Inborn genetic diseases [RCV003213243] Chr7:42023472 [GRCh38]
Chr7:42063071 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3659G>A (p.Ser1220Asn) single nucleotide variant Inborn genetic diseases [RCV003194611] Chr7:41965414 [GRCh38]
Chr7:42005012 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4332T>A (p.Tyr1444Ter) single nucleotide variant Postaxial polydactyly type B [RCV003228739] Chr7:41964741 [GRCh38]
Chr7:42004339 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2587C>T (p.Arg863Cys) single nucleotide variant not provided [RCV003228419] Chr7:41966486 [GRCh38]
Chr7:42006084 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4484A>G (p.Asp1495Gly) single nucleotide variant not provided [RCV003227333] Chr7:41964589 [GRCh38]
Chr7:42004187 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2875C>G (p.Leu959Val) single nucleotide variant not provided [RCV003135384] Chr7:41966198 [GRCh38]
Chr7:42005796 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2845G>A (p.Glu949Lys) single nucleotide variant not provided [RCV003135385] Chr7:41966228 [GRCh38]
Chr7:42005826 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.426T>A (p.His142Gln) single nucleotide variant not provided [RCV003135386] Chr7:42076799 [GRCh38]
Chr7:42116398 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.491G>A (p.Ser164Asn) single nucleotide variant not provided [RCV003135387] Chr7:42048679 [GRCh38]
Chr7:42088278 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.632C>T (p.Pro211Leu) single nucleotide variant not provided [RCV003135388] Chr7:42048538 [GRCh38]
Chr7:42088137 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1848G>C (p.Lys616Asn) single nucleotide variant not provided [RCV003135389] Chr7:41972592 [GRCh38]
Chr7:42012191 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3397G>A (p.Gly1133Arg) single nucleotide variant not provided [RCV003135390] Chr7:41965676 [GRCh38]
Chr7:42005274 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3386T>C (p.Phe1129Ser) single nucleotide variant not provided [RCV003135391] Chr7:41965687 [GRCh38]
Chr7:42005285 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.151C>T (p.His51Tyr) single nucleotide variant not provided [RCV003229419] Chr7:42148442 [GRCh38]
Chr7:42188041 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.148T>C (p.Tyr50His) single nucleotide variant not provided [RCV003228491] Chr7:42148445 [GRCh38]
Chr7:42188044 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1577C>T (p.Pro526Leu) single nucleotide variant not provided [RCV003318997] Chr7:41978669 [GRCh38]
Chr7:42018268 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3140A>C (p.Gln1047Pro) single nucleotide variant Inborn genetic diseases [RCV003285279] Chr7:41965933 [GRCh38]
Chr7:42005531 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.815A>G (p.His272Arg) single nucleotide variant not provided [RCV003321352] Chr7:42045395 [GRCh38]
Chr7:42084994 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1813-11G>A single nucleotide variant not provided [RCV003325694] Chr7:41972638 [GRCh38]
Chr7:42012237 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2892C>T (p.Leu964=) single nucleotide variant not provided [RCV003423554] Chr7:41966181 [GRCh38]
Chr7:42005779 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1846A>G (p.Lys616Glu) single nucleotide variant Polydactyly, postaxial, type A1 [RCV003338095] Chr7:41972594 [GRCh38]
Chr7:42012193 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4046G>A (p.Ser1349Asn) single nucleotide variant not provided [RCV003332533] Chr7:41965027 [GRCh38]
Chr7:42004625 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3224del (p.Leu1075fs) deletion GLI3-Related Disorders [RCV003335857] Chr7:41965849 [GRCh38]
Chr7:42005447 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3137T>C (p.Leu1046Pro) single nucleotide variant Inborn genetic diseases [RCV003369732] Chr7:41965936 [GRCh38]
Chr7:42005534 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1777C>A (p.Arg593Ser) single nucleotide variant GLI3-related condition [RCV003418844] Chr7:41977593 [GRCh38]
Chr7:42017192 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2692A>G (p.Ile898Val) single nucleotide variant GLI3-related condition [RCV003394399] Chr7:41966381 [GRCh38]
Chr7:42005979 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4168G>C (p.Gly1390Arg) single nucleotide variant Inborn genetic diseases [RCV003361921] Chr7:41964905 [GRCh38]
Chr7:42004503 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2407G>C (p.Ala803Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003455900] Chr7:41967620 [GRCh38]
Chr7:42007218 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1659C>T (p.Cys553=) single nucleotide variant not specified [RCV003479656] Chr7:41977711 [GRCh38]
Chr7:42017310 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1946G>A (p.Arg649Gln) single nucleotide variant not provided [RCV003487873] Chr7:41972494 [GRCh38]
Chr7:42012093 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2993C>G (p.Pro998Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003791510] Chr7:41966080 [GRCh38]
Chr7:42005678 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2610C>A (p.Cys870Ter) single nucleotide variant GLI3-related condition [RCV003397414] Chr7:41966463 [GRCh38]
Chr7:42006061 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.3378del (p.Gly1127fs) deletion not provided [RCV003442723] Chr7:41965695 [GRCh38]
Chr7:42005293 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.-116_-110del deletion not provided [RCV003423555] Chr7:42237038..42237044 [GRCh38]
Chr7:42276637..42276643 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3706G>A (p.Gly1236Arg) single nucleotide variant GLI3-related condition [RCV003400048] Chr7:41965367 [GRCh38]
Chr7:42004965 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3892C>G (p.Pro1298Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003791853] Chr7:41965181 [GRCh38]
Chr7:42004779 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4621_4625dup (p.Ala1543fs) duplication GLI3-related condition [RCV003404376] Chr7:41964447..41964448 [GRCh38]
Chr7:42004045..42004046 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.1369G>A (p.Gly457Arg) single nucleotide variant GLI3-related condition [RCV003404652] Chr7:42023596 [GRCh38]
Chr7:42063195 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.669C>G (p.Ser223Arg) single nucleotide variant GLI3-related condition [RCV003399916] Chr7:42048501 [GRCh38]
Chr7:42088100 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3523del (p.Ser1175fs) deletion GLI3-related condition [RCV003394450] Chr7:41965550 [GRCh38]
Chr7:42005148 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.4095A>C (p.Pro1365=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003778439]|not provided [RCV003433770] Chr7:41964978 [GRCh38]
Chr7:42004576 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1894C>T (p.His632Tyr) single nucleotide variant GLI3-related condition [RCV003402208] Chr7:41972546 [GRCh38]
Chr7:42012145 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1864A>C (p.Ser622Arg) single nucleotide variant GLI3-related condition [RCV003402380] Chr7:41972576 [GRCh38]
Chr7:42012175 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1937_1949dup (p.Pro652fs) duplication not provided [RCV003433773] Chr7:41972490..41972491 [GRCh38]
Chr7:42012089..42012090 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1318G>A (p.Asp440Asn) single nucleotide variant not provided [RCV003433774] Chr7:42025302 [GRCh38]
Chr7:42064901 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3751G>T (p.Ala1251Ser) single nucleotide variant GLI3-related condition [RCV003404642] Chr7:41965322 [GRCh38]
Chr7:42004920 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1448_1463dup (p.Arg489fs) duplication GLI3-related condition [RCV003419068] Chr7:42023501..42023502 [GRCh38]
Chr7:42063100..42063101 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.1570C>A (p.Gln524Lys) single nucleotide variant GLI3-related condition [RCV003394362] Chr7:41978676 [GRCh38]
Chr7:42018275 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3638A>G (p.Tyr1213Cys) single nucleotide variant GLI3-related condition [RCV003419034] Chr7:41965435 [GRCh38]
Chr7:42005033 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.371CTC[1] (p.Pro125del) microsatellite GLI3-related condition [RCV003419106] Chr7:42076849..42076851 [GRCh38]
Chr7:42116448..42116450 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3718A>G (p.Ser1240Gly) single nucleotide variant not provided [RCV003433771] Chr7:41965355 [GRCh38]
Chr7:42004953 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.837C>A (p.Phe279Leu) single nucleotide variant not provided [RCV003433775] Chr7:42040229 [GRCh38]
Chr7:42079828 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4168G>A (p.Gly1390Arg) single nucleotide variant GLI3-related condition [RCV003408621] Chr7:41964905 [GRCh38]
Chr7:42004503 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.758A>T (p.Asp253Val) single nucleotide variant GLI3-related condition [RCV003404205] Chr7:42045452 [GRCh38]
Chr7:42085051 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3739C>T (p.Gln1247Ter) single nucleotide variant not provided [RCV003441501] Chr7:41965334 [GRCh38]
Chr7:42004932 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.4317C>G (p.Tyr1439Ter) single nucleotide variant GLI3-related condition [RCV003406141] Chr7:41964756 [GRCh38]
Chr7:42004354 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.*2859G>A single nucleotide variant not provided [RCV003423553] Chr7:41961471 [GRCh38]
Chr7:42001069 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2429A>G (p.Asn810Ser) single nucleotide variant not provided [RCV003433772] Chr7:41967598 [GRCh38]
Chr7:42007196 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2664_2676del (p.Asn888fs) deletion GLI3-related condition [RCV003400011] Chr7:41966397..41966409 [GRCh38]
Chr7:42005995..42006007 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2488A>G (p.Arg830Gly) single nucleotide variant GLI3-related condition [RCV003397573] Chr7:41966585 [GRCh38]
Chr7:42006183 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2584C>T (p.Arg862Cys) single nucleotide variant GLI3-related condition [RCV003410532] Chr7:41966489 [GRCh38]
Chr7:42006087 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2482C>T (p.Pro828Ser) single nucleotide variant GLI3-related condition [RCV003400220] Chr7:41966591 [GRCh38]
Chr7:42006189 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4409A>G (p.Gln1470Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003784846] Chr7:41964664 [GRCh38]
Chr7:42004262 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2610C>T (p.Cys870=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003788572] Chr7:41966463 [GRCh38]
Chr7:42006061 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1626C>T (p.Gly542=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003796308] Chr7:41978620 [GRCh38]
Chr7:42018219 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.4331A>G (p.Tyr1444Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003794188] Chr7:41964742 [GRCh38]
Chr7:42004340 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3160G>A (p.Gly1054Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003797787] Chr7:41965913 [GRCh38]
Chr7:42005511 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.538C>T (p.Arg180Trp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003794318] Chr7:42048632 [GRCh38]
Chr7:42088231 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2957G>A (p.Gly986Asp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003783016] Chr7:41966116 [GRCh38]
Chr7:42005714 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4283A>C (p.Gln1428Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003784178] Chr7:41964790 [GRCh38]
Chr7:42004388 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.618C>T (p.Ser206=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003795838] Chr7:42048552 [GRCh38]
Chr7:42088151 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2965C>T (p.Arg989Trp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003784410] Chr7:41966108 [GRCh38]
Chr7:42005706 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2432-17C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003796879] Chr7:41966658 [GRCh38]
Chr7:42006256 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2608T>G (p.Cys870Gly) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003793468] Chr7:41966465 [GRCh38]
Chr7:42006063 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1415A>G (p.Gln472Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003796206] Chr7:42023550 [GRCh38]
Chr7:42063149 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4605C>T (p.Ser1535=) single nucleotide variant GLI3-related condition [RCV003929354]|Greig cephalopolysyndactyly syndrome [RCV003807501] Chr7:41964468 [GRCh38]
Chr7:42004066 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1818A>G (p.Pro606=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003781792] Chr7:41972622 [GRCh38]
Chr7:42012221 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2326G>A (p.Glu776Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003785991] Chr7:41967701 [GRCh38]
Chr7:42007299 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3620_3621delinsAA (p.Ser1207Lys) indel Greig cephalopolysyndactyly syndrome [RCV003796691] Chr7:41965452..41965453 [GRCh38]
Chr7:42005050..42005051 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4189A>G (p.Met1397Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003783965] Chr7:41964884 [GRCh38]
Chr7:42004482 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1674G>A (p.Ser558=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003805149] Chr7:41977696 [GRCh38]
Chr7:42017295 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.2973C>G (p.His991Gln) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003783379] Chr7:41966100 [GRCh38]
Chr7:42005698 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4483G>A (p.Asp1495Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003788213] Chr7:41964590 [GRCh38]
Chr7:42004188 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1749C>T (p.Cys583=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003793001] Chr7:41977621 [GRCh38]
Chr7:42017220 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1242+7G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003793756] Chr7:42026192 [GRCh38]
Chr7:42065791 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3548C>T (p.Pro1183Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003791115] Chr7:41965525 [GRCh38]
Chr7:42005123 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3761A>G (p.Tyr1254Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003783487] Chr7:41965312 [GRCh38]
Chr7:42004910 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2714G>C (p.Arg905Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003796346] Chr7:41966359 [GRCh38]
Chr7:42005957 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4181G>T (p.Arg1394Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003793830] Chr7:41964892 [GRCh38]
Chr7:42004490 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4315del (p.Tyr1439fs) deletion Greig cephalopolysyndactyly syndrome [RCV003804681] Chr7:41964758 [GRCh38]
Chr7:42004356 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.680-20C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003785459] Chr7:42045550 [GRCh38]
Chr7:42085149 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1029-15A>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003789851] Chr7:42026427 [GRCh38]
Chr7:42066026 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1056C>G (p.Ser352=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003784232] Chr7:42026385 [GRCh38]
Chr7:42065984 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2046T>C (p.Thr682=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003792583] Chr7:41972394 [GRCh38]
Chr7:42011993 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2828C>T (p.Thr943Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003786280] Chr7:41966245 [GRCh38]
Chr7:42005843 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4020del (p.Gly1341fs) deletion Greig cephalopolysyndactyly syndrome [RCV003805564] Chr7:41965053 [GRCh38]
Chr7:42004651 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2593_2628dup (p.Ser877_Glu878insGlyIleSerProCysPheSerSerArgArgSerSer) duplication Greig cephalopolysyndactyly syndrome [RCV003804361] Chr7:41966444..41966445 [GRCh38]
Chr7:42006042..42006043 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1461C>T (p.Cys487=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003796223] Chr7:42023504 [GRCh38]
Chr7:42063103 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.4322_4326del (p.Gly1441fs) deletion Greig cephalopolysyndactyly syndrome [RCV003806840] Chr7:41964747..41964751 [GRCh38]
Chr7:42004345..42004349 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3396C>T (p.Pro1132=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003793560] Chr7:41965677 [GRCh38]
Chr7:42005275 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.1056C>T (p.Ser352=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003785958] Chr7:42026385 [GRCh38]
Chr7:42065984 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2332G>A (p.Val778Ile) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003794002] Chr7:41967695 [GRCh38]
Chr7:42007293 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3305C>A (p.Ser1102Tyr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003796323] Chr7:41965768 [GRCh38]
Chr7:42005366 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3378C>T (p.Pro1126=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003789401] Chr7:41965695 [GRCh38]
Chr7:42005293 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3698A>G (p.Asn1233Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003781245] Chr7:41965375 [GRCh38]
Chr7:42004973 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3368C>T (p.Pro1123Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003786438] Chr7:41965705 [GRCh38]
Chr7:42005303 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4029G>C (p.Gln1343His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003792727] Chr7:41965044 [GRCh38]
Chr7:42004642 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1457G>C (p.Gly486Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003787007] Chr7:42023508 [GRCh38]
Chr7:42063107 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3971C>G (p.Ala1324Gly) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003782589] Chr7:41965102 [GRCh38]
Chr7:42004700 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.487T>C (p.Ser163Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003788743] Chr7:42048683 [GRCh38]
Chr7:42088282 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1902A>T (p.Pro634=) single nucleotide variant GLI3-related condition [RCV003949014]|Greig cephalopolysyndactyly syndrome [RCV003785709] Chr7:41972538 [GRCh38]
Chr7:42012137 [GRCh37]
Chr7:7p14.1
benign|likely benign
NM_000168.6(GLI3):c.3877C>T (p.Leu1293=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003782717] Chr7:41965196 [GRCh38]
Chr7:42004794 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2844G>A (p.Met948Ile) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003781376] Chr7:41966229 [GRCh38]
Chr7:42005827 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3961G>T (p.Gly1321Trp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003787311] Chr7:41965112 [GRCh38]
Chr7:42004710 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4574C>T (p.Pro1525Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003780269] Chr7:41964499 [GRCh38]
Chr7:42004097 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4346G>A (p.Gly1449Asp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003785382] Chr7:41964727 [GRCh38]
Chr7:42004325 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3635G>A (p.Gly1212Asp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003796123] Chr7:41965438 [GRCh38]
Chr7:42005036 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1647+11A>C single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003783934] Chr7:41978588 [GRCh38]
Chr7:42018187 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2737G>A (p.Asp913Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003806384] Chr7:41966336 [GRCh38]
Chr7:42005934 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.319A>G (p.Thr107Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003795758] Chr7:42148274 [GRCh38]
Chr7:42187873 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3273C>T (p.Phe1091=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003786260] Chr7:41965800 [GRCh38]
Chr7:42005398 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2103+5G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003807110] Chr7:41972332 [GRCh38]
Chr7:42011931 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3828del (p.Gln1277fs) deletion not provided [RCV003489373] Chr7:41965245 [GRCh38]
Chr7:42004843 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.12G>T (p.Gln4His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003792184] Chr7:42223242 [GRCh38]
Chr7:42262841 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2300G>A (p.Arg767Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003781050] Chr7:41967727 [GRCh38]
Chr7:42007325 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3411C>A (p.Ser1137Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003786329] Chr7:41965662 [GRCh38]
Chr7:42005260 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3285C>T (p.Asp1095=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003793843] Chr7:41965788 [GRCh38]
Chr7:42005386 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2961C>G (p.Tyr987Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003806113] Chr7:41966112 [GRCh38]
Chr7:42005710 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4193C>T (p.Pro1398Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003793598] Chr7:41964880 [GRCh38]
Chr7:42004478 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1949C>T (p.Pro650Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003790104] Chr7:41972491 [GRCh38]
Chr7:42012090 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.17A>C (p.His6Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003792183] Chr7:42223237 [GRCh38]
Chr7:42262836 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1812+7A>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003791243] Chr7:41977551 [GRCh38]
Chr7:42017150 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2745G>A (p.Leu915=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003787276] Chr7:41966328 [GRCh38]
Chr7:42005926 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3100G>A (p.Ala1034Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003791580] Chr7:41965973 [GRCh38]
Chr7:42005571 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.463C>T (p.Pro155Ser) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003789434] Chr7:42076762 [GRCh38]
Chr7:42116361 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1345C>T (p.Arg449Trp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003789318] Chr7:42025275 [GRCh38]
Chr7:42064874 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.331A>T (p.Met111Leu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003787611] Chr7:42148262 [GRCh38]
Chr7:42187861 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.433C>T (p.Arg145Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003789431] Chr7:42076792 [GRCh38]
Chr7:42116391 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1375A>G (p.Thr459Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003788827] Chr7:42023590 [GRCh38]
Chr7:42063189 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2144G>A (p.Ser715Asn) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003789569] Chr7:41967883 [GRCh38]
Chr7:42007481 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1327C>G (p.Leu443Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003801058] Chr7:42025293 [GRCh38]
Chr7:42064892 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4017_4018insG (p.Pro1340fs) insertion Greig cephalopolysyndactyly syndrome [RCV003801235] Chr7:41965055..41965056 [GRCh38]
Chr7:42004653..42004654 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.263A>G (p.Lys88Arg) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003798028] Chr7:42148330 [GRCh38]
Chr7:42187929 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1555_1567del (p.Asp519fs) deletion Greig cephalopolysyndactyly syndrome [RCV003813457] Chr7:41978679..41978691 [GRCh38]
Chr7:42018278..42018290 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1357-10C>T single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003808748] Chr7:42023618 [GRCh38]
Chr7:42063217 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.532C>A (p.Pro178Thr) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003810516] Chr7:42048638 [GRCh38]
Chr7:42088237 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2711G>A (p.Arg904His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003801779] Chr7:41966362 [GRCh38]
Chr7:42005960 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1629G>A (p.Glu543=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003798779] Chr7:41978617 [GRCh38]
Chr7:42018216 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.3630T>C (p.Ala1210=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003801782] Chr7:41965443 [GRCh38]
Chr7:42005041 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4564G>C (p.Ala1522Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003799391] Chr7:41964509 [GRCh38]
Chr7:42004107 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1366G>A (p.Glu456Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003810096] Chr7:42023599 [GRCh38]
Chr7:42063198 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4683C>G (p.Asp1561Glu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003817800] Chr7:41964390 [GRCh38]
Chr7:42003988 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1348G>T (p.Gly450Trp) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003808645] Chr7:42025272 [GRCh38]
Chr7:42064871 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1028+12C>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003799548] Chr7:42040026 [GRCh38]
Chr7:42079625 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.26C>T (p.Thr9Met) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003798892] Chr7:42223228 [GRCh38]
Chr7:42262827 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2719A>T (p.Ser907Cys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003801481] Chr7:41966354 [GRCh38]
Chr7:42005952 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3522C>T (p.Ser1174=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003809732] Chr7:41965551 [GRCh38]
Chr7:42005149 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3099G>A (p.Pro1033=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003798587] Chr7:41965974 [GRCh38]
Chr7:42005572 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2623del (p.Arg875fs) deletion Greig cephalopolysyndactyly syndrome [RCV003815627] Chr7:41966450 [GRCh38]
Chr7:42006048 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2044A>G (p.Thr682Ala) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003799728] Chr7:41972396 [GRCh38]
Chr7:42011995 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.826+10G>A single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003798637] Chr7:42045374 [GRCh38]
Chr7:42084973 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3114C>T (p.Ser1038=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003812733] Chr7:41965959 [GRCh38]
Chr7:42005557 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.4081G>T (p.Glu1361Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003813149] Chr7:41964992 [GRCh38]
Chr7:42004590 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3374G>A (p.Gly1125Glu) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003799924] Chr7:41965699 [GRCh38]
Chr7:42005297 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3110C>A (p.Thr1037Lys) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003815231] Chr7:41965963 [GRCh38]
Chr7:42005561 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1353G>T (p.Gln451His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003801289] Chr7:42025267 [GRCh38]
Chr7:42064866 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3818G>T (p.Gly1273Val) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003803077] Chr7:41965255 [GRCh38]
Chr7:42004853 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2264C>T (p.Ser755Phe) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003802961] Chr7:41967763 [GRCh38]
Chr7:42007361 [GRCh37]
Chr7:7p14.1
uncertain significance
GRCh37/hg19 7p14.1(chr7:42034018-42195168)x1 copy number loss not specified [RCV003986705] Chr7:42034018..42195168 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.3442C>T (p.Gln1148Ter) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003803344] Chr7:41965631 [GRCh38]
Chr7:42005229 [GRCh37]
Chr7:7p14.1
pathogenic
GRCh37/hg19 7p14.1(chr7:38484106-42786613)x1 copy number loss not specified [RCV003986704] Chr7:38484106..42786613 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.1325_1328dup (p.Ser445fs) duplication Greig cephalopolysyndactyly syndrome [RCV003985969] Chr7:42025291..42025292 [GRCh38]
Chr7:42064890..42064891 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.2876_2880dup (p.Gly961fs) duplication Greig cephalopolysyndactyly syndrome [RCV003986033] Chr7:41966192..41966193 [GRCh38]
Chr7:42005790..42005791 [GRCh37]
Chr7:7p14.1
likely pathogenic
GRCh37/hg19 7p14.1(chr7:41942712-42378563)x3 copy number gain not specified [RCV003986727] Chr7:41942712..42378563 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2884G>C (p.Asp962His) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003803239] Chr7:41966189 [GRCh38]
Chr7:42005787 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.558del (p.Glu187fs) deletion Greig cephalopolysyndactyly syndrome [RCV003802161] Chr7:42048612 [GRCh38]
Chr7:42088211 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.2970C>T (p.Arg990=) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003802183] Chr7:41966103 [GRCh38]
Chr7:42005701 [GRCh37]
Chr7:7p14.1
benign
NM_000168.6(GLI3):c.936G>A (p.Thr312=) single nucleotide variant GLI3-related condition [RCV003969635] Chr7:42040130 [GRCh38]
Chr7:42079729 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.601A>G (p.Met201Val) single nucleotide variant GLI3-related condition [RCV003912064] Chr7:42048569 [GRCh38]
Chr7:42088168 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.2104-6del deletion GLI3-related condition [RCV003971918] Chr7:41967929 [GRCh38]
Chr7:42007527 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2774A>C (p.Gln925Pro) single nucleotide variant Greig cephalopolysyndactyly syndrome [RCV003989004] Chr7:41966299 [GRCh38]
Chr7:42005897 [GRCh37]
uncertain significance
NM_000168.6(GLI3):c.4576A>G (p.Ser1526Gly) single nucleotide variant not provided [RCV003885205] Chr7:41964497 [GRCh38]
Chr7:42004095 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3885C>T (p.Phe1295=) single nucleotide variant GLI3-related condition [RCV003901844] Chr7:41965188 [GRCh38]
Chr7:42004786 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2994G>A (p.Pro998=) single nucleotide variant GLI3-related condition [RCV003957037] Chr7:41966079 [GRCh38]
Chr7:42005677 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3787G>A (p.Val1263Met) single nucleotide variant GLI3-related condition [RCV003982774] Chr7:41965286 [GRCh38]
Chr7:42004884 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3400C>T (p.Leu1134=) single nucleotide variant GLI3-related condition [RCV003969428] Chr7:41965673 [GRCh38]
Chr7:42005271 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4677C>A (p.Ile1559=) single nucleotide variant GLI3-related condition [RCV003963937] Chr7:41964396 [GRCh38]
Chr7:42003994 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4620G>A (p.Thr1540=) single nucleotide variant GLI3-related condition [RCV003936854] Chr7:41964453 [GRCh38]
Chr7:42004051 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.4731A>G (p.Ala1577=) single nucleotide variant GLI3-related condition [RCV003899099] Chr7:41964342 [GRCh38]
Chr7:42003940 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.45del (p.Val16fs) deletion not provided [RCV003887335] Chr7:42223209 [GRCh38]
Chr7:42262808 [GRCh37]
Chr7:7p14.1
pathogenic
NM_000168.6(GLI3):c.4122G>A (p.Pro1374=) single nucleotide variant GLI3-related condition [RCV003979399] Chr7:41964951 [GRCh38]
Chr7:42004549 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1991C>A (p.Ser664Ter) single nucleotide variant GLI3-related condition [RCV003926903] Chr7:41972449 [GRCh38]
Chr7:42012048 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.1028+1G>T single nucleotide variant GLI3-related condition [RCV003927055] Chr7:42040037 [GRCh38]
Chr7:42079636 [GRCh37]
Chr7:7p14.1
likely pathogenic
NM_000168.6(GLI3):c.4680G>A (p.Gly1560=) single nucleotide variant GLI3-related condition [RCV003947385] Chr7:41964393 [GRCh38]
Chr7:42003991 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.421C>A (p.His141Asn) single nucleotide variant GLI3-related condition [RCV003899146] Chr7:42076804 [GRCh38]
Chr7:42116403 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.1641A>G (p.Lys547=) single nucleotide variant GLI3-related condition [RCV003981300] Chr7:41978605 [GRCh38]
Chr7:42018204 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.3133G>C (p.Val1045Leu) single nucleotide variant GLI3-related condition [RCV003899104] Chr7:41965940 [GRCh38]
Chr7:42005538 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.3318A>C (p.Ala1106=) single nucleotide variant GLI3-related condition [RCV003899626] Chr7:41965755 [GRCh38]
Chr7:42005353 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1062C>G (p.Pro354=) single nucleotide variant GLI3-related condition [RCV003894198] Chr7:42026379 [GRCh38]
Chr7:42065978 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.1382T>C (p.Val461Ala) single nucleotide variant GLI3-related condition [RCV003894330] Chr7:42023583 [GRCh38]
Chr7:42063182 [GRCh37]
Chr7:7p14.1
uncertain significance
NM_000168.6(GLI3):c.4080A>G (p.Pro1360=) single nucleotide variant GLI3-related condition [RCV003902104] Chr7:41964993 [GRCh38]
Chr7:42004591 [GRCh37]
Chr7:7p14.1
likely benign
NM_000168.6(GLI3):c.2286T>C (p.Ala762=) single nucleotide variant GLI3-related condition [RCV003968922] Chr7:41967741 [GRCh38]
Chr7:42007339 [GRCh37]
Chr7:7p14.1
likely benign
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:2244
Count of miRNA genes:1054
Interacting mature miRNAs:1261
Transcripts:ENST00000395925, ENST00000428534, ENST00000437480, ENST00000448703, ENST00000464291, ENST00000479210
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

Markers in Region
D7S691  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,029,703 - 42,029,842UniSTSGRCh37
GRCh37742,029,608 - 42,029,722UniSTSGRCh37
Build 36741,996,228 - 41,996,367RGDNCBI36
Celera742,020,459 - 42,020,598RGD
Celera742,020,364 - 42,020,478UniSTS
Cytogenetic Map7p13UniSTS
HuRef741,915,302 - 41,915,441UniSTS
HuRef741,915,207 - 41,915,321UniSTS
CRA_TCAGchr7v2742,069,543 - 42,069,682UniSTS
CRA_TCAGchr7v2742,069,448 - 42,069,562UniSTS
Marshfield Genetic Map763.67RGD
Genethon Genetic Map764.6UniSTS
deCODE Assembly Map763.44UniSTS
Whitehead-YAC Contig Map7 UniSTS
RH65647  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,177,890 - 42,178,054UniSTSGRCh37
Build 36742,144,415 - 42,144,579RGDNCBI36
Celera742,168,628 - 42,168,792RGD
Cytogenetic Map7p13UniSTS
HuRef742,063,670 - 42,063,834UniSTS
CRA_TCAGchr7v2742,217,739 - 42,217,903UniSTS
GeneMap99-GB4 RH Map7199.92UniSTS
NCBI RH Map7649.5UniSTS
RH123527  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,116,706 - 42,117,014UniSTSGRCh37
Build 36742,083,231 - 42,083,539RGDNCBI36
Celera742,107,453 - 42,107,761RGD
Cytogenetic Map7p13UniSTS
HuRef742,002,296 - 42,002,606UniSTS
CRA_TCAGchr7v2742,156,533 - 42,156,841UniSTS
TNG Radiation Hybrid Map720576.0UniSTS
GDB:435308  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,003,794 - 42,004,371UniSTSGRCh37
Build 36741,970,319 - 41,970,896RGDNCBI36
Celera741,994,566 - 41,995,143RGD
Cytogenetic Map7p13UniSTS
HuRef741,888,674 - 41,889,251UniSTS
CRA_TCAGchr7v2742,043,647 - 42,044,224UniSTS
SHGC-106357  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,078,229 - 42,078,539UniSTSGRCh37
Build 36742,044,754 - 42,045,064RGDNCBI36
Celera742,068,967 - 42,069,277RGD
Cytogenetic Map7p13UniSTS
HuRef741,963,813 - 41,964,123UniSTS
CRA_TCAGchr7v2742,118,053 - 42,118,363UniSTS
TNG Radiation Hybrid Map720553.0UniSTS
SHGC-152225  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,029,567 - 42,029,835UniSTSGRCh37
Build 36741,996,092 - 41,996,360RGDNCBI36
Celera742,020,323 - 42,020,591RGD
Cytogenetic Map7p13UniSTS
HuRef741,915,166 - 41,915,434UniSTS
CRA_TCAGchr7v2742,069,407 - 42,069,675UniSTS
TNG Radiation Hybrid Map1063666.0UniSTS
GLI3_973.2  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,003,561 - 42,004,305UniSTSGRCh37
Build 36741,970,086 - 41,970,830RGDNCBI36
Celera741,994,333 - 41,995,077RGD
HuRef741,888,441 - 41,889,185UniSTS
CRA_TCAGchr7v2742,043,414 - 42,044,158UniSTS
GDB:1317516  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,136,793 - 42,136,891UniSTSGRCh37
Build 36742,103,318 - 42,103,416RGDNCBI36
Celera742,127,527 - 42,127,625RGD
Cytogenetic Map7p13UniSTS
HuRef742,022,546 - 42,022,644UniSTS
CRA_TCAGchr7v2742,176,615 - 42,176,713UniSTS
GLI3  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,018,136 - 42,018,411UniSTSGRCh37
Build 36741,984,661 - 41,984,936RGDNCBI36
Celera742,008,892 - 42,009,167RGD
Cytogenetic Map7p13UniSTS
HuRef741,903,734 - 41,904,009UniSTS
CRA_TCAGchr7v2742,057,976 - 42,058,251UniSTS
TNG Radiation Hybrid Map720532.0UniSTS
GeneMap99-G3 RH Map71834.0UniSTS
D7S2746  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,003,762 - 42,003,879UniSTSGRCh37
Build 36741,970,287 - 41,970,404RGDNCBI36
Celera741,994,534 - 41,994,651RGD
Cytogenetic Map7p13UniSTS
HuRef741,888,642 - 41,888,759UniSTS
CRA_TCAGchr7v2742,043,615 - 42,043,732UniSTS
TNG Radiation Hybrid Map720490.0UniSTS
Stanford-G3 RH Map71834.0UniSTS
Whitehead-YAC Contig Map7 UniSTS
NCBI RH Map7645.2UniSTS
GeneMap99-G3 RH Map71834.0UniSTS
GDB:1317704  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,246,176 - 42,246,254UniSTSGRCh37
Build 36742,212,701 - 42,212,779RGDNCBI36
Celera742,236,910 - 42,236,988RGD
Cytogenetic Map7p13UniSTS
HuRef742,131,974 - 42,132,052UniSTS
CRA_TCAGchr7v2742,286,018 - 42,286,096UniSTS
GDB:1318579  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,087,633 - 42,087,779UniSTSGRCh37
Build 36742,054,158 - 42,054,304RGDNCBI36
Celera742,078,371 - 42,078,517RGD
Cytogenetic Map7p13UniSTS
HuRef741,973,217 - 41,973,363UniSTS
CRA_TCAGchr7v2742,127,456 - 42,127,602UniSTS
RH46965  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37742,000,613 - 42,000,746UniSTSGRCh37
Build 36741,967,138 - 41,967,271RGDNCBI36
Celera741,991,385 - 41,991,518RGD
Cytogenetic Map7p13UniSTS
HuRef741,885,493 - 41,885,626UniSTS
CRA_TCAGchr7v2742,040,466 - 42,040,599UniSTS
GeneMap99-GB4 RH Map7197.98UniSTS
NCBI RH Map7653.3UniSTS
D7S691  
Human AssemblyChrPosition (strand)SourceJBrowse
Cytogenetic Map7p13UniSTS
Marshfield Genetic Map763.67UniSTS
Genethon Genetic Map764.6UniSTS
deCODE Assembly Map763.44UniSTS
Whitehead-YAC Contig Map7 UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system visual system adipose tissue appendage entire extraembryonic component
High
Medium 928 65 404 9 55 10 1978 364 280 52 683 462 6 578 859 1
Low 1388 2071 918 237 531 74 2240 1617 3020 307 727 1039 167 1 626 1792 2
Below cutoff 45 781 377 355 796 357 137 211 418 57 25 35 2 137 1

Sequence

Nucleotide Sequences
RefSeq Transcripts NG_008434 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_000168 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_011515274 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_017011997 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047420205 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047420206 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047420207 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047420208 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047420209 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054357913 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054357914 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054357915 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054357916 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054357917 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054357918 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054357919 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide AA330409 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AC005026 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AC005028 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AC005158 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AC073852 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AI863961 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AJ000757 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AJ250408 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK299299 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK308429 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC032660 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC113616 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC117168 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BF194991 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BI497308 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CH236951 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CH471073 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CP068271 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  DA713549 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  KF458449 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  KF510289 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M20674 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M57609 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  OP794603 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

RefSeq Acc Id: ENST00000395925   ⟹   ENSP00000379258
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl741,960,949 - 42,237,209 (-)Ensembl
RefSeq Acc Id: ENST00000428534
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl742,221,618 - 42,237,870 (-)Ensembl
RefSeq Acc Id: ENST00000437480   ⟹   ENSP00000407963
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl742,172,491 - 42,237,059 (-)Ensembl
RefSeq Acc Id: ENST00000448703   ⟹   ENSP00000406135
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl742,048,630 - 42,227,721 (-)Ensembl
RefSeq Acc Id: ENST00000464291
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl741,972,440 - 41,977,922 (-)Ensembl
RefSeq Acc Id: ENST00000479210   ⟹   ENSP00000496377
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl741,964,082 - 42,152,453 (-)Ensembl
RefSeq Acc Id: ENST00000642432   ⟹   ENSP00000495498
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl742,118,193 - 42,152,420 (-)Ensembl
RefSeq Acc Id: ENST00000643264   ⟹   ENSP00000495207
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl742,118,193 - 42,152,420 (-)Ensembl
RefSeq Acc Id: ENST00000647255   ⟹   ENSP00000495745
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl742,145,318 - 42,152,420 (-)Ensembl
RefSeq Acc Id: ENST00000677288   ⟹   ENSP00000503986
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl741,960,949 - 42,152,430 (-)Ensembl
RefSeq Acc Id: ENST00000677605   ⟹   ENSP00000503743
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl741,960,949 - 42,237,555 (-)Ensembl
RefSeq Acc Id: ENST00000677990
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl742,235,474 - 42,237,209 (-)Ensembl
RefSeq Acc Id: ENST00000678429   ⟹   ENSP00000502957
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl741,960,949 - 42,227,721 (-)Ensembl
RefSeq Acc Id: ENST00000678978   ⟹   ENSP00000503352
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl742,220,173 - 42,264,100 (-)Ensembl
RefSeq Acc Id: NM_000168   ⟹   NP_000159
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38741,960,949 - 42,237,209 (-)NCBI
GRCh37742,000,547 - 42,277,469 (-)NCBI
Build 36741,967,072 - 42,243,137 (-)NCBI Archive
HuRef741,885,427 - 42,162,362 (-)ENTREZGENE
CHM1_1742,003,855 - 42,280,223 (-)NCBI
T2T-CHM13v2.0742,119,298 - 42,395,514 (-)NCBI
CRA_TCAGchr7v2742,040,400 - 42,316,460 (-)ENTREZGENE
Sequence:
RefSeq Acc Id: XM_011515274   ⟹   XP_011513576
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38741,960,949 - 42,152,453 (-)NCBI
Sequence:
RefSeq Acc Id: XM_017011997   ⟹   XP_016867486
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38741,960,949 - 42,182,615 (-)NCBI
Sequence:
RefSeq Acc Id: XM_047420205   ⟹   XP_047276161
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38741,960,949 - 42,237,656 (-)NCBI
RefSeq Acc Id: XM_047420206   ⟹   XP_047276162
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38741,960,949 - 42,235,739 (-)NCBI
RefSeq Acc Id: XM_047420207   ⟹   XP_047276163
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38741,960,949 - 42,237,904 (-)NCBI
RefSeq Acc Id: XM_047420208   ⟹   XP_047276164
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38741,960,949 - 42,264,268 (-)NCBI
RefSeq Acc Id: XM_047420209   ⟹   XP_047276165
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38741,960,949 - 42,235,834 (-)NCBI
RefSeq Acc Id: XM_054357913   ⟹   XP_054213888
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0742,119,298 - 42,395,961 (-)NCBI
RefSeq Acc Id: XM_054357914   ⟹   XP_054213889
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0742,119,298 - 42,394,044 (-)NCBI
RefSeq Acc Id: XM_054357915   ⟹   XP_054213890
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0742,119,298 - 42,396,209 (-)NCBI
RefSeq Acc Id: XM_054357916   ⟹   XP_054213891
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0742,119,298 - 42,422,619 (-)NCBI
RefSeq Acc Id: XM_054357917   ⟹   XP_054213892
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0742,119,298 - 42,394,139 (-)NCBI
RefSeq Acc Id: XM_054357918   ⟹   XP_054213893
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0742,119,298 - 42,340,938 (-)NCBI
RefSeq Acc Id: XM_054357919   ⟹   XP_054213894
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0742,119,298 - 42,322,642 (-)NCBI
Protein Sequences
Protein RefSeqs NP_000159 (Get FASTA)   NCBI Sequence Viewer  
  XP_011513576 (Get FASTA)   NCBI Sequence Viewer  
  XP_016867486 (Get FASTA)   NCBI Sequence Viewer  
  XP_047276161 (Get FASTA)   NCBI Sequence Viewer  
  XP_047276162 (Get FASTA)   NCBI Sequence Viewer  
  XP_047276163 (Get FASTA)   NCBI Sequence Viewer  
  XP_047276164 (Get FASTA)   NCBI Sequence Viewer  
  XP_047276165 (Get FASTA)   NCBI Sequence Viewer  
  XP_054213888 (Get FASTA)   NCBI Sequence Viewer  
  XP_054213889 (Get FASTA)   NCBI Sequence Viewer  
  XP_054213890 (Get FASTA)   NCBI Sequence Viewer  
  XP_054213891 (Get FASTA)   NCBI Sequence Viewer  
  XP_054213892 (Get FASTA)   NCBI Sequence Viewer  
  XP_054213893 (Get FASTA)   NCBI Sequence Viewer  
  XP_054213894 (Get FASTA)   NCBI Sequence Viewer  
GenBank Protein AAA52564 (Get FASTA)   NCBI Sequence Viewer  
  AAI13617 (Get FASTA)   NCBI Sequence Viewer  
  AAI17169 (Get FASTA)   NCBI Sequence Viewer  
  AAP21869 (Get FASTA)   NCBI Sequence Viewer  
  AAS01998 (Get FASTA)   NCBI Sequence Viewer  
  AAS02015 (Get FASTA)   NCBI Sequence Viewer  
  BAG61313 (Get FASTA)   NCBI Sequence Viewer  
  CAB59315 (Get FASTA)   NCBI Sequence Viewer  
  EAL24002 (Get FASTA)   NCBI Sequence Viewer  
  EAW94144 (Get FASTA)   NCBI Sequence Viewer  
  EAW94145 (Get FASTA)   NCBI Sequence Viewer  
Ensembl Protein ENSP00000379258
  ENSP00000379258.3
  ENSP00000407963.1
  ENSP00000495207.1
  ENSP00000495498.1
  ENSP00000495745.1
  ENSP00000496377
  ENSP00000496377.1
  ENSP00000502957
  ENSP00000502957.1
  ENSP00000503352.1
  ENSP00000503743
  ENSP00000503743.1
  ENSP00000503957.1
  ENSP00000503986.1
GenBank Protein P10071 (Get FASTA)   NCBI Sequence Viewer  
RefSeq Acc Id: NP_000159   ⟸   NM_000168
- UniProtKB: Q9UDT5 (UniProtKB/Swiss-Prot),   Q75MU9 (UniProtKB/Swiss-Prot),   Q75MT0 (UniProtKB/Swiss-Prot),   Q17RW4 (UniProtKB/Swiss-Prot),   O75219 (UniProtKB/Swiss-Prot),   A4D1W1 (UniProtKB/Swiss-Prot),   Q9UJ39 (UniProtKB/Swiss-Prot),   P10071 (UniProtKB/Swiss-Prot),   A0A7I2V4X9 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_011513576   ⟸   XM_011515274
- Peptide Label: isoform X3
- UniProtKB: A0A2R8YGX0 (UniProtKB/TrEMBL),   A0A7I2V4X9 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_016867486   ⟸   XM_017011997
- Peptide Label: isoform X2
- UniProtKB: A0A7I2V4X9 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSP00000496377   ⟸   ENST00000479210
RefSeq Acc Id: ENSP00000495498   ⟸   ENST00000642432
RefSeq Acc Id: ENSP00000495207   ⟸   ENST00000643264
RefSeq Acc Id: ENSP00000406135   ⟸   ENST00000448703
RefSeq Acc Id: ENSP00000379258   ⟸   ENST00000395925
RefSeq Acc Id: ENSP00000495745   ⟸   ENST00000647255
RefSeq Acc Id: ENSP00000407963   ⟸   ENST00000437480
RefSeq Acc Id: ENSP00000503986   ⟸   ENST00000677288
RefSeq Acc Id: ENSP00000503743   ⟸   ENST00000677605
RefSeq Acc Id: ENSP00000502957   ⟸   ENST00000678429
RefSeq Acc Id: ENSP00000503352   ⟸   ENST00000678978
RefSeq Acc Id: XP_047276164   ⟸   XM_047420208
- Peptide Label: isoform X1
- UniProtKB: Q9UDT5 (UniProtKB/Swiss-Prot),   Q75MU9 (UniProtKB/Swiss-Prot),   Q75MT0 (UniProtKB/Swiss-Prot),   Q17RW4 (UniProtKB/Swiss-Prot),   P10071 (UniProtKB/Swiss-Prot),   O75219 (UniProtKB/Swiss-Prot),   A4D1W1 (UniProtKB/Swiss-Prot),   Q9UJ39 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_047276163   ⟸   XM_047420207
- Peptide Label: isoform X1
- UniProtKB: Q9UDT5 (UniProtKB/Swiss-Prot),   Q75MU9 (UniProtKB/Swiss-Prot),   Q75MT0 (UniProtKB/Swiss-Prot),   Q17RW4 (UniProtKB/Swiss-Prot),   P10071 (UniProtKB/Swiss-Prot),   O75219 (UniProtKB/Swiss-Prot),   A4D1W1 (UniProtKB/Swiss-Prot),   Q9UJ39 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_047276161   ⟸   XM_047420205
- Peptide Label: isoform X1
- UniProtKB: Q9UDT5 (UniProtKB/Swiss-Prot),   Q75MU9 (UniProtKB/Swiss-Prot),   Q75MT0 (UniProtKB/Swiss-Prot),   Q17RW4 (UniProtKB/Swiss-Prot),   P10071 (UniProtKB/Swiss-Prot),   O75219 (UniProtKB/Swiss-Prot),   A4D1W1 (UniProtKB/Swiss-Prot),   Q9UJ39 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_047276165   ⟸   XM_047420209
- Peptide Label: isoform X1
- UniProtKB: Q9UDT5 (UniProtKB/Swiss-Prot),   Q75MU9 (UniProtKB/Swiss-Prot),   Q75MT0 (UniProtKB/Swiss-Prot),   Q17RW4 (UniProtKB/Swiss-Prot),   P10071 (UniProtKB/Swiss-Prot),   O75219 (UniProtKB/Swiss-Prot),   A4D1W1 (UniProtKB/Swiss-Prot),   Q9UJ39 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_047276162   ⟸   XM_047420206
- Peptide Label: isoform X1
- UniProtKB: Q9UDT5 (UniProtKB/Swiss-Prot),   Q75MU9 (UniProtKB/Swiss-Prot),   Q75MT0 (UniProtKB/Swiss-Prot),   Q17RW4 (UniProtKB/Swiss-Prot),   P10071 (UniProtKB/Swiss-Prot),   O75219 (UniProtKB/Swiss-Prot),   A4D1W1 (UniProtKB/Swiss-Prot),   Q9UJ39 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_054213891   ⟸   XM_054357916
- Peptide Label: isoform X1
- UniProtKB: Q9UDT5 (UniProtKB/Swiss-Prot),   Q75MU9 (UniProtKB/Swiss-Prot),   Q75MT0 (UniProtKB/Swiss-Prot),   Q17RW4 (UniProtKB/Swiss-Prot),   P10071 (UniProtKB/Swiss-Prot),   O75219 (UniProtKB/Swiss-Prot),   A4D1W1 (UniProtKB/Swiss-Prot),   Q9UJ39 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_054213890   ⟸   XM_054357915
- Peptide Label: isoform X1
- UniProtKB: Q9UDT5 (UniProtKB/Swiss-Prot),   Q75MU9 (UniProtKB/Swiss-Prot),   Q75MT0 (UniProtKB/Swiss-Prot),   Q17RW4 (UniProtKB/Swiss-Prot),   P10071 (UniProtKB/Swiss-Prot),   O75219 (UniProtKB/Swiss-Prot),   A4D1W1 (UniProtKB/Swiss-Prot),   Q9UJ39 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_054213888   ⟸   XM_054357913
- Peptide Label: isoform X1
- UniProtKB: Q9UDT5 (UniProtKB/Swiss-Prot),   Q75MU9 (UniProtKB/Swiss-Prot),   Q75MT0 (UniProtKB/Swiss-Prot),   Q17RW4 (UniProtKB/Swiss-Prot),   P10071 (UniProtKB/Swiss-Prot),   O75219 (UniProtKB/Swiss-Prot),   A4D1W1 (UniProtKB/Swiss-Prot),   Q9UJ39 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_054213892   ⟸   XM_054357917
- Peptide Label: isoform X1
- UniProtKB: Q9UDT5 (UniProtKB/Swiss-Prot),   Q75MU9 (UniProtKB/Swiss-Prot),   Q75MT0 (UniProtKB/Swiss-Prot),   Q17RW4 (UniProtKB/Swiss-Prot),   P10071 (UniProtKB/Swiss-Prot),   O75219 (UniProtKB/Swiss-Prot),   A4D1W1 (UniProtKB/Swiss-Prot),   Q9UJ39 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_054213889   ⟸   XM_054357914
- Peptide Label: isoform X1
- UniProtKB: Q9UDT5 (UniProtKB/Swiss-Prot),   Q75MU9 (UniProtKB/Swiss-Prot),   Q75MT0 (UniProtKB/Swiss-Prot),   Q17RW4 (UniProtKB/Swiss-Prot),   P10071 (UniProtKB/Swiss-Prot),   O75219 (UniProtKB/Swiss-Prot),   A4D1W1 (UniProtKB/Swiss-Prot),   Q9UJ39 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_054213893   ⟸   XM_054357918
- Peptide Label: isoform X2
RefSeq Acc Id: XP_054213894   ⟸   XM_054357919
- Peptide Label: isoform X3
- UniProtKB: A0A2R8YGX0 (UniProtKB/TrEMBL)
Protein Domains
C2H2-type

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P10071-F1-model_v2 AlphaFold P10071 1-1580 view protein structure

Promoters
RGD ID:6805718
Promoter ID:HG_KWN:57147
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:HeLa_S3
Transcripts:ENST00000395925,   OTTHUMT00000250806,   OTTHUMT00000338490,   UC003THU.2
Position:
Human AssemblyChrPosition (strand)Source
Build 36742,243,076 - 42,243,576 (-)MPROMDB

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:4319 AgrOrtholog
COSMIC GLI3 COSMIC
Ensembl Genes ENSG00000106571 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Ensembl Transcript ENST00000395925 ENTREZGENE
  ENST00000395925.8 UniProtKB/Swiss-Prot
  ENST00000428534.2 UniProtKB/TrEMBL
  ENST00000437480.1 UniProtKB/TrEMBL
  ENST00000479210 ENTREZGENE
  ENST00000479210.1 UniProtKB/TrEMBL
  ENST00000642432.1 UniProtKB/TrEMBL
  ENST00000643264.1 UniProtKB/TrEMBL
  ENST00000647255.1 UniProtKB/TrEMBL
  ENST00000677288.1 UniProtKB/TrEMBL
  ENST00000677605 ENTREZGENE
  ENST00000677605.1 UniProtKB/Swiss-Prot
  ENST00000678429 ENTREZGENE
  ENST00000678429.1 UniProtKB/Swiss-Prot
  ENST00000678978.1 UniProtKB/TrEMBL
Gene3D-CATH Classic Zinc Finger UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
GTEx ENSG00000106571 GTEx
HGNC ID HGNC:4319 ENTREZGENE
Human Proteome Map GLI3 Human Proteome Map
InterPro GLI-like UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Znf_C2H2_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Znf_C2H2_type UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report hsa:2737 UniProtKB/Swiss-Prot
NCBI Gene 2737 ENTREZGENE
OMIM 165240 OMIM
PANTHER PTHR45718 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  PTHR45718:SF5 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam zf-C2H2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB PA28722 PharmGKB
PROSITE ZINC_FINGER_C2H2_1 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  ZINC_FINGER_C2H2_2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
SMART ZnF_C2H2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP SSF57667 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt A0A2R8Y6R3_HUMAN UniProtKB/TrEMBL
  A0A2R8Y723_HUMAN UniProtKB/TrEMBL
  A0A2R8YGX0 ENTREZGENE, UniProtKB/TrEMBL
  A0A7I2V3B8_HUMAN UniProtKB/TrEMBL
  A0A7I2V4V2_HUMAN UniProtKB/TrEMBL
  A0A7I2V4X9 ENTREZGENE, UniProtKB/TrEMBL
  A4D1W1 ENTREZGENE
  F8WEV4_HUMAN UniProtKB/TrEMBL
  GLI3_HUMAN UniProtKB/Swiss-Prot
  O75219 ENTREZGENE
  P10071 ENTREZGENE
  Q17RW4 ENTREZGENE
  Q75MT0 ENTREZGENE
  Q75MU9 ENTREZGENE
  Q9UDT5 ENTREZGENE
  Q9UJ39 ENTREZGENE
UniProt Secondary A4D1W1 UniProtKB/Swiss-Prot
  O75219 UniProtKB/Swiss-Prot
  Q17RW4 UniProtKB/Swiss-Prot
  Q75MT0 UniProtKB/Swiss-Prot
  Q75MU9 UniProtKB/Swiss-Prot
  Q9UDT5 UniProtKB/Swiss-Prot
  Q9UJ39 UniProtKB/Swiss-Prot